PART I: FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

TRINITY CAPITAL INC.

Consolidated Statements of Assets and Liabilities

(In thousands, except share and per share data)

June 30,

December 31,

2021

2020

(Unaudited)

ASSETS




Investments at fair value:




Control investments (cost of $62,363 and $57,072, respectively)

$
41,938

$
48,730
Affiliate investments (cost of $13,001 and $20,653, respectively)

11,795

27,650
Non-control / Non-affiliate investments (cost of $499,191 and $420,611, respectively)

543,963

417,271
Total investments (cost of $574,555 and $498,336, respectively)

597,696

493,651
Cash and cash equivalents

19,124

44,656
Restricted cash

15,341

16,445
Interest receivable

4,065

3,468
Prepaid expenses

1,298

744
Other assets

3,923

744
Total assets

$
641,447

$
559,708




LIABILITIES




Credit Facility, net of $1,053 and $2,107, respectively, of unamortized deferred financing costs

$
68,947

$
132,893
2025 Notes, net of $4,168, and $4,697, respectively, of unamortized deferred financing costs

120,832

120,303
Convertible Notes, net of $2,786, and $3,448, respectively, of unamortized deferred financing costs and discount

47,214

46,552
Distribution payable

7,682

4,947
Security deposits

8,812

7,874
Accounts payable, accrued expenses and other liabilities

8,240

8,391
Total liabilities

261,727

320,960




Commitments and contingencies (Note 6)








NET ASSETS




Common stock, $0.001 par value per share (200,000,000 authorized, 26,491,274 and 18,321,274 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively)

26

18
Paid-in capital in excess of par

369,379

263,366
Distributable earnings/(accumulated loss)

10,315

(24,636)
Total net assets

379,720

238,748
Total liabilities and net assets

$
641,447

$
559,708
NET ASSET VALUE PER SHARE

$
14.33

$
13.03


	June 30,		December 31,
	2022		2021
	(Unaudited)
ASSETS
Investments at fair value:
Control investments (cost of $36,704 and $38,994, respectively)	$	24,788	$	32,214
Affiliate investments (cost of $29,604 and $41,609, respectively)		23,837		32,192
Non-control / Non-affiliate investments (cost of $1,000,290 and $717,253, respectively)		1,002,449		809,064
Total investments (cost of $1,066,598 and $797,856, respectively)		1,051,074		873,470
Cash and cash equivalents		13,226		31,685
Restricted cash		—		15,057
Interest receivable		8,600		5,551
Deferred credit facility costs		2,848		2,308
Other assets		14,432		9,047
Total assets	$	1,090,180	$	937,118

LIABILITIES
KeyBank Credit Facility	$	220,000	$	81,000
August 2026 Notes, net of $2,391 and $2,679, respectively, of unamortized deferred financing costs		122,609		122,321
2025 Notes, net of $3,021 and $3,616, respectively, of unamortized deferred financing costs		121,979		121,384
December 2026 Notes, net of $1,661 and $1,842, respectively, of unamortized deferred financing costs		73,339		73,158
Convertible Notes, net of $2,201 and $2,515, respectively, of unamortized deferred financing costs and discount		47,799		47,485
Credit Suisse Credit Facility		—		10,000
Distribution payable		17,873		9,803
Security deposits		12,515		10,840
Accounts payable, accrued expenses and other liabilities		15,724		14,594
Total liabilities		631,838		490,585

Commitments and contingencies (Note 6)

NET ASSETS
Common stock, $0.001 par value per share (200,000,000 authorized, 31,355,832 and 27,229,541 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively)		31		27
Paid-in capital in excess of par		430,464		368,609
Distributable earnings/(accumulated loss)		27,847		77,897
Total net assets		458,342		446,533
Total liabilities and net assets	$	1,090,180	$	937,118
NET ASSET VALUE PER SHARE	$	14.62	$	16.40

See accompanying notes to consolidated financial statements.

3

TRINITY CAPITAL INC.

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)


	Three Months Ended				Six Months Ended
	June 30, 2022		June 30, 2021		June 30, 2022		June 30, 2021
INVESTMENT INCOME:
Interest income:
Control investments	$	1,365	$	1,266	$	2,738	$	2,572
Affiliate investments		433		443		862		882
Non-Control / Non-Affiliate investments		30,713		16,405		57,317		31,004
Total interest income		32,511		18,114		60,917		34,458
Fee income:
Non-Control / Non-Affiliate investments		947		1,362		4,386		2,337
Total fee income		947		1,362		4,386		2,337
Total investment income		33,458		19,476		65,303		36,795

EXPENSES:
Interest expense and other debt financing costs		7,761		4,425		14,559		9,041
Compensation and benefits		6,877		3,370		13,331		7,366
Professional fees		891		570		1,723		1,216
General and administrative		1,558		1,031		3,035		1,780
Total expenses		17,087		9,396		32,648		19,403

NET INVESTMENT INCOME (LOSS) BEFORE TAXES		16,371		10,080		32,655		17,392

Excise tax expense		657		—		1,331		58

NET INVESTMENT INCOME		15,714		10,080		31,324		17,334

NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:
Control investments		(228)		—		(228)		—
Affiliate investments		(9,633)		1,491		(9,633)		—
Non-Control / Non-Affiliate investments		244		504		52,888		4,590
Net realized gain/(loss) from investments		(9,617)		1,995		43,027		4,590

NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:
Control investments		(804)		(4,530)		(5,136)		(12,084)
Affiliate investments		6,913		(1,892)		3,650		(8,204)
Non-Control / Non-Affiliate investments		(19,929)		19,052		(89,652)		48,394
Net change in unrealized appreciation/(depreciation) from investments		(13,820)		12,630		(91,138)		28,106

NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	(7,723)	$	24,705	$	(16,787)	$	50,030

NET INVESTMENT INCOME PER SHARE - BASIC	$	0.51	$	0.38	$	1.07	$	0.69
NET INVESTMENT INCOME PER SHARE - DILUTED⁽¹⁾	$	0.48		0.38	$	1.02	$	0.69

NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC & DILUTED	$	(0.25)	$	0.93	$	(0.58)	$	2.00

WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC & DILUTED		30,955,022		26,478,747		29,188,790		25,024,925

Three Months Ended

Six Months Ended


June 30, 2021

June 30, 2020

June 30, 2021

June 30, 2020
INVESTMENT INCOME:








Interest income:








Control investments

$
1,266

$
832

$
2,572

$
1,627
Affiliate investments

443

604

882

733
Non-Control / Non-Affiliate investments

16,405

12,004

31,004

21,894
Total interest income

18,114

13,440

34,458

24,254
Fee income:

Non-Control / Non-Affiliate investments

1,362

407

2,337

1,841
Total fee income

1,362

407

2,337

1,841
Total investment income

19,476

13,847

36,795

26,095








EXPENSES:








Interest expense and other debt financing costs

4,425

4,281

9,041

8,539
Compensation and benefits

3,370

1,690

7,366

3,079
Professional fees

570

700

1,216

1,180
General and administrative

1,031

415

1,838

827
Total expenses

9,396

7,086

19,461

13,625








NET INVESTMENT INCOME

10,080

6,761

17,334

12,470








NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:








Control investments

—

—

—

—
Affiliate investments

1,491

—

—

—
Non-Control / Non-Affiliate investments

504

(2,002)

4,590

(2,884)
Net realized gain/(loss) from investments

1,995

(2,002)

4,590

(2,884)








NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:








Control investments

(4,530)

1,342

(12,084)

(8,234)
Affiliate investments

(1,892)

(969)

(8,204)

(2,136)
Non-Control / Non-Affiliate investments

19,052

1,750

48,394

(11,799)
Net change in unrealized appreciation/(depreciation) from investments

12,630

2,123

28,106

(22,169)








NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS BEFORE FORMATION COSTS

24,705

6,882

50,030

(12,583)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds

—

—

—

(15,586)
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$
24,705

$
6,882

$
50,030

$
(28,169)








NET INVESTMENT INCOME PER SHARE - BASIC AND DILUTED

$
0.38

$
0.37

$
0.69

$
0.69








NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC AND DILUTED

$
0.93

$
0.38

$
2.00

$
(1.57)








WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED

26,478,747

18,074,929

25,024,925

17,959,728

(1)	Diluted net investment income per share for the three and six months ended June 30, 2022 has been calculated based on diluted weighted average shares of 34,331,597 and 32,565,365.

See accompanying notes to consolidated financial statements.

4

TRINITY CAPITAL INC.

Consolidated Statements of Changes in Net Assets

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended June 30, 2022:


						Distributable
						Earnings /
	Common Stock			Paid In Capital		(Accumulated		Total
	Shares	Par Value		in Excess of Par		Loss)		Net Assets
Balance as of March 31, 2022	27,982,842	$	28	$	370,570	$	53,443	$	424,041
Issuance of common stock pursuant to distribution reinvestment plan	30,800		—		588		—		588
Stock based compensation	—		—		1,767		—		1,767
Issuance of restricted stock awards	13,540		—		—		—		—
Issuance of common stock, net of issuance costs	3,344,214		3		57,911		—		57,914
Retired and forfeited shares of restricted stock	(15,564)		—		(372)		—		(372)
Distributions to stockholders	—		—		—		(17,873)		(17,873)
Net increase/(decrease) in net assets resulting from operations	—		—		—		(7,723)		(7,723)
Balance as of June 30, 2022	31,355,832	$	31	$	430,464	$	27,847	$	458,342

Three Months Ended June 30, 2021:


						Distributable									Distributable
						Earnings /							Paid In Capital		Earnings /
	Common Stock			Paid In Capital		(Accumulated		Total		Common Stock			in Excess of		(Accumulated		Total
	Shares	Par Value		in Excess of Par		Loss)		Net Assets		Shares	Par Value		Par Value		Loss)		Net Assets
Balance as of March 31, 2021	26,415,275	$	26	$	368,245	$	(6,708)	$	361,563	26,415,275	$	26	$	368,245	$	(6,708)	$	361,563
Issuance of common stock pursuant to distribution reinvestment plan	75,999		—		1,134		—		1,134	75,999		—		1,134		—		1,134
Distributions to stockholders	—		—		—		(7,682)		(7,682)	—		—		—		(7,682)		(7,682)
Net increase/(decrease) in net assets resulting from operations:
Net investment income	—		—		—		10,080		10,080
Net realized gain/(loss) from investments	—		—		—		1,995		1,995
Net unrealized appreciation/(depreciation) from investments	—		—		—		12,630		12,630
Net increase/(decrease) in net assets resulting from operations										—		—		—		24,705		24,705
Balance as of June 30, 2021	26,491,274	$	26	$	369,379	$	10,315	$	379,720	26,491,274	$	26	$	369,379	$	10,315	$	379,720

~~Three Month Ended June 30, 2020:~~

Distributable


Paid In Capital

Earnings /

Common Stock

in Excess of

(Accumulated

Total

Shares

Par Value

Par Value

Loss)

Net Assets
Balance as of March 31, 2020

18,049,860

$
18

$
260,120

$
(35,575)

$
224,563
Issuance of common stock, net of issuance costs

—

—

81

—

81
Issuance of common stock pursuant to distribution reinvestment plan

87,740

—

1,091

—

1,091
Distributions to stockholders

—

—

—

(3,971)

(3,971)
Net increase/(decrease) in net assets resulting from operations:









Net investment income/(loss)

—

—

—

6,761

6,761
Net realized gain/(loss) from investments

—

—

—

(2,002)

(2,002)
Net unrealized appreciation/(depreciation) from investments

—

—

—

2,123

2,123
Balance as of June 30, 2020

18,137,600

$
18

$
261,292

$
(32,664)

$
228,646

5

Six Months Ended June 30, ~~2021:~~2022:

Distributable


Paid In Capital

Earnings /

Common Stock

in Excess of

(Accumulated

Total

Shares

Par Value

Par Value

Loss)

Net Assets
Balance as of December 31, 2020

18,321,274

$
18

$
263,366

$
(24,636)

$
238,748
Impact of adoption of ASU 2020-06

—

—

(462)

—

(462)
Issuance of common stock in initial public offering, net of issuance costs

8,006,291

8

104,200

—

104,208
Issuance of common stock pursuant to distribution reinvestment plan

163,709

—

2,275

—

2,275
Distributions to stockholders

—

—

—

(15,079)

(15,079)
Net increase/(decrease) in net assets resulting from operations:









Net investment income/(loss)

—

—

—

17,334

17,334
Net realized gain/(loss) from investments

—

—

—

4,590

4,590
Net unrealized appreciation/(depreciation) from investments

—

—

—

28,106

28,106
Balance as of June 30, 2021

26,491,274

$
26

$
369,379

$
10,315

$
379,720


						Distributable
				Paid In Capital		Earnings /
	Common Stock			in Excess of		(Accumulated		Total
	Shares	Par Value		Par Value		Loss)		Net Assets
Balance as of December 31, 2021	27,229,541	$	27	$	368,609	$	77,897	$	446,533
Issuance of common stock pursuant to distribution reinvestment plan	90,334		—		1,642		—		1,642
Stock based compensation	—		—		2,677		—		2,677
Issuance of restricted stock	718,263		1		—		—		1
Issuance of common stock, net of issuance costs	3,344,214		3		57,911		—		57,914
Retired and forfeited shares of restricted stock	(26,520)		—		(375)		—		(375)
Distributions to stockholders	—		—		—		(33,263)		(33,263)
Net increase/(decrease) in net assets resulting from operations	—		—		—		(16,787)		(16,787)
Balance as of June 30, 2022	31,355,832	$	31	$	430,464	$	27,847	$	458,342

Six Months Ended June 30, ~~2020:~~2021:

Distributable


Paid In Capital

Earnings /

Common Stock

in Excess of

(Accumulated

Total

Shares

Par Value

Par Value

Loss)

Net Assets
Balance as of December 31, 2019

10

$
—

$
—

$
(524)

$
(524)
Issuance of shares related to Formation Transaction ⁽¹⁾

9,716,517

10

145,738

—

145,748
Issuance of common stock, net of issuance costs

8,333,333

8

114,463

—

114,471
Issuance of common stock pursuant to distribution reinvestment plan

87,740

—

1,091

—

1,091
Distributions to stockholders

—

—

—

(3,971)

(3,971)
Net increase/(decrease) in net assets resulting from operations:









Net investment income/(loss)

—

—

—

12,470

12,470
Net realized gain/(loss) from investments

—

—

—

(2,884)

(2,884)
Net unrealized appreciation/(depreciation) from investments

—

—

—

(22,169)

(22,169)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds

—

—

—

(15,586)

(15,586)
Balance as of June 30, 2020

18,137,600

$
18

$
261,292

$
(32,664)

$
228,646

~~(1)~~

~~See “Note 1 - Organization and Basis of Presentation”~~


						Distributable
				Paid In Capital		Earnings /
	Common Stock			in Excess of		(Accumulated		Total
	Shares	Par Value		Par Value		Loss)		Net Assets
Balance as of December 31, 2020	18,321,274	$	18	$	263,366	$	(24,636)	$	238,748
Impact of adoption of ASU 2020-06	—		—		(462)		—		(462)
Issuance of common stock in initial public offering, net of issuance costs	8,006,291		8		104,200		—		104,208
Issuance of common stock pursuant to distribution reinvestment plan	163,709		—		2,275		—		2,275
Distributions to stockholders	—		—		—		(15,079)		(15,079)
Net increase/(decrease) in net assets resulting from operations	—		—		—		50,030		50,030
Balance as of June 30, 2021	26,491,274	$	26	$	369,379	$	10,315	$	379,720

See accompanying notes to consolidated financial statements.

6

TRINITY CAPITAL INC.

Consolidated ~~Statement~~Statements of Cash Flows

(In thousands)

(Unaudited)




	Six Months Ended				Six Months Ended		Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2022		June 30, 2021
Cash flows provided by/(used in) operating activities:
Net increase/(decrease) in net assets resulting from operations	$	50,030	$	(28,169)	$	(16,787)	$	50,030
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by/(used in) operating activities:
Purchase of investments, net of deferred fees		(208,232)		(101,503)		(413,615)		(208,232)
Proceeds from sales and paydowns of investments		146,879		79,731		203,416		146,879
Net change in unrealized appreciation/(depreciation) from investments, net of third party participation		(27,823)		22,168		91,138		(27,823)
Net realized gain/(loss) from investments		(4,590)		2,884		(43,027)		(4,590)
Accretion of original issue discounts and end of term payments on investments		(10,279)		(5,049)		(15,516)		(10,279)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds		—		15,586
Amortization of deferred financing costs		1,837		1,416		1,653		—
Stock-based compensation						2,677		1,837
Change in operating assets and liabilities
(Increase)/Decrease in interest receivable		(597)		(2,069)		(3,049)		(597)
(Increase)/Decrease in prepaid expenses		(554)		(118)
(Increase)/Decrease in receivable from sale of investments						(3,086)		(554)
(Increase)/Decrease in other assets		(2,357)		(419)		(2,323)		(2,357)
Increase/(Decrease) in security deposits		938		1,810		1,675		938
Increase/(Decrease) in accounts payable, accrued expenses and other liabilities		(151)		2,643		1,130		(151)
Increase/(Decrease) in due to related party		—		(1,059)
Net cash provided by/(used in) operating activities		(54,899)		(12,148)		(195,714)		(54,899)

Cash flows provided by/(used in) investing activities:
Formation Transactions of Legacy Funds, net of cash acquired ⁽¹⁾		—		(89,515)
Acquisition of Trinity Capital Holdings		—		(2,211)
Acquisition of fixed assets		(822)		(34)
Disposal/(Acquisition) of fixed assets						24		(822)
Net cash provided by/(used in) investing activities		(822)		(91,760)		24		(822)

Cash flows provided by/(used in) financing activities
Issuance of common stock		112,088		125,000		60,417		112,088
Common stock issuance costs		(7,880)		(10,529)		(2,503)		(7,880)
Retirement of employee shares						(375)		—
Cash distributions paid		(10,069)		(2,880)		(23,550)		(10,069)
Proceeds from issuance of 2025 Notes		—		125,000
Financing costs paid related to 2025 Notes		(54)		(5,542)
Proceeds under Credit Facility		25,000		—
Repayments under Credit Facility		(90,000)		(85,000)
Financing costs paid related to credit facility		—		(3,740)
Debt issuance costs						(815)		(54)
Borrowings under Credit Facilities						184,000		25,000
Repayments under Credit Facilities						(55,000)		(90,000)
Net cash provided by/(used in) financing activities		29,085		142,309		162,174		29,085

Net increase/(decrease) in cash, cash equivalents and restricted cash		(26,636)		38,401		(33,516)		(26,636)
Cash, cash equivalents and restricted cash at beginning of period		61,101		—		46,742		61,101
Cash, cash equivalents and restricted cash at end of period	$	34,465	$	38,401	$	13,226	$	34,465


	For the Six Months Ended
	June 30, 2021		June 30, 2020
Supplemental and non-cash investing and financing activities:
Cash paid for interest	$	6,829	$	6,455
Shares issued to Trinity Capital Holdings ⁽¹⁾	$	—	$	8,000
Assumption of severance liability ⁽¹⁾	$	—	$	3,508
Shares issued to the Legacy Investors as part of the Formation Transactions ⁽¹⁾	$	—	$	137,748
Accrued but unpaid distributions	$	7,682	$	—
Value of shares issued in connection with the distribution reinvestment plan	$	2,275	$	1,091




	Six Months Ended		Six Months Ended
	June 30, 2022		June 30, 2021
Supplemental and non-cash investing and financing activities:
Cash paid for interest	$	12,279	$	6,829
Accrued but unpaid distributions	$	17,873	$	7,682
Distributions reinvested	$	1,642	$	2,275
Income tax, including excise tax, paid	$	310	$	79
Change to investments and net assets related to adoption of ASU 2020-06	$	—	$	(462)

7

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Statements of Assets and Liabilities that sum to the total of the same such amounts on the Consolidated Statement of Cash Flows:

June 30,

June 30

2021

2020
Cash and cash equivalents

$
19,124

$
21,849
Restricted cash

15,341

16,552
Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows

$
34,465

$
38,401

~~(1)~~

~~See “Note 1 - Organization and Basis of Presentation”~~


	June 30, 2022		June 30, 2021
Cash and cash equivalents	$	13,226	$	19,124
Restricted cash		—		15,341
Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows	$	13,226	$	34,465

See accompanying notes to consolidated financial statements.

8

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities
Debt Securities- United States

Administrative and Support and Waste Management and Remediation ⁽²⁾
Accommodation and Food Services ⁽⁷⁾											Accommodation and Food Services ⁽⁷⁾
BlueGround US, Inc.												Equipment Financing	June 6, 2022	January 1, 2026	Fixed interest rate 9.6%; EOT 8.0%	$	3,905	$	3,915	$	3,915

Sub-total: Accommodation and Food Services (0.4%)*											Sub-total: Accommodation and Food Services (0.4%)*					$	3,905	$	3,915	$	3,915

Administrative and Support and Waste Management and Remediation ⁽⁷⁾											Administrative and Support and Waste Management and Remediation ⁽⁷⁾
Qwick, Inc.												Secured Loan	December 31, 2021	January 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.0%; EOT 5.0% ⁽⁸⁾	$	5,000	$	4,966	$	5,169

RTS Holding, Inc.												Secured Loan	December 31, 2021	January 1, 2027	Fixed interest rate 10.5%; EOT 3.0%	$	23,000	$	22,834	$	22,626

SeaOn Environmental, LLC	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.0%; EOT 12.0%	$	1,636	$	1,951	$	1,947		Equipment Financing⁽¹⁴⁾	June 16, 2022	June 1, 2026	Fixed interest rate 9.3%; EOT 11.0%	$	6,750	$	6,731	$	6,731

Sub-total: Administrative and Support and Waste Management and Remediation (0.5%)*					$	1,636	$	1,951	$	1,947
Sub-total: Administrative and Support and Waste Management and Remediation (3.2%)*											Sub-total: Administrative and Support and Waste Management and Remediation (3.2%)*					$	34,750	$	34,531	$	34,526

Agriculture, Forestry, Fishing and Hunting ⁽²⁾
Agriculture, Forestry, Fishing and Hunting ⁽⁷⁾
Bowery Farming, Inc.	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.5%; EOT 8.5%	$	1,899	$	2,198	$	2,136		Secured Loan⁽¹⁴⁾	September 10, 2021	January 1, 2026	Variable interest rate LIBOR + 11.0% or Floor rate 10.1% ⁽⁸⁾	$	10,000	$	9,396	$	9,294

Robotany, Inc.												Equipment Financing⁽¹⁴⁾	January 16, 2020	January 1, 2024	Fixed interest rate 7.6%; EOT 17.3%	$	906	$	1,289	$	1,271

Sub-total: Agriculture, Forestry, Fishing and Hunting (1.0%)*											Sub-total: Agriculture, Forestry, Fishing and Hunting (1.0%)*					$	10,906	$	10,685	$	10,565

Arts, Entertainment, and Recreation ⁽⁷⁾
SI Tickets, Inc.												Secured Loan	May 11, 2022	September 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾	$	3,000	$	2,924	$	2,924

Sub-total: Arts, Entertainment, and Recreation (0.3%)*																$	3,000	$	2,924	$	2,924

Construction ⁽⁷⁾
Dandelion Energy, Inc.												Equipment Financing	March 17, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 12.5%	$	264	$	312	$	308
	Equipment Financing	January 16, 2020	February 1, 2023	Fixed interest rate 8.7%; EOT 8.5%		1,904		2,157		2,162		Equipment Financing	October 27, 2020	November 1, 2024	Fixed interest rate 9.2%; EOT 12.5%		354		400		393
	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 8.7%; EOT 8.5%		2,451		2,719		2,793		Equipment Financing	November 19, 2020	December 1, 2024	Fixed interest rate 9.1%; EOT 12.5%		444		498		488
	Equipment Financing	December 22, 2020	January 1, 2024	Fixed interest rate 7.5%; EOT 8.5%		8,449		8,636		9,518		Equipment Financing	December 29, 2020	January 1, 2025	Fixed interest rate 9.2%; EOT 12.5%		524		583		572
Total Bowery Farming, Inc.						14,703		15,710		16,609
												Equipment Financing	March 25, 2021	April 1, 2025	Fixed interest rate 9.1%; EOT 12.5%		1,070		1,166		1,146
Robotany, Inc.	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.6%; EOT 22.0%	$	1,456	$	1,624	$	1,612

Sub-total: Agriculture, Forestry, Fishing and Hunting (4.8%)*					$	16,159	$	17,334	$	18,221

Construction ⁽²⁾
Dandelion Energy, Inc.	Equipment Financing	March 17, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 12.5%	$	397	$	419	$	422
	Equipment Financing	October 27, 2020	November 1, 2024	Fixed interest rate 9.2%; EOT 12.5%		485		506		506		Equipment Financing	December 1, 2021	January 1, 2026	Fixed interest rate 8.8%; EOT 12.5%		1,211		1,254		1,241
	Equipment Financing ⁽¹⁴⁾	November 19, 2020	December 1, 2024	Fixed interest rate 9.1%; EOT 12.5%		485		508		509		Equipment Financing	April 8, 2022	May 1, 2026	Fixed interest rate 8.9%; EOT 12.5%		2,159		2,178		2,178
	Equipment Financing	December 29, 2020	January 1, 2025	Fixed interest rate 9.2%; EOT 12.5%		702		724		725		Equipment Financing	May 27, 2022	June 1, 2026	Fixed interest rate 9.2%; EOT 12.5%		989		990		990
	Equipment Financing ⁽¹⁴⁾	March 25, 2021	April 1, 2025	Fixed interest rate 9.1%; EOT 12.5%		1,073		1,096		1,101		Equipment Financing	June 13, 2022	June 1, 2026	Fixed interest rate 9.5%; EOT 12.5%		1,500		1,497		1,497
Total Dandelion Energy, Inc.						3,142		3,253		3,263							8,515		8,878		8,813

Project Frog, Inc. ⁽¹⁹⁾	Secured Loan	April 30, 2020	May 1, 2023	Fixed interest rate 12.0%	$	4,128	$	4,071	$	3,763
Sub-total: Construction (0.8%)*																$	8,515	$	8,878	$	8,813

Sub-total: Construction (1.9%)*					$	7,270	$	7,324	$	7,026
Educational Services ⁽⁷⁾
Medical Sales Training Holding Company												Secured Loan⁽¹⁴⁾	March 18, 2021	April 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾	$	6,000	$	6,039	$	5,999
												Secured Loan⁽¹⁴⁾	July 21, 2021	August 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾		2,000		1,998		1,987
Educational Services ⁽²⁾
Medical Sales Training Holding Company	Secured Loan	March 18, 2021	April 1, 2025	Variable interest rate PRIME + 8.8% or Floor rate 12.0%; EOT 12.5% ⁽¹¹⁾	$	6,000	$	5,959	$	5,998
Total Medical Sales Training Holding Company																	8,000		8,037		7,986

Yellowbrick Learning, Inc.	Secured Loan	February 1, 2021	September 1, 2025	Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽¹¹⁾	$	7,500	$	7,514	$	7,581		Secured Loan⁽¹⁴⁾	February 1, 2021	September 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾	$	7,500	$	7,640	$	6,822
												Secured Loan⁽¹⁴⁾	August 10, 2021	March 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾		2,500		2,524		2,194
Sub-total: Educational Services (3.6%)*					$	13,500	$	13,473	$	13,579
Total Yellowbrick Learning, Inc.																	10,000		10,164		9,016

Sub-total: Educational Services (1.6%)*																$	18,000	$	18,201	$	17,002

9

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities- United States, Continued

Finance and Insurance ⁽⁷⁾
BoardRE, Inc.	Secured Loan	October 15, 2021	June 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾	$	5,000	$	5,225	$	4,945

DailyPay, Inc.	Secured Loan	September 30, 2020	November 1, 2024	Variable interest rate Prime + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾	$	16,651	$	17,238	$	17,210
	Secured Loan	December 30, 2020	January 1, 2025	Variable interest rate Prime + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾		4,408		4,546		4,524
Total DailyPay, Inc.						21,059		21,784		21,734

Petal Card, Inc.	Secured Loan	January 16, 2020	October 1, 2024	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾	$	10,000	$	10,183	$	10,208
	Secured Loan	August 6, 2021	October 1, 2024	Variable interest rate Prime + 4.3% or Floor rate 11.5% ⁽⁸⁾		7,000		6,957		7,020
	Secured Loan ^(12)(14)	January 28, 2021	January 1, 2024	Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 0.0% ⁽⁸⁾		17,748		18,815		18,973
Total Petal Card, Inc.						34,748		35,955		36,201

Stilt, Inc.	Secured Loan ^(12)(14)	February 10, 2022	August 1, 2024	Variable interest rate SOFR 30 Day Forward + 1.0% or Floor rate 11.0% ⁽⁸⁾	$	3,824	$	4,022	$	3,823

Sub-total: Finance and Insurance (6.1%)*					$	64,631	$	66,986	$	66,703

Health Care and Social Assistance ⁽⁷⁾
FemTec Health, Inc.	Secured Loan	December 1, 2021	February 1, 2026	Fixed interest rate 11.0%; EOT 7.5%	$	10,000	$	10,747	$	9,799
	Secured Loan	July 23, 2021	September 1, 2022	Fixed interest rate 11.0%		2,151		2,150		2,162
	Secured Loan	September 29, 2021	April 1, 2026	Fixed interest rate 11.0%; EOT 7.5%		3,000		3,053		2,921
Total FemTec Health, Inc. ⁽²⁰⁾						15,151		15,950		14,882

Lark Technologies, Inc.	Secured Loan	September 30, 2020	April 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	4,766	$	4,772	$	4,863
	Secured Loan	June 30, 2021	January 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		5,000		4,888		4,992
Total Lark Technologies, Inc.						9,766		9,660		9,855

WorkWell Prevention & Care Inc.	Secured Loan^(14)(18)	January 16, 2020	July 1, 2024	Fixed interest rate 8.0%; EOT 10.0%	$	3,370	$	3,659	$	834
	Secured Loan^(14)(18)	January 16, 2020	July 1, 2024	Fixed interest rate 8.0%		700		718		173
Total WorkWell Prevention & Care Inc. ⁽²⁰⁾						4,070		4,377		1,007

Sub-total: Health Care and Social Assistance (2.4%)*					$	28,987	$	29,987	$	25,744

Information ⁽⁷⁾
Rigetti & Co, Inc.	Secured Loan	March 10, 2021	April 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾	$	12,000	$	11,989	$	12,185
	Secured Loan	May 18, 2021	June 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾		8,000		7,962		8,101
	Secured Loan	November 10, 2021	December 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾		7,000		6,907		7,050
	Secured Loan	January 27, 2022	February 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾		5,000		4,996		5,106
Total Rigetti & Co, Inc.						32,000		31,854		32,442

Stratifyd, Inc.	Secured Loan	September 3, 2021	January 1, 2026	Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾	$	6,000	$	5,994	$	6,137

Whip Networks, Inc.	Secured Loan	June 14, 2021	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾	$	5,000	$	5,028	$	4,971
	Secured Loan	September 10, 2021	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾		1,000		1,003		991
	Secured Loan	February 3, 2022	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾		4,000		3,988		3,939
Total Whip Networks, Inc.						10,000		10,019		9,901

Zuum Transportation, Inc.	Secured Loan	December 17, 2021	January 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾	$	5,000	$	4,995	$	4,959

Sub-total: Information (4.9%)*					$	53,000	$	52,862	$	53,439

10

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities- United States, Continued

Information, Continued ⁽⁷⁾

Management of Companies and Enterprises ⁽⁷⁾
Bestow, Inc.	Secured Loan	April 25, 2022	May 1, 2027	Variable interest rate Prime + 6.5% or Floor rate 10.0%; EOT 1.5% ⁽⁸⁾	$	25,000	$	24,900	$	24,900
	Secured Loan	May 12, 2022	June 1, 2027	Variable interest rate Prime + 6.5% or Floor rate 10.0%; EOT 1.5% ⁽⁸⁾		15,000		14,933		14,933
Total Bestow, Inc.						40,000		39,833		39,833

Exer Holdings, LLC	Secured Loan	November 19, 2021	December 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾	$	22,500	$	22,361	$	21,859
	Secured Loan	February 18, 2022	December 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾		7,500		7,436		7,282
Total Exer Holdings, LLC						30,000		29,797		29,141

Sub-total: Management of Companies and Enterprises (6.3%)*					$	70,000	$	69,630	$	68,974

Manufacturing ⁽⁷⁾
3DEO, Inc.	Equipment Financing	February 23, 2022	March 1, 2025	Fixed interest rate 9.6%; EOT 9.0%	$	3,172	$	3,208	$	3,001
	Equipment Financing	April 12, 2022	May 1, 2025	Fixed interest rate 9.4%; EOT 9.0%		1,493		1,497		1,497
Total 3DEO, Inc.						4,665		4,705		4,498


Athletic Brewing Company, LLC	Equipment Financing	December 7, 2021	January 1, 2026	Fixed interest rate 11.0%; EOT 7.0%	$	19,944	$	20,111	$	19,978
	Equipment Financing	March 16, 2022	April 1, 2026	Fixed interest rate 11.1%; EOT 7.0%		4,976		4,987		4,969
Total Athletic Brewing Company, LLC						24,920		25,098		24,947

Bolb, Inc.	Equipment Financing	October 12, 2021	November 1, 2024	Fixed interest rate 10.3%; EOT 6.0%	$	1,370	$	1,403	$	1,401

Cepton Technologies, Inc.	Secured Loan	January 4, 2022	February 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾	$	10,000	$	9,855	$	10,026

Daring Foods, Inc.	Equipment Financing	April 8, 2021	May 1, 2024	Fixed interest rate 9.6%; EOT 7.5%	$	322	$	342	$	342
	Equipment Financing	July 7, 2021	August 1, 2024	Fixed interest rate 9.5%; EOT 7.5%		1,582		1,651		1,641
	Equipment Financing	August 17, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 7.5%		783		812		811
	Equipment Financing	August 31, 2021	September 1, 2024	Fixed interest rate 10.0%; EOT 7.5%		455		471		470
	Equipment Financing	November 1, 2021	December 1, 2024	Fixed interest rate 9.4%; EOT 7.5%		877		896		894
	Equipment Financing	March 8, 2022	April 1, 2025	Fixed interest rate 9.5%; EOT 7.5%		2,107		2,111		2,111
	Equipment Financing	April 29, 2022	May 1, 2025	Fixed interest rate 10.2%; EOT 7.5%		948		942		942
	Equipment Financing	June 1, 2022	July 1, 2025	Fixed interest rate 10.1%; EOT 7.5%		3,808		3,791		3,791
Total Daring Foods, Inc.						10,882		11,016		11,002

Deerfield Imaging Holdings, Inc.	Secured Loan⁽¹⁴⁾	April 14, 2022	May 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾	$	18,250	$	18,213	$	18,213

Eterneva, Inc.	Equipment Financing⁽¹⁴⁾	November 24, 2021	December 1, 2025	Fixed interest rate 10.6%; EOT 11.5%	$	486	$	502	$	493
	Equipment Financing⁽¹⁴⁾	March 16, 2022	April 1, 2026	Fixed interest rate 10.4%; EOT 11.5%		715		725		715
	Equipment Financing⁽¹⁴⁾	June 17, 2022	July 1, 2026	Fixed interest rate 16.2%; EOT 11.0%		1,898		1,897		1,897
Total Eterneva, Inc.						3,099		3,124		3,105

Footprint International Holding, Inc.	Secured Loan	February 18, 2022	March 1, 2027	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.0% ⁽⁸⁾	$	20,000	$	17,738	$	18,581
	Secured Loan	April 20, 2022	March 1, 2027	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.0% ⁽⁸⁾		20,000		17,612		17,612
Total Footprint International Holding, Inc.						40,000		35,350		36,193

11

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities- United States, Continued

Manufacturing, Continued ⁽⁷⁾
Hadrian, Inc.	Equipment Financing	March 2, 2022	October 1, 2025	Fixed interest rate 12.6%; EOT 0.0%	$	471	$	469	$	472
	Equipment Financing	May 6, 2022	December 1, 2025	Fixed interest rate 12.9%; EOT 0.0%		4,787		4,763		4,763
Total Hadrian, Inc.						5,258		5,232		5,235

Happiest Baby, Inc.	Equipment Financing	January 16, 2020	September 1, 2022	Fixed interest rate 8.4%; EOT 9.5%	$	98	$	259	$	255
	Equipment Financing	January 16, 2020	November 1, 2022	Fixed interest rate 8.6%; EOT 9.5%		145		263		261
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.6%; EOT 9.5%		191		295		293
	Equipment Financing	February 7, 2020	June 1, 2023	Fixed interest rate 8.2%; EOT 9.5%		363		466		462
	Equipment Financing	September 16, 2020	January 1, 2024	Fixed interest rate 8.4%; EOT 9.5%		663		764		759
	Equipment Financing	January 22, 2021	May 1, 2024	Fixed interest rate 8.4%; EOT 9.5%		597		662		657
Total Happiest Baby, Inc.						2,057		2,709		2,687

Hi-Power, LLC	Equipment Financing	September 30, 2021	April 1, 2025	Fixed interest rate 12.4%; EOT 1.0%	$	5,687	$	5,700	$	5,743

Mainspring Energy, Inc.	Secured Loan	March 18, 2022	October 1, 2026	Fixed interest rate 11.0%; EOT 3.8%	$	30,000	$	29,785	$	29,562

Miyoko's Kitchen	Equipment Financing	February 19, 2020	September 1, 2022	Fixed interest rate 8.8%; EOT 9.0%	$	62	$	138	$	136
	Equipment Financing	August 27, 2020	March 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		285		368		365
	Equipment Financing	February 5, 2021	September 1, 2023	Fixed interest rate 8.5%; EOT 9.0%		321		368		365
	Equipment Financing	June 25, 2021	January 1, 2024	Fixed interest rate 8.9%; EOT 9.0%		372		407		403
Total Miyoko's Kitchen						1,040		1,281		1,269

Molekule, Inc.	Equipment Financing	June 19, 2020	January 1, 2024	Fixed interest rate 8.8%; EOT 10.0%	$	1,346	$	1,570	$	1,559
	Equipment Financing	September 29, 2020	April 1, 2025	Fixed interest rate 12.3%; EOT 15.7%		323		377		386
	Equipment Financing	December 18, 2020	July 1, 2025	Fixed interest rate 11.9%; EOT 16.3%		550		629		640
	Equipment Financing	August 25, 2021	March 1, 2026	Fixed interest rate 11.3%; EOT 17.8%		434		481		478
Total Molekule, Inc.						2,653		3,057		3,063

Quip NYC, Inc.	Secured Loan	March 9, 2021	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾	$	17,500	$	17,425	$	17,879
	Secured Loan	February 10, 2022	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾		2,500		2,510		2,517
Total Quip NYC, Inc.						20,000		19,935		20,396

Space Perspective, Inc.	Secured Loan	March 3, 2022	July 1, 2026	Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 5.0% ⁽⁸⁾	$	5,000	$	4,881	$	5,057

The Fynder Group, Inc.	Equipment Financing	October 14, 2020	May 1, 2024	Fixed interest rate 9.1%; EOT 10.0%	$	393	$	433	$	428
	Equipment Financing	March 31, 2022	October 1, 2025	Fixed interest rate 9.3%; EOT 10.0%		2,594		2,569		2,562
Total The Fynder Group, Inc.						2,987		3,002		2,990

Vertical Communications, Inc.	Secured Loan⁽¹⁴⁾	August 23, 2021	March 1, 2026	Fixed interest rate 11.0%; EOT 23.8%	$	13,300	$	15,268	$	13,837

viaPhoton, Inc.	Secured Loan⁽¹⁴⁾	March 31, 2022	April 1, 2027	Variable interest rate Prime + 6.6% or Floor rate 9.9%; EOT 5.0% ⁽⁸⁾	$	15,000	$	14,941	$	15,362

VitaCup, Inc.	Secured Loan	June 23, 2021	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 2.5% ⁽⁸⁾	$	5,500	$	5,500	$	5,563

Sub-total: Manufacturing (20.2%)*					$	221,668	$	220,055	$	220,149

12

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities- United States, Continued											Debt Securities- United States, Continued

Debt Securities, Continued
Other Services (except Public Administration) ⁽⁷⁾
Rinse, Inc.												Secured Loan	May 10, 2022	June 1, 2027	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8% ⁽⁸⁾	$	5,000	$	4,895	$	4,895

Finance and Insurance ⁽²⁾
DailyPay, Inc.	Secured Loan	September 30, 2020	November 1, 2024	Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽¹¹⁾	$	20,000	$	20,055	$	20,294
Sub-total: Other Services (except Public Administration)(0.4%)*																$	5,000	$	4,895	$	4,895
	Secured Loan	December 30, 2020	January 1, 2025	Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽¹¹⁾		5,000		5,006		5,046
Total DailyPay, Inc.						25,000		25,061		25,340
Professional, Scientific, and Technical Services ⁽⁷⁾
AllSeated, Inc.												Secured Loan	February 28, 2022	March 1, 2027	Variable interest rate Prime + 7.0% or Floor rate 10.8%; EOT 3.5% ⁽⁸⁾	$	6,000	$	5,983	$	6,101

Petal Card, Inc.	Secured Loan	January 16, 2020	December 1, 2023	Fixed interest rate 11.0%; EOT 3.0%	$	10,000	$	10,078	$	10,004
BackBlaze, Inc.												Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 7.2%; EOT 11.5%	$	239	$	430	$	425
	Secured Loan ⁽¹⁶⁾	January 28, 2021	January 1, 2024	Variable interest rate PRIME + 7.3% or Floor rate 11.5% ⁽¹¹⁾		3,052		4,973		5,229		Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		41		63		62
						13,052		15,051		15,233		Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		362		516		509
												Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		80		108		106
Sub-total: Finance and Insurance (10.7%)*					$	38,052	$	40,112	$	40,573

Health Care and Social Assistance ⁽²⁾
Lark Technologies, Inc.	Secured Loan	September 30, 2020	April 1, 2025	Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽¹¹⁾	$	5,000	$	4,871	$	4,932
	Secured Loan	June 30, 2021	January 1, 2026	Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽¹¹⁾		5,000		4,743		4,742
Total Lark Technologies, Inc.						10,000		9,614		9,674

WorkWell Prevention & Care Inc.	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%; EOT 10.0%	$	3,370	$	3,632	$	3,597
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%		700		726		692
Total WorkWell Prevention & Care Inc. ⁽¹⁹⁾						4,070		4,358		4,289

Sub-total: Health Care and Social Assistance (3.7%)*					$	14,070	$	13,972	$	13,963

Information ⁽²⁾
Firefly Systems, Inc.	Equipment Financing	January 29, 2020	February 1, 2023	Fixed interest rate 9.0%; EOT 10.0%	$	3,065	$	3,370	$	3,336
	Equipment Financing	August 28, 2020	September 1, 2023	Fixed interest rate 9.0%; EOT 10.0%		2,663		2,852		2,842		Equipment Financing	January 16, 2020	September 1, 2023	Fixed interest rate 7.7%; EOT 11.5%		85		113		112
	Equipment Financing	September 18, 2020	October 1, 2023	Fixed interest rate 9.0%; EOT 10.0%		323		344		342		Equipment Financing	January 16, 2020	October 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		89		116		114
Total Firefly Systems, Inc.						6,051		6,566		6,520
												Equipment Financing	January 16, 2020	November 1, 2023	Fixed interest rate 7.2%; EOT 11.5%		308		394		389
Gobiquity, Inc.	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 7.5%; EOT 20.0%	$	181	$	301	$	296
												Equipment Financing	January 16, 2020	December 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		422		531		523
Rigetti & Co, Inc.	Secured Loan	March 10, 2021	April 1, 2025	Variable interest rate PRIME + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽¹¹⁾	$	12,000	$	11,784	$	11,888
	Secured Loan	May 18, 2021	June 1, 2025	Variable interest rate PRIME + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽¹¹⁾		8,000		7,822		7,822		Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		378		469		462
Total Rigetti & Co, Inc.						20,000		19,606		19,710
												Equipment Financing	January 20, 2020	February 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		396		486		478
Smule, Inc.	Secured Loan	July 1, 2020	January 1, 2022	Fixed interest rate 0.0% ⁽¹⁷⁾	$	69	$	69	$	69
												Equipment Financing	February 1, 2020	March 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		353		428		421
Whip Networks, Inc.	Secured Loan	June 14, 2021	July 1, 2025	Variable interest rate PRIME + 7.8% or Floor rate 11.0%; EOT 3.5% ⁽¹¹⁾	$	5,000	$	4,953	$	4,953
												Equipment Financing	March 26, 2020	April 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		109		131		130
Sub-total: Information (8.3%)*					$	31,301	$	31,495	$	31,548
												Equipment Financing	April 17, 2020	May 1, 2024	Fixed interest rate 7.3%; EOT 11.5%		723		857		847
												Equipment Financing	July 27, 2020	August 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		820		944		930
												Equipment Financing	September 4, 2020	October 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		151		171		169
												Equipment Financing	March 29, 2021	April 1, 2025	Fixed interest rate 7.5%; EOT 11.5%		1,990		2,162		2,133
Total BackBlaze, Inc.																	6,546		7,919		7,810

Cleanspark, Inc.												Equipment Financing	April 22, 2022	May 1, 2025	Fixed interest rate 10.3%; EOT 5.0%		18,929		18,960		18,792

Commonwealth Fusion Systems, LLC												Equipment Financing	September 10, 2021	October 1, 2024	Fixed interest rate 9.5%; EOT 8.5%	$	1,815	$	1,897	$	1,887
												Equipment Financing	October 20, 2021	November 1, 2024	Fixed interest rate 9.7%; EOT 8.5%		543		564		561
Total Commonwealth Fusion Systems, LLC																	2,358		2,461		2,448

Core Scientific, Inc.												Equipment Financing	August 31, 2021	October 1, 2024	Fixed interest rate 10.3%; EOT 5.0%	$	778	$	801	$	801
												Equipment Financing	November 19, 2021	December 1, 2024	Fixed interest rate 10.7%; EOT 5.0%		11,555		11,799		11,802
												Equipment Financing	December 13, 2021	January 1, 2025	Fixed interest rate 10.5%; EOT 5.0%		4,258		4,336		4,338
												Equipment Financing	February 9, 2022	March 1, 2025	Fixed interest rate 10.5%; EOT 5.0%		9,012		9,127		9,130
Total Core Scientific, Inc.																	25,603		26,063		26,071

Edeniq, Inc.												Secured Loan⁽¹⁴⁾	November 30, 2021	June 1, 2025	Fixed interest rate 18.0%	$	5,267	$	1,707	$	5,331

Emerald Cloud Lab, Inc.												Equipment Financing	July 13, 2021	August 1, 2024	Fixed interest rate 9.7%; EOT 7.0%	$	7,658	$	8,046	$	8,016

Emergy, Inc.												Equipment Financing	January 8, 2021	May 1, 2024	Fixed interest rate 9.1%; EOT 8.5%	$	348	$	381	$	378
												Equipment Financing	December 15, 2021	July 1, 2025	Fixed interest rate 9.3%; EOT 11.5%		9,684		9,967		9,840
Total Emergy, Inc.																	10,032		10,348		10,218

1013

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued
Debt Securities- United States, Continued											Debt Securities- United States, Continued

Manufacturing ⁽²⁾
Circle Media Labs, Inc.	Secured Loan	May 5, 2021	June 1, 2025	Variable interest rate PRIME + 6.8% or Floor rate 12.0%; EOT 5.0% ⁽¹¹⁾	$	5,000	$	4,948	$	4,948
Professional, Scientific, and Technical Services, Continued											Professional, Scientific, and Technical Services, Continued
Eqis Capital Management, Inc.												Secured Loan	June 15, 2022	July 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 3.0% ⁽⁸⁾	$	7,000	$	6,942	$	6,942

Daring Foods, Inc.	Equipment Financing	April 8, 2021	May 1, 2024	Fixed interest rate 9.5%; EOT 8.0%	$	475	$	473	$	473
Grabit Interactive Media, Inc.												Secured Loan	April 8, 2022	November 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾	$	4,500	$	4,450	$	4,450

Footprint International Holding, Inc.	Equipment Financing	February 14, 2020	March 1, 2024	Fixed interest rate 10.3%; EOT 8.0%	$	12,744	$	13,475	$	13,549
Greenlight Biosciences Inc.												Equipment Financing⁽¹⁴⁾	March 29, 2021	April 1, 2024	Fixed interest rate 9.7%; EOT 8.0%	$	2,050	$	2,203	$	2,184
	Secured Loan	June 22, 2020	July 1, 2024	Fixed interest rate 12.0%; EOT 9.0%		7,000		7,214		7,273		Equipment Financing⁽¹⁴⁾	June 17, 2021	July 1, 2024	Fixed interest rate 9.5%; EOT 8.0%		3,042		3,202		3,180
Total Footprint International Holding, Inc.						19,744		20,689		20,822
												Equipment Financing⁽¹⁴⁾	August 31, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 8.0%		1,665		1,728		1,705
Happiest Baby, Inc.	Equipment Financing	January 16, 2020	September 1, 2022	Fixed interest rate 8.4%; EOT 9.5%	$	660	$	795	$	775
												Equipment Financing⁽¹⁴⁾	August 31, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 8.0%		965		1,001		982
Total Greenlight Biosciences Inc.																	7,722		8,134		8,051

Incontext Solutions, Inc.												Secured Loan⁽¹⁴⁾	January 16, 2020	October 1, 2024	Fixed interest rate 11.8%; EOT 16.4%	$	6,149	$	6,958	$	5,853

Nomad Health, Inc.												Secured Loan	March 29, 2022	October 1, 2026	Variable interest rate Prime + 5.5% or Floor rate 9.3%; EOT 4.0% ⁽⁸⁾	$	30,000	$	29,812	$	30,433

PebblePost, Inc.												Secured Loan	May 7, 2021	June 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.8% ⁽⁸⁾	$	12,500	$	12,558	$	12,824

Pendulum Therapeutics, Inc.												Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 7.7%; EOT 5.0%	$	131	$	152	$	152
	Equipment Financing	January 16, 2020	November 1, 2022	Fixed interest rate 8.6%; EOT 9.5%		556		653		654		Equipment Financing	January 17, 2020	August 1, 2023	Fixed interest rate 7.8%; EOT 5.0%		925		1,049		1,052
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.6%; EOT 9.5%		550		628		633		Equipment Financing	March 6, 2020	October 1, 2023	Fixed interest rate 7.7%; EOT 5.0%		296		327		328
	Equipment Financing	February 7, 2020	June 1, 2023	Fixed interest rate 8.2%; EOT 9.5%		729		802		802		Equipment Financing	July 15, 2020	February 1, 2024	Fixed interest rate 9.8%; EOT 6.0%		492		536		538
	Equipment Financing	September 16, 2020	January 1, 2024	Fixed interest rate 7.8%; EOT 9.5%		1,061		1,114		1,118		Secured Loan	December 31, 2021	January 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾		5,000		4,984		5,132
	Equipment Financing	January 22, 2021	May 1, 2025	Fixed interest rate 8.4%; EOT 9.5%		886		909		912		Secured Loan	February 28, 2022	March 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾		5,000		4,975		5,119
Total Happiest Baby, Inc.						4,442		4,901		4,894

Health-Ade, LLC	Equipment Financing	January 16, 2020	February 1, 2022	Fixed interest rate 9.4%; EOT 15.0%	$	750	$	1,329	$	1,311
	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 8.6%; EOT 15.0%		480		762		753
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.1%; EOT 15.0%		1,333		1,895		1,879
Total Health-Ade, LLC						2,563		3,986		3,943

Mainspring Energy, Inc.	Secured Loan	January 16, 2020	August 1, 2023	Fixed interest rate 11.0%; EOT 3.8%	$	7,166	$	7,392	$	7,424
	Secured Loan	November 20, 2020	December 1, 2024	Fixed interest rate 11.0%; EOT 3.8%		5,500		5,348		5,483
Total Mainspring Energy, Inc.						12,666		12,740		12,907

Miyoko's Kitchen	Equipment Financing	February 19, 2020	September 1, 2022	Fixed interest rate 8.8%; EOT 9.0%	$	415	$	470	$	470
	Equipment Financing	August 27, 2020	March 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		682		731		732		Secured Loan	March 30, 2022	April 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾		5,000		4,970		5,096
	Equipment Financing	February 5, 2021	September 1, 2023	Fixed interest rate 8.5%; EOT 9.0%		573		590		591		Secured Loan	May 6, 2022	June 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾		5,000		4,961		4,961
	Equipment Financing	June 25, 2021	December 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		598		598		598		Secured Loan	June 17, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾		5,000		4,954		4,954
Total Miyoko's Kitchen						2,268		2,389		2,391
Total Pendulum Therapeutics, Inc.																	26,844		26,908		27,332

Molekule, Inc.	Equipment Financing	June 19, 2020	January 1, 2024	Fixed interest rate 8.8%; EOT 10.0%	$	2,149	$	2,264	$	2,275
Reciprocity, Inc.												Secured Loan	September 25, 2020	October 1, 2024	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾	$	9,420	$	9,466	$	9,439
	Equipment Financing	September 29, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 10.0%		468		490		492		Secured Loan	April 29, 2021	May 1, 2025	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾		5,000		5,008		4,954
Total Reciprocity, Inc.																	14,420		14,474		14,393
	Equipment Financing	December 18, 2020	July 1, 2024	Fixed interest rate 8.8%; EOT 10.0%		766		790		792
Total Molekule, Inc.						3,383		3,544		3,559
Smartly, Inc.												Secured Loan	May 16, 2022	December 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 10.5%; EOT 2.5% ⁽⁸⁾	$	10,000	$	9,854	$	9,854

Quip NYC, Inc.	Secured Loan	March 9, 2021	April 1, 2026	Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽¹¹⁾	$	17,500	$	17,193	$	17,350
Sun Basket, Inc.												Secured Loan	December 31, 2020	April 1, 2023	Variable interest rate Prime + 8.5% or Floor rate 11.8%; EOT 5.8% ⁽⁸⁾	$	16,905	$	17,961	$	17,388

Store Intelligence, Inc. ⁽¹⁹⁾	Secured Loan	May 2, 2020	June 1, 2024	Fixed interest rate 12.0%; EOT 7.8%	$	12,001	$	12,393	$	11,795
TMRW Life Sciences, Inc.												Secured Loan	April 29, 2022	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0% ⁽⁸⁾	$	5,000	$	4,966	$	4,967

Tarana Wireless, Inc.	Secured Loan	June 30, 2021	July 1, 2025	Variable interest rate PRIME + 8.0% or Floor rate 11.5%; EOT 4.5% ⁽¹¹⁾	$	18,500	$	17,353	$	17,353
Utility Associates, Inc.												Secured Loan⁽¹⁸⁾	January 16, 2020	September 30, 2023	PIK Fixed interest rate 11.0% ⁽¹⁵⁾	$	750	$	830	$	729

The Fynder Group, Inc.	Equipment Financing	October 14, 2020	May 1, 2024	Fixed interest rate 9.1%; EOT 10.0%	$	582	$	592	$	594
ZenDrive, Inc.												Secured Loan	July 16, 2021	August 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 3.0% ⁽⁸⁾	$	15,000	$	14,977	$	15,395

Vertical Communications, Inc.	Secured Loan	May 1, 2020	November 1, 2024	Fixed interest rate 9.5%; EOT 26.4%	$	12,000	$	13,385	$	13,148
	Secured Loan	June 18, 2020	July 1, 2022	Fixed interest rate 9.5%		565		565		571
Total Vertical Communications, Inc. ⁽¹⁹⁾						12,565		13,950		13,719

VitaCup, Inc.	Secured Loan	June 23, 2021	July 1, 2025	Variable interest rate PRIME + 7.5% or Floor rate 11.5%; EOT 2.5% ⁽¹¹⁾	$	5,500	$	5,438	$	5,438

Sub-total: Manufacturing (31.7%)*					$	117,189	$	120,589	$	120,186
Sub-total: Professional, Scientific, and Technical Services (22.3%)*											Sub-total: Professional, Scientific, and Technical Services (22.3%)*					$	239,183	$	240,311	$	243,398

1114

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities- United States, Continued

Real Estate ⁽⁷⁾
Knockaway, Inc.	Secured Loan	November 10, 2021	June 1, 2026	Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾	$	14,734	$	14,694	$	14,337
	Secured Loan	November 30, 2021	June 1, 2026	Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾		2,000		1,993		1,947
	Secured Loan	December 28, 2021	July 1, 2026	Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾		4,275		4,257		4,152
Total Knockaway, Inc.						21,009		20,944		20,436

Orchard Technologies, Inc.	Secured Loan	March 11, 2021	April 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾	$	5,000	$	5,060	$	5,140
	Secured Loan	July 23, 2021	April 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾		12,500		12,601		12,814
Total Orchard Technologies, Inc.						17,500		17,661		17,954

Wanderjaunt, Inc.	Equipment Financing⁽¹⁸⁾	January 16, 2020	June 1, 2023	Fixed interest rate 10.2%; EOT 12.0%	$	155	$	201	$	20
	Equipment Financing⁽¹⁸⁾	January 16, 2020	August 1, 2023	Fixed interest rate 10.2%; EOT 12.0%		545		699		61
	Equipment Financing⁽¹⁸⁾	January 7, 2022	August 1, 2025	Fixed interest rate 10.3%; EOT 11.0%		2,649		2,658		114
	Equipment Financing⁽¹⁸⁾	March 4, 2022	October 1, 2025	Fixed interest rate 10.2%; EOT 11.0%		2,133		2,121		88
Total Wanderjaunt, Inc.						5,482		5,679		283

Sub-total: Real Estate (3.5%)*					$	43,991	$	44,284	$	38,673

Rental and Leasing Services⁽⁷⁾
EquipmentShare, Inc.	Equipment Financing	June 24, 2020	July 1, 2023	Fixed interest rate 11.0%; EOT 5.0%	$	2,238	$	2,510	$	2,525
	Equipment Financing	August 7, 2020	September 1, 2023	Fixed interest rate 10.2%; EOT 5.0%		899		989		993
	Equipment Financing	October 2, 2020	November 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		411		446		448
	Equipment Financing	October 9, 2020	November 1, 2023	Fixed interest rate 10.5%; EOT 5.0%		1,299		1,408		1,417
Total EquipmentShare, Inc.						4,847		5,353		5,383

Maxwell Financial Labs, Inc.	Secured Loan	September 30, 2021	April 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾	$	18,000	$	17,998	$	18,156

NextCar Holding Company, Inc.	Secured Loan	December 14, 2021	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾	$	5,000	$	5,065	$	5,100
	Secured Loan	December 15, 2021	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		2,000		2,028		2,040
	Secured Loan	February 23, 2022	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		2,500		2,515		2,577
	Secured Loan	March 16, 2022	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		3,000		3,012		3,098
	Secured Loan	April 18, 2022	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		2,500		2,490		2,550
	Secured Loan	April 18, 2022	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		2,500		2,490		2,550
	Secured Loan	May 17, 2022	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		5,000		4,965		5,100
	Secured Loan	June 22, 2022	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾		2,500		2,470		2,550
Total NextCar Holding Company, Inc.						25,000		25,035		25,565

Sub-total: Rental and Leasing Services (4.5%)*					$	47,847	$	48,386	$	49,104

15

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued
Debt Securities- United States, Continued											Debt Securities- United States, Continued

Pharmaceutical ⁽²⁾
Zosano Pharma Corporation	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 9.4%; EOT 12.0%	$	1,385	$	1,950	$	1,833
Retail Trade ⁽⁷⁾
Fernished, Inc.												Equipment Financing⁽¹⁴⁾	October 29, 2021	November 1, 2024	Fixed interest rate 13.4%; EOT 3.0%	$	401	$	404	$	407
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.7%; EOT 12.0%		1,025		1,325		1,256		Equipment Financing⁽¹⁴⁾	March 21, 2022	April 1, 2025	Fixed interest rate 13.2%; EOT 3.0%		1,387		1,382		1,345
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,235		1,446		1,399		Equipment Financing⁽¹⁴⁾	May 10, 2022	June 1, 2025	Fixed interest rate 13.2%; EOT 3.0%		975		969		969
Total Fernished, Inc.																	2,763		2,755		2,721
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,424		1,611		1,578
Gobble, Inc.												Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.3%; EOT 6.0%	$	1,566	$	1,780	$	1,762
	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 10.5%; EOT 12.0%		1,070		1,205		1,176		Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.5%; EOT 6.0%		788		895		886
Total Zosano Pharma Corporation						6,139		7,537		7,242
Total Gobble Inc.																	2,354		2,675		2,648

Sub-total: Pharmaceutical (1.9%)*					$	6,139	$	7,537	$	7,242
Portofino Labs, Inc.												Secured Loan	April 1, 2021	November 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	2,000	$	1,904	$	1,941

Professional, Scientific, and Technical Services ⁽²⁾
BackBlaze, Inc.	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 7.2%; EOT 11.5%	$	692	$	853	$	851
Super73, Inc.												Secured Loan	December 31, 2020	January 1, 2025	Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	4,844	$	4,925	$	4,945
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		93		110		110		Secured Loan	October 25, 2021	January 1, 2025	Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		3,963		3,982		4,000
Total Super73, Inc.																	8,807		8,907		8,945
	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		731		851		851
UnTuckIt, Inc.												Secured Loan⁽¹⁴⁾	January 16, 2020	June 1, 2025	Fixed interest rate 12.0%; EOT 3.8%	$	15,000	$	15,778	$	15,202
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		148		169		169
Sub-total: Retail Trade (2.9%)*																$	30,924	$	32,019	$	31,457
	Equipment Financing	January 16, 2020	September 1, 2023	Fixed interest rate 7.7%; EOT 11.5%		153		174		173
Space Research and Technology ⁽⁷⁾
Axiom Space, Inc.												Secured Loan	May 28, 2021	June 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 9.3%; EOT 2.5% ⁽⁸⁾	$	30,000	$	29,975	$	30,755
	Equipment Financing	January 16, 2020	October 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		155		174		174
Sub-total: Space Research and Technology (2.8%)*											Sub-total: Space Research and Technology (2.8%)*					$	30,000	$	29,975	$	30,755
	Equipment Financing	January 16, 2020	November 1, 2023	Fixed interest rate 7.2%; EOT 11.5%		521		585		583
Wholesale Trade ⁽⁷⁾
BaubleBar, Inc.												Secured Loan⁽¹⁴⁾	January 16, 2020	March 1, 2023	Fixed interest rate 11.5%; EOT 7.3%	$	2,084	$	3,014	$	2,904
	Equipment Financing	January 16, 2020	December 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		694		772		770
Grandpad, Inc.												Equipment Financing	November 16, 2020	June 1, 2023	Fixed interest rate 10.6%; EOT 5.0%	$	1,188	$	1,317	$	1,312
	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		608		672		670		Equipment Financing	December 23, 2020	July 1, 2023	Fixed interest rate 10.8%; EOT 5.0%		1,578		1,730		1,724
Total Grandpad, Inc.																	2,766		3,047		3,036
	Equipment Financing	January 20, 2020	February 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		624		685		683
Sub-total: Wholesale Trade (0.5%)*																$	4,850	$	6,061	$	5,940
	Equipment Financing	February 1, 2020	March 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		545		597		595
Total: Debt Securities- United States (84.1%)*																$	919,157	$	924,585	$	916,976
	Equipment Financing	March 26, 2020	April 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		166		180		182
Debt Securities- Canada
	Equipment Financing	April 17, 2020	May 1, 2024	Fixed interest rate 7.3%; EOT 11.5%		1,078		1,165		1,167
Information ⁽⁷⁾
Hut 8 Holdings, Inc. ⁽¹⁰⁾												Equipment Financing	December 30, 2021	January 1, 2025	Fixed interest rate 9.5%; EOT 3.5%	$	25,383	$	25,477	$	25,320
	Equipment Financing	July 27, 2020	August 1, 2024	Fixed interest rate 7.5%; EOT 11.5%		1,170		1,242		1,241
Sub-total: Information (2.3%)*																$	25,383	$	25,477	$	25,320
	Equipment Financing	September 4, 2020	October 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		211		221		221
	Equipment Financing	March 29, 2021	April 1, 2025	Fixed interest rate 7.5%; EOT 11.5%		2,618		2,667		2,675
Total BackBlaze, Inc.						10,207		11,117		11,115

Edeniq, Inc.	Secured Loan	January 16, 2020	September 1, 2021	Fixed interest rate 13.0%; EOT 9.5%	$	2,072	$	212	$	212
	Secured Loan	January 16, 2020	September 1, 2021	Fixed interest rate 13.0%; EOT 9.5%		1,551		131		131
Total Edeniq, Inc. ^{(13) (19)}						3,623		343		343

Emergy, Inc. ⁽¹⁶⁾	Equipment Financing	January 8, 2021	May 1, 2024	Fixed interest rate 9.1%; EOT 5.0%	$	515	$	526	$	527

1216

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities- Canada, Continued

Manufacturing ⁽⁷⁾
Nexii Building Solutions, Inc. ⁽¹⁰⁾	Secured Loan	August 27, 2021	September 1, 2025	Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾	$	10,000	$	9,698	$	9,938
	Secured Loan	June 8, 2022	July 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾		5,000		4,750		4,750
Total Nexii Building Solutions, Inc.						15,000		14,448		14,688

Sub-total: Manufacturing (1.3%)*					$	15,000	$	14,448	$	14,688

Transportation and Warehousing ⁽⁷⁾
GoFor Industries, Inc. ⁽¹⁰⁾	Secured Loan⁽¹⁸⁾	January 21, 2022	February 1, 2026	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 2.5% ⁽⁸⁾	$	9,792	$	9,660	$	3,838

Sub-total: Transportation and Warehousing (0.4%)*					$	9,792	$	9,660	$	3,838

Utilities ⁽⁷⁾
Invenia, Inc.	Secured Loan	January 16, 2020	January 1, 2023	Fixed interest rate 11.5%; EOT 5.0%	$	2,000	$	2,451	$	2,427
	Secured Loan	January 16, 2020	May 1, 2023	Fixed interest rate 11.5%; EOT 5.0%		1,371		1,572		1,556
	Secured Loan	January 16, 2020	January 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		1,711		1,835		1,831
	Secured Loan	January 17, 2020	February 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		2,390		2,565		2,547
	Secured Loan	June 8, 2020	July 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		2,920		3,063		3,063
	Secured Loan	October 29, 2020	November 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		4,157		4,309		4,301
Total Invenia, Inc. ⁽¹⁰⁾						14,549		15,795		15,725

Sub-total: Utilities (1.4%)*					$	14,549	$	15,795	$	15,725

Total: Debt Securities- Canada (5.5%)*					$	64,724	$	65,380	$	59,571

Debt Securities- Europe

Manufacturing ⁽⁷⁾
Aledia, Inc. ⁽¹⁰⁾	Equipment Financing⁽¹⁴⁾	March 31, 2022	April 1, 2025	Fixed interest rate 9.0%; EOT 7.0%	$	16,774	$	16,868	$	16,880
	Equipment Financing⁽¹⁴⁾	June 30, 2022	July 1, 2025	Fixed interest rate 9.7%; EOT 7.0%		1,174		1,166		1,166
Total Aledia, Inc.						17,948		18,034		18,046

Sub-total: Manufacturing (1.7%)*					$	17,948	$	18,034	$	18,046

Total: Debt Securities- Europe (1.7%)*					$	17,948	$	18,034	$	18,046

Total: Debt Securities (91.2%)⁽¹⁹⁾*					$	1,001,829	$	1,007,999	$	994,593

17

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments- United States

Administrative and Support and Waste Management and Remediation ⁽⁷⁾

Qwick, Inc.	Warrant⁽¹⁴⁾	December 31, 2021	December 31, 2031	Common Stock	16,956	$	2.79	$	96	$	64

BetterLeap, Inc.	Warrant⁽¹⁴⁾	April 20, 2022	April 20, 2032	Common Stock	88,435	$	2.26	$	38	$	38

RTS Holding, Inc.	Warrant⁽¹⁴⁾	December 10, 2021	December 10, 2031	Preferred Series C	3,857	$	205.28	$	153	$	184

Sub-Total: Administrative and Support and Waste Management and Remediation (0.0%)*								$	287	$	286

Agriculture, Forestry, Fishing and Hunting ⁽⁷⁾
Bowery Farming, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	June 10, 2029	Common Stock	68,863	$	5.08	$	410	$	1,372
	Warrant⁽¹⁴⁾	December 22, 2020	December 22, 2030	Common Stock	29,925	$	6.24		160		569
	Warrant⁽¹⁴⁾	September 10, 2021	September 10, 2028	Common Stock	21,577	$	0.01		616		518
Total Bowery Farming, Inc.									1,186		2,459

Robotany, Inc.	Warrant	January 16, 2020	July 19, 2029	Common Stock	262,870	$	0.26	$	129	$	37

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.2%)*								$	1,315	$	2,496

Arts, Entertainment, and Recreation ⁽⁷⁾
SI Tickets, Inc.	Warrant⁽¹⁴⁾	May 11, 2022	May 11, 2032	Common Stock	53,029	$	2.52	$	162	$	199

Sub-total: Arts, Entertainment, and Recreation (0.0%)*								$	162	$	199

Construction ⁽⁷⁾
Project Frog, Inc. ⁽²⁰⁾	Warrant⁽¹⁴⁾	January 16, 2020	July 26, 2026	Preferred Series AA	211,633	$	0.19	$	9	$	—
	Warrant⁽¹⁴⁾	January 16, 2020	July 26, 2026	Common Stock	180,356	$	0.19		9		—
	Warrant⁽¹⁴⁾	August 3, 2021	December 31, 2031	Preferred Series CC	250,000	$	0.01		20		22
Total Project Frog, Inc.									38		22

Sub-Total: Construction (0.0%)*								$	38	$	22

Educational Services ⁽⁷⁾
Medical Sales Training Holding Company	Warrant⁽¹⁴⁾	March 18, 2021	March 18, 2031	Common Stock	28,732	$	7.74	$	108	$	62

Yellowbrick Learning, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	September 28, 2028	Common Stock	222,222	$	0.90	$	120	$	7

Sub-Total: Educational Services (0.0%)*								$	228	$	69

18

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued
Warrant Investments- United States

Professional, Scientific, and Technical Services, Continued
Greenlight Biosciences Inc.	Equipment Financing	March 29, 2021	April 1, 2024	Fixed interest rate 9.7%; EOT 8.0%	$	3,075	$	3,068	$	3,088
Finance and Insurance ⁽⁷⁾
DailyPay, Inc.												Warrant⁽¹⁴⁾	September 30, 2020	September 30, 2030	Common Stock	89,264	$	3.00	$	151	$	720
	Equipment Financing	June 17, 2021	July 1, 2024	Fixed interest rate 9.5%; EOT 8.0%		4,378		4313		4,313
Total Greenlight Biosciences Inc.						7,453		7,381		7,401

Incontext Solutions, Inc.	Secured Loan	January 16, 2020	October 1, 2023	Fixed interest rate 11.75%; EOT 11.4%	$	7,149	$	6,670	$	5,268

Matterport, Inc.	Secured Loan	January 16, 2020	May 1, 2022	Fixed interest rate 11.5%; EOT 5.0%	$	3,427	$	3,888	$	3,958

PebblePost, Inc.	Secured Loan	May 7, 2021	June 1, 2025	Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 3.8% ⁽⁹⁾	$	12,500	$	12,337	$	12,337

Pendulum Therapeutics, Inc.	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 7.7%; EOT 5.0%	$	278	$	281	$	285
Petal Card, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	November 27, 2029	Preferred Series B	250,268	$	1.32	$	147	$	1,233
	Equipment Financing	January 17, 2020	August 1, 2023	Fixed interest rate 7.8%; EOT 5.0%		1,712		1,800		1,844		Warrant⁽¹⁴⁾	January 11, 2021	January 11, 2031	Common Stock	135,835	$	0.01		312		797
	Equipment Financing	March 6, 2020	October 1, 2023	Fixed interest rate 7.7%; EOT 5.0%		513		528		542		Warrant⁽¹⁴⁾	August 6, 2021	August 6, 2031	Common Stock	111,555	$	1.60		197		528
Total Petal Card, Inc.																				656		2,558
	Equipment Financing	July 15, 2020	February 1, 2024	Fixed interest rate 9.8%; EOT 6.0%		766		785		809
Total Pendulum Therapeutics, Inc.						3,269		3,394		3,480
RealtyMogul, Co.												Warrant⁽¹⁴⁾	January 16, 2020	December 18, 2027	Preferred Series B	234,421	$	3.88	$	285	$	23

Reciprocity, Inc.	Secured Loan	September 25, 2020	October 1, 2024	Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽¹¹⁾	$	10,000	$	9,918	$	9,896
Stilt, Inc.												Warrant⁽¹⁴⁾	February 10, 2022	February 10, 2032	Common Stock	67,465	$	0.01	$	106	$	117
	Secured Loan	April 29, 2021	May 1, 2025	Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽¹¹⁾		5,000		4,955		4,955
Total Reciprocity, Inc.						15,000		14,873		14,851
Sub-Total: Finance and Insurance (0.3%)*																			$	1,198	$	3,418

Sun Basket, Inc.	Secured Loan	December 31, 2020	December 1, 2024	Variable interest rate PRIME + 8.5% or Floor rate 11.8%; EOT 5.0% ⁽¹¹⁾	$	18,375	$	18,126	$	18,269
Health Care and Social Assistance ⁽⁷⁾
Lark Technologies, Inc.												Warrant⁽¹⁴⁾	September 30, 2020	September 30, 2030	Common Stock	76,231	$	1.76	$	177	$	461
												Warrant⁽¹⁴⁾	June 30, 2021	June 30, 2031	Common Stock	79,325	$	1.76		258		479
Utility Associates, Inc. ⁽¹³⁾	Secured Loan	January 16, 2020	October 1, 2023	Fixed interest rate 11.0%	$	750	$	830	$	603
Total Lark Technologies, Inc.																				435		940

Sub-total: Professional, Scientific, and Technical Services (20.6%)*					$	82,268	$	79,485	$	78,152
Sub-Total: Health Care and Social Assistance (0.1%)*											Sub-Total: Health Care and Social Assistance (0.1%)*								$	435	$	940

Information ⁽⁷⁾
Everalbum, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	July 29, 2026	Preferred Series A	851,063	$	0.10	$	25	$	1

Figg, Inc.												Warrant⁽¹¹⁾⁽¹⁴⁾	January 16, 2020	March 31, 2028	Common Stock	935,198	$	0.10	$	—	$	—

Firefly Systems, Inc.												Warrant⁽¹⁴⁾	January 31, 2020	January 29, 2030	Common Stock	133,147	$	1.14	$	282	$	465

Gtxcel, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	September 24, 2025	Preferred Series C	1,000,000	$	0.21	$	83	$	8
												Warrant⁽¹⁴⁾	January 16, 2020	September 24, 2025	Preferred Series D	1,000,000	$	0.21		83		8
Total Gtxcel, Inc.																				166		16

Lucidworks, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	June 27, 2026	Preferred Series D	619,435	$	0.77	$	806	$	1,615

RapidMiner, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	March 25, 2029	Preferred Series C-1	11,624	$	60.22	$	528	$	—

Stratifyd, Inc.												Warrant⁽¹⁴⁾	September 3, 2021	September 3, 2031	Preferred Series B-2	106,719	$	2.53	$	83	$	27

Sub-Total: Information (0.2%)*																			$	1,890	$	2,124

Management of Companies and Enterprises ⁽⁷⁾

Exer Holdings, LLC												Warrant⁽¹⁴⁾	November 19, 2021	November 19, 2031	Common Stock	281	$	479.25	$	93	$	59

Sub-Total: Management of Companies and Enterprises (0.0%)*																			$	93	$	59

1319

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾		Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued
Warrant Investments- United States, Continued
Manufacturing ⁽⁷⁾
3DEO, Inc.											Warrant⁽¹⁴⁾	February 23, 2022	February 23, 2032	Common Stock	37,218	$	1.81	$	93	$	37

Real Estate ⁽²⁾
Knockaway, Inc.	Secured Loan	January 16, 2020	December 1, 2023	Fixed interest rate 11.0%; EOT 3.0%	$	8,553	$	8,710	$	8,724
Bolb, Inc.											Warrant⁽¹⁴⁾	October 12, 2021	October 12, 2031	Common Stock	181,784	$	0.07	$	36	$	10

Daring Foods, Inc.											Warrant⁽¹⁴⁾	April 8, 2021	April 8, 2031	Common Stock	68,100	$	0.27	$	106	$	666

Footprint International Holding, Inc.											Warrant⁽¹⁴⁾	February 14, 2020	February 14, 2030	Common Stock	38,171	$	0.31	$	9	$	926
	Secured Loan	January 16, 2020	February 1, 2024	Fixed interest rate 11.0%; EOT 3.0%		2,261		2,295		2,309	Warrant⁽¹⁴⁾	February 18, 2022	February 18, 2032	Common Stock	77,524	$	0.01		4,246		1,903
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 11.0%; EOT 3.0%		2,322		2,352		2,369	Warrant⁽¹⁴⁾	June 23, 2022	June 23, 2032	Common Stock	14,624	$	0.01		359		359
Total Knockaway, Inc.						13,136		13,357		13,402
Total Footprint International Holding, Inc.																		$	4,614		3,188

Orchard Technologies, Inc.	Secured Loan	March 11, 2021	April 1, 2026	Variable interest rate PRIME + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽¹¹⁾	$	5,000	$	4,995	$	5,038
Happiest Baby, Inc.											Warrant⁽¹⁴⁾	January 16, 2020	May 16, 2029	Common Stock	182,554	$	0.33	$	193	$	262

Wanderjaunt, Inc.	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 10.2%; EOT 12.0%	$	314	$	337	$	328
Mainspring Energy, Inc.											Warrant⁽¹⁴⁾	January 16, 2020	July 9, 2029	Common Stock	140,186	$	1.15	$	283	$	462
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 10.2%; EOT 12.0%		1,016		1,132		1,115	Warrant⁽¹⁴⁾	November 20, 2020	November 20, 2030	Common Stock	81,294	$	1.15		226	$	268
Total Wanderjaunt, Inc.						1,330		1,469		1,443
											Warrant⁽¹⁴⁾	March 18, 2022	March 18, 2032	Common Stock	137,692	$	1.66		344		430
Sub-total: Real Estate (5.2%)*					$	19,466	$	19,821	$	19,883
Total Mainspring Energy, Inc.																		$	853		1,160

Rental and Leasing Services⁽²⁾
EquipmentShare, Inc.	Equipment Financing	June 24, 2020	July 1, 2023	Fixed interest rate 10.7%; EOT 5.0%	$	6,188	$	6,438	$	6,481
Molekule, Inc.											Warrant⁽¹⁴⁾	June 19, 2020	June 19, 2030	Common Stock	3,205	$	3.12	$	8	$	11
											Warrant⁽¹⁴⁾	June 1, 2022	June 1, 2032	Preferred Series 1	257,135	$	0.39		22		22
											Warrant⁽¹⁴⁾	June 19, 2020	June 19, 2030	Preferred Series 2	100,000	$	1.00		8		11
Total Molekule, Inc.																		$	38		44


Quip NYC, Inc.											Warrant⁽¹⁴⁾	March 9, 2021	March 9, 2031	Preferred Series A-1	10,833	$	48.46	$	203	$	458

SBG Labs, Inc.											Warrant⁽¹⁴⁾	January 16, 2020	July 29, 2023	Preferred Series A-1	42,857	$	0.70	$	13	$	—
	Equipment Financing	July 2, 2020	August 1, 2023	Fixed interest rate 10.1%; EOT 5.0%		714		740		745	Warrant⁽¹⁴⁾	January 16, 2020	September 18, 2024	Preferred Series A-1	25,714	$	0.70		8		—
	Equipment Financing	August 7, 2020	September 1, 2023	Fixed interest rate 10.2%; EOT 5.0%		1,589		1,642		1,651	Warrant⁽¹⁴⁾	January 16, 2020	January 14, 2024	Preferred Series A-1	21,492	$	0.70		7		—
	Equipment Financing	September 18, 2020	October 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		2,870		2,954		2,968	Warrant⁽¹⁴⁾	January 16, 2020	March 24, 2025	Preferred Series A-1	12,155	$	0.70		4		—
	Equipment Financing	September 29, 2020	October 1, 2024	Fixed interest rate 8.3%; EOT 10.0%		379		394		394	Warrant⁽¹⁴⁾	January 16, 2020	October 10, 2023	Preferred Series A-1	11,150	$	0.70		4		—
	Equipment Financing	October 2, 2020	November 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		685		703		710	Warrant⁽¹⁴⁾	January 16, 2020	May 6, 2024	Preferred Series A-1	11,145	$	0.70		4		—
	Equipment Financing	October 9, 2020	November 1, 2023	Fixed interest rate 10.5%; EOT 5.0%		2,161		2,217		2,241	Warrant⁽¹⁴⁾	January 16, 2020	June 9, 2024	Preferred Series A-1	7,085	$	0.70		2		—
	Equipment Financing	November 4, 2020	December 1, 2023	Fixed interest rate 10.1%; EOT 5.0%		2,114		2,163		2,185	Warrant⁽¹⁴⁾	January 16, 2020	May 20, 2024	Preferred Series A-1	342,857	$	0.70		110		—
	Equipment Financing	December 4, 2020	January 1, 2024	Fixed interest rate 10.1%; EOT 5.0%		1,702		1,736		1,752	Warrant⁽¹⁴⁾	January 16, 2020	March 26, 2025	Preferred Series A-1	200,000	$	0.70		65		—
Total SBG Labs, Inc.																			217		—
	Equipment Financing	December 21, 2020	January 1, 2024	Fixed interest rate 10.5%; EOT 5.0%		677		690		696
Space Perspective, Inc.											Warrant⁽¹⁴⁾	March 3, 2022	March 3, 2032	Preferred Series A	221,280	$	2.75	$	256	$	252
	Equipment Financing	January 26, 2021	February 1, 2024	Fixed interest rate 10.6%; EOT 5.0%		1,259		1,277		1,223
Tarana Wireless, Inc.											Warrant⁽¹⁴⁾	June 30, 2021	June 30, 2031	Common Stock	5,027,629	$	0.19	$	967	$	2,058
	Equipment Financing	February 26, 2021	March 1, 2024	Fixed interest rate 10.6%; EOT 5.0%		1,658		1,679		1,693
The Fynder Group, Inc.											Warrant⁽¹⁴⁾	October 14, 2020	October 14, 2030	Common Stock	36,445	$	0.49	$	68	$	322
	Equipment Financing	March 16, 2021	April 1, 2024	Fixed interest rate 10.7%; EOT 5.0%		1,769		1,787		1,801
Total EquipmentShare, Inc.						23,765		24,420		24,540
Vertical Communications, Inc. ⁽²⁰⁾											Warrant⁽¹¹⁾⁽¹⁴⁾	January 16, 2020	July 11, 2026	Preferred Series A	828,479	$	1.00	$	—	$	—

Maxwell Financial Labs, Inc.	Secured Loan	October 7, 2020	November 1, 2024	Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% ⁽¹¹⁾	$	3,000	$	2,992	$	3,030
viaPhoton, Inc.											Warrant⁽¹⁴⁾	March 31, 2022	March 31, 2032	Common Stock	15,839	$	0.60	$	22	$	29
	Secured Loan	December 22, 2020	January 1, 2025	Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% ⁽¹¹⁾		3,000		2,969		2,997
Total Maxwell Financial Labs, Inc.						6,000		5,961		6,027
VitaCup, Inc.											Warrant⁽¹⁴⁾	June 23, 2021	June 23, 2031	Preferred Series C	68,996	$	2.79	$	9	$	6

Sub-total: Rental and Leasing Services (8.1%)*					$	29,765	$	30,381	$	30,567
Sub-Total: Manufacturing (0.8%)*																		$	7,675	$	8,492

Retail Trade ⁽²⁾
Birchbox, Inc. ⁽¹⁹⁾	Secured Loan	January 16, 2020	July 1, 2024	Fixed interest rate 9.0%; EOT 7.5%	$	10,000	$	10,497	$	8,995

Boosted eCommerce, Inc. ⁽¹⁶⁾	Secured Loan	December 18, 2020	January 1, 2023	Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽¹¹⁾	$	5,000	$	4,987	$	5,037
	Secured Loan	January 29, 2021	January 1, 2023	Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽¹¹⁾		2,500		2,488		2,510
	Secured Loan	February 26, 2021	January 1, 2023	Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽¹¹⁾		7,500		7,458		7,522
	Secured Loan	April 12, 2021	January 1, 2023	Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽¹¹⁾		6,000		5,949		5,949
	Secured Loan	April 26, 2021	January 1, 2023	Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽¹¹⁾		9,000		8,980		8,994
Total Boosted eCommerce, Inc.						30,000		29,862		30,012

Gobble, Inc.	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.3%; EOT 6.0%	$	2,852	$	2,999	$	3,010
	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.5%; EOT 6.0%		1,434		1,508		1,513
Total Gobble Inc.						4,286		4,507		4,523

Portofino Labs, Inc. ⁽¹⁶⁾	Secured Loan	December 31, 2020	July 1, 2025	Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% ⁽¹¹⁾	$	2,000	$	1,998	$	2,010
	Secured Loan	March 12, 2021	October 1, 2025	Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% ⁽¹¹⁾		3,000		2,858		2,881
	Secured Loan	April 1, 2021	November 1, 2025	Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% ⁽¹¹⁾		2,000		1,820		1,820
Total Portofino Labs, Inc.						7,000		6,676		6,711

Super73, Inc.	Secured Loan	December 31, 2020	January 1, 2025	Variable interest rate PRIME + 7.3% or Floor rate 11.8%; EOT 4.0% ⁽¹¹⁾	$	5,500	$	5,470	$	5,519

UnTuckIt, Inc.	Secured Loan	January 16, 2020	June 1, 2024	Fixed interest rate 12.0%; EOT 5.0%	$	15,000	$	15,800	$	15,075

Sub-total: Retail Trade (18.7%)*					$	71,786	$	72,812	$	70,835

1420

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments- United States, Continued
Other Services (except Public Administration) ⁽⁷⁾
Rinse, Inc.	Warrant⁽¹⁴⁾	May 10, 2022	May 10, 2032	Preferred Series C	278,761	$	1.13	$	118	$	120

Sub-total: Other Services (except Public Administration)(0.0%)*								$	118	$	120

Pharmaceutical ⁽⁷⁾
Zosano Pharma Corporation	Warrant ⁽⁹⁾	January 16, 2020	September 25, 2025	Common Stock	75,000	$	3.59	$	69	$	—

Sub-Total: Pharmaceutical (0.0%)*								$	69	$	—

Professional, Scientific, and Technical Services ⁽⁷⁾
All Seated, Inc.	Warrant⁽¹⁴⁾	February 28, 2022	February 28, 2032	Common Stock	5,101	$	15.72	$	20	$	29

Crowdtap, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	December 16, 2025	Preferred Series B	442,233	$	1.09	$	42	$	172
	Warrant⁽¹⁴⁾	January 16, 2020	December 11, 2027	Preferred Series B	100,000	$	1.09		9		39
Total Crowdtap, Inc.									51		211

Dynamics, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	March 10, 2024	Common Stock	17,000	$	10.59	$	85	$	—

E La Carte, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	April 28, 2027	Preferred Series A	497,183	$	0.30	$	185	$	2,159
	Warrant⁽¹⁴⁾	January 16, 2020	July 28, 2027	Common Stock	104,284	$	7.49		14		259
	Warrant⁽¹⁴⁾	January 16, 2020	April 28, 2027	Preferred Series AA-1	106,841	$	7.49		14		122
Total E La Carte, Inc.									213		2,540

Edeniq, Inc.	Warrant^(11)(14)	January 16, 2020	December 23, 2026	Preferred Series B	2,685,501	$	0.22	$	—	$	8
	Warrant^(11)(14)	January 16, 2020	December 23, 2026	Preferred Series B	2,184,672	$	0.01		—		18
	Warrant^(11)(14)	January 16, 2020	June 29, 2027	Preferred Series C	5,106,972	$	0.44		—		—
	Warrant^(11)(14)	January 16, 2020	November 2, 2028	Preferred Series C	3,850,294	$	0.01		—		99
	Warrant⁽¹⁴⁾	November 29, 2021	November 29, 2031	Preferred Series D	154,906,320	$	0.01		7		36
Total Edeniq, Inc.⁽²⁰⁾									7		161

Eqis Capital Management, Inc.	Warrant⁽¹⁴⁾	June 15, 2022	June 15, 2032	Preferred Class B	904,000	$	0.99	$	10	$	10

Grabit Interactive Media, Inc.	Warrant⁽¹⁴⁾	April 8, 2022	April 8, 2034	Preferred Series A	142,828	$	1.00	$	39	$	25

Hologram, Inc.	Warrant⁽¹⁴⁾	January 31, 2020	January 27, 2030	Common Stock	193,054	$	0.26	$	49	$	658

Hospitalists Now, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	March 30, 2026	Preferred Series D-2	135,807	$	5.89	$	71	$	887
	Warrant⁽¹⁴⁾	January 16, 2020	December 6, 2026	Preferred Series D-2	750,000	$	5.89		391		4,898
Total Hospitalists Now, Inc.									462		5,785

Incontext Solutions, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	September 28, 2028	Common Stock	2,219	$	220.82	$	34	$	—

PebblePost, Inc.	Warrant⁽¹⁴⁾	May 7, 2021	May 7, 2031	Common Stock	657,343	$	0.75	$	68	$	248

Pendulum Therapeutics, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	October 9, 2029	Preferred Series B	55,263	$	1.90	$	44	$	14
	Warrant⁽¹⁴⁾	June 1, 2020	July 15, 2030	Preferred Series B	36,842	$	1.90		36		9
	Warrant⁽¹⁴⁾	December 31, 2021	December 31, 2031	Preferred Series C	322,251	$	3.24		118		16
Total Pendulum Therapeutics, Inc.									198		39

21

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Maturity Date	Interest Rate ⁽⁵⁾	Principal Amount ⁽⁶⁾		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares		Strike Price			Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued
Warrant Investments- United States, Continued

Space Research and Technology ⁽²⁾
Professional, Scientific, and Technical Services, Continued ⁽⁷⁾
Reciprocity, Inc.												Warrant⁽¹⁴⁾	September 25, 2020	September 25, 2030	Common Stock	114,678		$	4.17		$	99	$	77
												Warrant⁽¹⁴⁾	April 29, 2021	April 29, 2031	Common Stock	57,195		$	4.17			54		38
Axiom Space, Inc. ⁽¹⁶⁾	Secured Loan	May 28, 2021	June 1, 2026	Variable interest rate PRIME + 6.0% or Floor rate 9.3%; EOT 2.5% ⁽¹¹⁾	$	30,000	$	29,670	$	29,670
Total Reciprocity, Inc.																						153		115

Sub-total: Space Research and Technology (7.8%)*					$	30,000	$	29,670	$	29,670
Resilinc, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	December 15, 2025	Preferred Series A	589,275		$	0.51		$	40	$	—

Utilities ⁽²⁾
Invenia, Inc.	Secured Loan	January 16, 2020	January 1, 2023	Fixed interest rate 11.5%; EOT 5.0%	$	5,133	$	5,593	$	5,525
Smartly, Inc.												Warrant⁽¹⁴⁾	May 16, 2022	May 16, 2034	Common Stock	68,939		$	1.10		$	84	$	89

Sun Basket, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	October 5, 2027	Common Stock	103,636		$	14.47		$	111	$	8
												Warrant⁽¹⁴⁾	December 31, 2020	December 29, 2032	Common Stock	33,348		$	3.17			546		191
Total Sun Basket, Inc.																						657		199

TMRW Life Sciences, Inc.												Warrant⁽¹⁴⁾	April 29, 2022	April 29, 2032	Preferred Class A	537,966		$	2.09		$	160	$	78

Utility Associates, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	June 30, 2025	Preferred Series A	92,511		$	4.54		$	55	$	—
��												Warrant⁽¹⁴⁾	January 16, 2020	May 1, 2026	Preferred Series A	60,000		$	4.54			36		—
												Warrant⁽¹⁴⁾	January 16, 2020	May 22, 2027	Preferred Series A	200,000		$	4.54			120		—
Total Utility Associates, Inc.																						211		—

ZenDrive, Inc.												Warrant⁽¹⁴⁾	July 16, 2021	July 16, 2031	Common Stock	30,466		$	2.46		$	29	$	20

Sub-Total: Professional, Scientific, and Technical Services (0.9%)*											Sub-Total: Professional, Scientific, and Technical Services (0.9%)*										$	2,570	$	10,207

Real Estate ⁽⁷⁾
Egomotion Corporation												Warrant⁽¹¹⁾⁽¹⁴⁾	January 16, 2020	December 10, 2028	Preferred Series A	60,786		$	1.32		$	—	$	46
												Warrant⁽¹⁴⁾	January 16, 2020	June 29, 2028	Preferred Series A	121,571		$	1.32			219		93
Total Egomotion Corporation																						219		139

Knockaway, Inc.												Warrant⁽¹⁴⁾	January 16, 2020	May 24, 2029	Preferred Series B	87,955		$	8.53		$	209	$	—
												Warrant⁽¹⁴⁾	November 10, 2021	November 10, 2031	Common Stock	148,730		$	7.74			265		4
Total Knockaway, Inc.																						474		4

Sub-Total: Real Estate (0.0%)*																					$	693	$	143

Rental and Leasing Services ⁽⁷⁾

Maxwell Financial Labs, Inc.												Warrant⁽¹⁴⁾	October 7, 2020	October 7, 2030	Common Stock	106,735		$	0.29		$	20	$	318
												Warrant⁽¹⁴⁾	December 22, 2020	December 22, 2030	Common Stock	110,860		$	0.29			34		330
												Warrant⁽¹⁴⁾	September 30, 2021	September 30, 2031	Common Stock	79,135		$	1.04			148		210
Total Maxwell Financial Labs, Inc.																						202		858

NextCar Holding Company, Inc.												Warrant⁽¹⁴⁾	December 14, 2021	December 14, 2026	Preferred Series A	169,898	⁽¹³⁾	$	2.81	⁽¹³⁾	$	35	$	26
	Secured Loan	January 16, 2020	May 1, 2023	Fixed interest rate 11.5%; EOT 5.0%		2,711		2,917		2,902		Warrant⁽¹⁴⁾	February 23, 2022	February 23, 2032	Preferred Series A	13,273	⁽¹³⁾	$	2.81	⁽¹³⁾		3		5
	Secured Loan	January 16, 2020	January 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		2,642		2,726		2,777		Warrant⁽¹⁴⁾	March 16, 2022	March 16, 2032	Preferred Series A	15,928	⁽¹³⁾	$	2.81	⁽¹³⁾		3		6
	Secured Loan	January 17, 2020	February 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		3,620		3,752		3,798		Warrant⁽¹⁴⁾	April 18, 2022	April 18, 2032	Preferred Series A	146,006	⁽¹³⁾	$	2.81	⁽¹³⁾		6		52
Total NextCar Holding Company, Inc.																						47		89
	Secured Loan	June 8, 2020	July 1, 2024	Fixed interest rate 11.5%: EOT 5.0%		4,000		4,078		4,183
Sub-Total: Rental and Leasing Services (0.1%)*																					$	249	$	947
	Secured Loan	October 29, 2020	November 1, 2024	Fixed interest rate 11.5%: EOT 5.0%		5,000		5,062		5,193
Total Invenia, Inc. ⁽¹⁰⁾						23,106		24,128		24,378

Sub-total: Utilities (6.4%)*					$	23,106	$	24,128	$	24,378

Wholesale Trade ⁽²⁾
BaubleBar, Inc.	Secured Loan	January 16, 2020	March 1, 2023	Fixed interest rate 11.5%; EOT 7.3%	$	4,599	$	5,467	$	5,160

Grandpad, Inc.	Equipment Financing	November 16, 2020	June 1, 2023	Fixed interest rate 10.6%; EOT 5.0%	$	2,359	$	2,416	$	2,431
	Equipment Financing	December 23, 2020	July 1, 2023	Fixed interest rate 10.8%; EOT 5.0%		2,996		3,055		3,072
Total Grandpad, Inc. ⁽¹⁶⁾						5,355		5,471		5,503

Sub-total: Wholesale Trade (2.8%)*					$	9,954	$	10,938	$	10,663

Total: Debt Securities (136.5%)* ⁽¹⁵⁾					$	511,661	$	521,022	$	518,433

1522

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company ⁽¹⁾

Type of
Investment ⁽³⁾

Investment Date ⁽⁴⁾

Expiration Date

Series

Shares

Strike Price

Cost

Fair Value ⁽⁷⁾
Warrant Investments













Agriculture, Forestry, Fishing and Hunting ⁽²⁾












Bowery Farming, Inc.

Warrant

January 16, 2020

June 10, 2029

Common Stock

68,863

$
5.08

$
410

$
1,790

Warrant

December 22, 2020

December 22, 2030

Common Stock

29,925

$
6.24

$
160

$
760
Total Bowery Farming, Inc.

570

2,550

Robotany, Inc.

Warrant

January 16, 2020

July 19, 2029

Common Stock

262,870

$
0.26

$
128

$
84

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.7%)*

$
698

$
2,634

Construction ⁽²⁾






Project Frog, Inc. ⁽¹⁹⁾

Warrant

January 16, 2020

July 26, 2026

Preferred Series AA

391,990

$
0.19

$
18

$
1

Sub-Total: Construction (0.0%)*



$
18

$
1

Educational Services ⁽²⁾






Medical Sales Training Holding Company

Warrant

March 18, 2021

March 18, 2031

Common Stock

3,232

$
7.74

$
21

$
17

Yellowbrick Learning, Inc.

Warrant

January 16, 2020

September 28, 2028

Common Stock

222,222

$
0.90

$
120

$
551

Sub-Total: Educational Services (0.1%)*





$
141

$
568

Finance and Insurance ⁽²⁾








DailyPay, Inc.

Warrant

September 30, 2020

September 30, 2030

Common Stock

89,264

$
3.00

$
151

$
863

Petal Card, Inc.

Warrant

January 16, 2020

November 27, 2029

Preferred Series B

250,268

$
1.32

$
147

$
471

Warrant

January 11, 2021

January 11, 2031

Common Stock ⁽¹⁶⁾

135,835

0.01

312

384
Total Petal Card, Inc.

459

855

Realty Mogul

Warrant

January 16, 2020

December 18, 2027

Preferred Series B

234,421

$
3.88

$
285

$
25

Sub-Total: Finance and Insurance (0.5%)*



$
895

$
1,743

Health Care and Social Assistance ⁽²⁾






Lark Technologies, Inc.

Warrant

September 30, 2020

September 30, 2030

Common Stock

76,231

$
1.76

$
177

$
248

Warrant

June 30, 2021

June 30, 2031

Common Stock

79,325

$
1.76

258

258
Total Lark Technologies, Inc.

435

506

Sub-Total: Health Care and Social Assistance (0.1%)*

$
435

$
506

Information ⁽²⁾






Everalbum, Inc.

Warrant

January 16, 2020

July 29, 2026

Preferred Series A

851,063

$
0.10

$
24

$
8

Figg, Inc. ⁽⁹⁾

Warrant

January 16, 2020

March 31, 2028

Common Stock

935,198

$
0.07

$
—

$
—

Firefly Systems, Inc.

Warrant

January 31, 2020

January 29, 2030

Common Stock

133,147

$
1.14

$
282

$
142

Gtxcel, Inc.

Warrant

January 16, 2020

September 24, 2025

Preferred Series C

1,000,000

$
0.21

$
83

$
13

Warrant

January 16, 2020

September 24, 2025

Preferred Series D

1,000,000

$
0.21

83

—
Total Gtxcel, Inc.



166

13

Lucidworks, Inc.

Warrant

January 16, 2020

June 27, 2026

Preferred Series D

619,435

$
0.77

$
806

$
1,718

Oto Analytics, Inc.

Warrant

January 16, 2020

August 31, 2028

Preferred Series B

1,018,718

$
0.79

$
295

$
164

RapidMiner, Inc.

Warrant

January 16, 2020

March 25, 2029

Preferred Series C-1

11,624

$
60.22

$
528

$
55

Rigetti & Co, Inc.

Warrant

May 18, 2021

May 18, 2031

Common Stock

995,099

$
0.21

$
506

$
560

Sub-Total: Information (0.7%)*





$
2,607

$
2,660


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments- United States, Continued

Retail Trade ⁽⁷⁾
Boosted eCommerce, Inc.	Warrant⁽¹⁴⁾	December 18, 2020	December 14, 2030	Preferred Series A-1	759,263	$	0.84	$	259	$	79

Fernished, Inc.	Warrant⁽¹⁴⁾	May 5, 2021	May 5, 2031	Common Stock	54,427	$	0.15	$	39	$	30

Gobble, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	May 9, 2028	Common Stock	74,635	$	1.20	$	73	$	48
	Warrant⁽¹⁴⁾	January 16, 2020	December 27, 2029	Common Stock	10,000	$	1.22		617		358
Total Gobble, Inc.									690		406

Madison Reed, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	March 23, 2027	Preferred Series C	194,553	$	2.57	$	185	$	300
	Warrant⁽¹⁴⁾	January 16, 2020	July 18, 2028	Common Stock	43,158	$	0.99		71		118
	Warrant⁽¹⁴⁾	January 16, 2020	June 30, 2029	Common Stock	36,585	$	1.23		56		93
Total Madison Reed, Inc.									312		511

Portofino Labs, Inc.	Warrant⁽¹⁴⁾	December 31, 2020	December 31, 2030	Common Stock	39,659	$	1.53	$	160	$	109
	Warrant⁽¹⁴⁾	April 1, 2021	April 1, 2031	Common Stock	39,912	$	1.46		100		45
Total Portofino Labs, Inc.									260		154

Super73, Inc.	Warrant⁽¹⁴⁾	December 31, 2020	December 31, 2030	Common Stock	177,305	$	3.16	$	105	$	136

Trendly, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	August 10, 2026	Preferred Series A	245,506	$	1.14	$	221	$	37

Sub-Total: Retail Trade (0.1%)*								$	1,886	$	1,353

Space Research and Technology ⁽⁷⁾
Axiom Space, Inc.	Warrant⁽¹⁴⁾	May 28, 2021	May 28, 2031	Common Stock	1,773	$	169.24	$	121	$	62
	Warrant⁽¹⁴⁾	May 28, 2021	May 28, 2031	Common Stock	882	$	340.11		39		10
Total Axiom Space, Inc.									160		72

Sub-Total: Space Research and Technology (0.0%)*								$	160	$	72


Wholesale Trade ⁽⁷⁾
BaubleBar, Inc.	Warrant⁽¹⁴⁾	January 16, 2020	March 29, 2027	Preferred Series C	531,806	$	1.96	$	639	$	483
	Warrant⁽¹⁴⁾	January 16, 2020	April 20, 2028	Preferred Series C	60,000	$	1.96		72		54
Total BaubleBar, Inc.									711		537

GrubMarket, Inc.	Warrant⁽¹⁴⁾	June 15, 2020	June 15, 2030	Common Stock	405,000	$	1.10	$	115	$	703

Sub-Total: Wholesale Trade (0.1%)*								$	826	$	1,240

Total: Warrant Investments- United States (3.0%)*								$	19,892	$	32,187

1623

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares		Strike Price			Cost		Fair Value ⁽⁶⁾
Warrant Investments- Canada

Manufacturing ⁽⁷⁾
Nexii Building Solutions, Inc. ⁽¹⁰⁾	Warrant⁽¹⁴⁾	August 27, 2021	August 27, 2026	Common Stock	63,071	⁽¹³⁾	$	15.86	⁽¹³⁾	$	410	$	386
	Warrant⁽¹⁴⁾	June 8, 2022	June 8, 2027	Common Stock	24,196	⁽¹³⁾	$	15.96	⁽¹³⁾		204		204
Total Nexii Building Solutions, Inc.											614		590

Sub-Total: Manufacturing (0.1%)*										$	614	$	590

Transportation and Warehousing ⁽⁷⁾
GoFor Industries, Inc. ⁽¹⁰⁾	Warrant⁽¹⁴⁾	January 21, 2022	February 21, 2022	Common Stock	171,954		$	0.45		$	105	$	—

Sub-Total: Transportation and Warehousing (0.0%)*										$	105	$	—

Total: Warrant Investments- Canada (0.1%)*										$	719	$	590

Warrant Investments- Europe

Manufacturing ⁽⁷⁾

Aledia, Inc. ⁽¹⁰⁾	Warrant⁽¹⁴⁾	March 31, 2022	March 31, 2032	Preferred Series D-3	33,552	⁽¹³⁾	$	148.92	⁽¹³⁾	$	130	$	415

Sub-Total: Manufacturing (0.0%)*										$	130	$	415

Total: Warrant Investments- Europe (0.0%)*										$	130	$	415

Total: Warrant Investments- (3.0%)⁽¹⁹⁾*										$	20,741	$	33,192

24

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽⁴⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁷⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Shares / Principal		Series	Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued
Equity Investments- United States
Construction ⁽⁷⁾
Project Frog, Inc.													Equity⁽¹⁴⁾	January 16, 2020		4,383,173	Preferred Series AA-1⁽¹⁷⁾	$	351	$	17
													Equity⁽¹⁴⁾	January 16, 2020		3,401,427	Preferred Series BB⁽¹⁷⁾		1,333		40
Manufacturing ⁽²⁾
Circle Media Labs, Inc.	Warrant	May 5, 2021	May 5, 2031	Common Stock	101,667	$	0.31	$	29	$	31
													Equity⁽¹⁴⁾	August 3, 2021		6,634,061	Common Stock		1,684		10
Daring Foods, Inc.	Warrant	April 8, 2021	April 8, 2031	Common Stock	68,100	$	0.27	$	106	$	440
													Equity⁽¹⁴⁾	August 3, 2021		3,129,887	Preferred Series CC⁽¹⁷⁾		1,254		296
Footprint International Holding, Inc.	Warrant	February 14, 2020	February 14, 2030	Common Stock	26,852	$	0.31	$	5	$	32
Total Project Frog, Inc. ⁽²⁰⁾																			4,622		363
	Warrant	June 22, 2020	June 22, 2030	Common Stock	10,836	$	0.31		4		80
Total Footprint International Holding, Inc.									9		112
Sub-Total: Construction (0.0%)*																		$	4,622	$	363

Happiest Baby, Inc.	Warrant	January 16, 2020	May 16, 2029	Common Stock	182,554	$	0.33	$	193	$	177
Health Care and Social Assistance ⁽⁷⁾
FemTec, Inc. ⁽²⁰⁾													Equity⁽¹⁴⁾	July 22, 2021		1,098,093	Common Stock	$	13,046	$	8,956

Lensvector, Inc.	Warrant	January 16, 2020	December 30, 2021	Preferred Series C	85,065	$	1.18	$	32	$	—
Lark Technologies, Inc.													Equity⁽¹⁴⁾	August 19, 2021		32,416	Preferred Series D⁽¹⁷⁾	$	500	$	457

WorkWell Prevention & Care Inc.													Equity⁽¹⁴⁾	January 16, 2020		7,000,000	Common Stock	$	51	$	—
													Equity⁽¹⁴⁾	January 16, 2020		3,450	Preferred Series P⁽¹⁷⁾		3,450		—
													Equity⁽¹⁴⁾	January 16, 2020	$	3,170	Convertible Note⁽¹⁶⁾		3,219		—
Total WorkWell Prevention & Care Inc. ⁽²⁰⁾																			6,720		—

Sub-Total: Health Care and Social Assistance (0.9%)*																		$	20,266	$	9,413

Information ⁽⁷⁾
Rigetti & Co, Inc.													Equity^(9)(14)	February 25, 2022		50,000	Common Stock	$	500	$	184
													Equity^(9)(14)	May 18, 2021		757,297	Common Stock		506		2,670
Total Rigetti & Co, Inc.																			1,006		2,854

Sub-Total: Information (0.3%)*																		$	1,006	$	2,854

Manufacturing ⁽⁷⁾
Hadrian, Inc.													Equity⁽¹⁴⁾	March 29, 2022		53,154	Preferred A-4⁽¹⁷⁾	$	500	$	500

Mainspring Energy, Inc.	Warrant	January 16, 2020	July 9, 2029	Common Stock	140,186	$	1.15	$	283	$	480		Equity⁽¹⁴⁾	March 30, 2022	$	500	Convertible Note⁽¹⁶⁾	$	500	$	500
	Warrant	November 20, 2020	November 20, 2030	Common Stock	81,294	$	1.15		226		279
Total Mainspring Energy, Inc.									509		759

Molekule, Inc.	Warrant	June 19, 2020	June 19, 2030	Preferred Series C-1	32,051	$	3.12	$	16	$	10

Quip NYC, Inc.	Warrant	March 9, 2021	March 9, 2031	Preferred Series A-1	10,833	$	48.46	$	204	$	216		Equity⁽¹⁴⁾	August 17, 2021		3,320	Preferred Series B-1⁽¹⁷⁾	$	500	$	445

SBG Labs, Inc.	Warrant	January 16, 2020	June 29, 2023	Preferred Series A-1	42,857	$	0.70	$	13	$	—
	Warrant	January 16, 2020	September 18, 2024	Preferred Series A-1	25,714	$	0.70		8		—
	Warrant	January 16, 2020	January 14, 2024	Preferred Series A-1	21,492	$	0.70		7		—
	Warrant	January 16, 2020	March 24, 2025	Preferred Series A-1	12,155	$	0.70		4		—
	Warrant	January 16, 2020	October 10, 2023	Preferred Series A-1	11,150	$	0.70		4		—
	Warrant	January 16, 2020	May 6, 2024	Preferred Series A-1	11,145	$	0.70		4		—
	Warrant	January 16, 2020	June 9, 2024	Preferred Series A-1	7,085	$	0.70		2		—
	Warrant	January 16, 2020	May 20, 2024	Preferred Series A-1	342,857	$	0.70		110		—
	Warrant	January 16, 2020	March 26, 2025	Preferred Series A-1	200,000	$	0.70		65		—
Total SBG Labs, Inc.									217		—
Store Intelligence, Inc. ⁽²⁰⁾													Equity⁽¹⁴⁾	May 2, 2020		1,430,000	Preferred Series A⁽¹⁷⁾	$	608	$	—

Tarana Wireless, Inc.	Warrant	June 30, 2021	June 30, 2031	Common Stock	5,027,629	$	0.19	$	967	$	967		Equity⁽¹⁴⁾	March 16, 2022		611,246	Preferred Series 6⁽¹⁷⁾	$	500	$	487

The Fynder Group, Inc.	Warrant	October 14, 2020	October 14, 2030	Common Stock	107,190	$	0.49	$	201	$	1,176
Vertical Communications, Inc.													Equity⁽¹¹⁾⁽¹⁴⁾	January 16, 2020		3,892,485	Preferred Series 1⁽¹⁷⁾	$	—	$	—
													Equity⁽¹⁴⁾	January 16, 2020	$	5,500	Convertible Note⁽¹⁶⁾		3,966		3,550
Vertical Communications, Inc. ^{(9) (19)}	Warrant	January 16, 2020	July 11, 2026	Preferred Series A	828,479	$	1.00	$	—	$	—
Total Vertical Communications, Inc. ⁽²⁰⁾																			3,966		3,550

VitaCup, Inc.	Warrant	June 23, 2021	June 23, 2031	Preferred Series C	68,996	$	2.79	$	9	$	7
Sub-Total: Manufacturing (0.5%)*																		$	6,574	$	5,482

Sub-Total: Manufacturing (1.0%)*								$	2,492	$	3,895
Professional, Scientific, and Technical Services ⁽⁷⁾
Dynamics, Inc.													Equity⁽¹⁴⁾	January 16, 2020		17,726	Preferred Series A⁽¹⁷⁾	$	390	$	—


Edeniq, Inc.													Equity⁽¹¹⁾⁽¹⁴⁾	January 16, 2020		2,527,449	Preferred Series B⁽¹⁷⁾	$	—	$	66
													Equity⁽¹¹⁾⁽¹⁴⁾	January 16, 2020		3,657,487	Preferred Series C⁽¹⁷⁾		—		98
													Equity⁽¹¹⁾⁽¹⁴⁾	November 29, 2021		133,766,138	Preferred Series D⁽¹⁷⁾		—		354
Total Edeniq, Inc. ⁽²⁰⁾																			—		518

Emerald Cloud Lab, Inc.													Equity⁽¹¹⁾⁽¹⁴⁾	June 3, 2022		—	Preferred Series C⁽¹⁷⁾	$	500	$	500

Emergy, Inc.													Equity⁽¹⁴⁾	June 28, 2021		75,958	Preferred Series B⁽¹⁷⁾	$	500	$	509

Nomad Health, Inc.													Equity⁽¹¹⁾⁽¹⁴⁾	May 27, 2022		37,920	Preferred Series D-1⁽¹⁷⁾	$	500	$	500

Sub-Total: Professional, Scientific, and Technical Services (0.2%)*												Sub-Total: Professional, Scientific, and Technical Services (0.2%)*						$	1,890	$	2,027

1725

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, ~~2021~~2022

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Shares / Principal		Series	Cost		Fair Value ⁽⁶⁾
Equity Investments- United States, Continued
Real Estate ⁽⁷⁾
Knockaway, Inc.	Equity⁽¹⁴⁾	March 30, 2022	$	500	Convertible Note⁽¹⁶⁾	$	500	$	500

Orchard Technologies, Inc.	Equity⁽¹⁴⁾	August 6, 2021		74,406	Preferred Series D⁽¹⁷⁾	$	500	$	281

Sub-Total: Real Estate (0.1%)*						$	1,000	$	781

Rental and Leasing Services ⁽⁷⁾
Maxwell Financial Labs, Inc	Equity⁽¹⁴⁾	January 22, 2021		135,641	Preferred Series B⁽¹⁷⁾	$	500	$	508

Sub-Total: Rental and Leasing Services (0.0%)*						$	500	$	508

Retail Trade ⁽⁷⁾
Fernished, Inc.	Equity⁽¹⁴⁾	October 6, 2021		454,905	Preferred Series B-1⁽¹⁷⁾	$	500	$	389

Portofino Labs, Inc.	Equity⁽¹⁴⁾	November 1, 2021		256,291	Preferred Series B-1⁽¹⁷⁾	$	500	$	496

Sub-Total: Retail Trade (0.1%)*						$	1,000	$	885

Space Research and Technology ⁽⁷⁾
Axiom Space, Inc.	Equity⁽¹⁴⁾	August 11, 2021	$	500	Convertible Note⁽¹⁶⁾	$	500	$	500

Sub-Total: Rental and Leasing Services (0.0%)*						$	500	$	500

Total: Equity Investments- United States (2.1%)*						$	37,358	$	22,813

Equity Investments- Canada

Manufacturing ⁽⁷⁾
Nexii Building Solutions, Inc. ⁽¹⁰⁾	Equity⁽¹⁴⁾	February 28, 2022		24,418	Common Stock	$	500	$	476

Sub-Total: Manufacturing (0.0%)*						$	500	$	476

Total: Equity Investments- Canada (0.0%)*						$	500	$	476

Total: Equity Investments (2.1%)⁽¹⁹⁾*						$	37,858	$	23,289

Total Investment in Securities (96.4%)*						$	1,066,598	$	1,051,074

Cash, Cash Equivalents, and Restricted Cash
Goldman Sachs Financial Square Government Institutional Fund						$	12,474	$	12,474
Other cash accounts							752		752
Cash, Cash Equivalents, and Restricted Cash (1.2%)*							13,226		13,226

Total Portfolio Investments and Cash and Cash Equivalents (97.6% of net assets)						$	1,079,824	$	1,064,300

Portfolio Company ⁽¹⁾

Type of
Investment ⁽³⁾

Investment Date ⁽⁴⁾

Expiration Date

Series

Shares

Strike Price

Cost

Fair Value ⁽⁷⁾
Warrant Investments, Continued











Pharmaceutical ⁽²⁾










Zosano Pharma Corporation

Warrant

January 16, 2020

September 25, 2025

Common Stock ⁽⁸⁾

75,000

$
3.59

$
69

$
36

Sub-Total: Pharmaceutical (0.0%)*







$
69

$
36

Professional, Scientific, and Technical Services ⁽²⁾










Augmedix, Inc.

Warrant

January 16, 2020

September 3, 2029

Common Stock

580,383

$
2.88

$
449

$
1,281

Continuity, Inc.

Warrant

January 16, 2020

March 29, 2026

Preferred Series C

1,588,806

$
0.25

$
21

$
32

Crowdtap, Inc.

Warrant

January 16, 2020

December 16, 2025

Preferred Series B

442,233

$
1.09

$
42

$
120

Warrant

January 16, 2020

November 30, 2027

Preferred Series B

100,000

$
1.09

9

27
Total Crowdtap, Inc.



51

147

Dynamics, Inc.

Warrant

January 16, 2020

March 10, 2024

Common Stock

17,000

$
10.59

$
86

$
—

E La Carte, Inc.

Warrant

January 16, 2020

July 28, 2027

Common Stock

497,183

$
0.30

$
186

$
128

Warrant

January 16, 2020

July 28, 2027

Preferred Series A

104,284

$
7.49

15

36

Warrant

January 16, 2020

July 28, 2027

Preferred Series AA-1

106,841

$
7.49

15

1
Total E La Carte, Inc.



216

165

Edeniq, Inc.

Warrant

January 16, 2020

December 23, 2026

Preferred Series B

2,685,501

$
0.22

$
—

$
—

Warrant

January 16, 2020

December 23, 2026

Preferred Series B

2,184,672

$
0.01

—

—

Warrant

January 16, 2020

March 12, 2028

Preferred Series C

5,106,972

$
0.44

—

—

Warrant

January 16, 2020

October 15, 2028

Preferred Series C

3,850,294

$
0.01

—

—
Total Edeniq, Inc. ^(9)(19)



—

—

Greenlight Biosciences Inc.

Warrant

March 29, 2021

March 29, 2031

Common Stock

219,839

$
0.81

$
138

$
164

Hologram, Inc.

Warrant

January 31, 2020

January 27, 2030

Common Stock

193,054

$
0.26

$
49

$
51

Hospitalists Now, Inc.

Warrant

January 16, 2020

March 30, 2026

Preferred Series D-2

135,807

$
5.89

$
71

$
181

Warrant

January 16, 2020

December 6, 2026

Preferred Series D-2

750,000

$
5.89

391

999
Total Hospitalists Now, Inc.



462

1,180

��

Incontext Solutions, Inc.

Warrant

January 16, 2020

September 28, 2028

Preferred Series AA-1

332,858

$
1.47

$
34

$
2

Matterport, Inc.

Warrant

January 16, 2020

April 20, 2028

Common Stock

143,813

$
1.43

$
434

$
6,667

PebblePost, Inc. ⁽¹⁴⁾

Warrant

May 7, 2021

May 7, 2031

Common Stock

657,343

$
1.76

$
68

$
142

Pendulum Therapeutics, Inc.

Warrant

January 16, 2020

October 9, 2029

Preferred Series B

55,263

$
1.90

$
44

$
48

Warrant

June 1, 2020

July 15, 2030

Preferred Series B

36,842

$
1.90

36

32
Total Pendulum Therapeutics, Inc.

80

80

Reciprocity, Inc.

Warrant

September 25, 2020

September 25, 2030

Common Stock

114,678

$
4.17

$
99

$
109

Warrant

April 29, 2021

April 29, 2031

Common Stock

57,195

$
1.90

54

54
Total Reciprocity, Inc.

153

163

Resilinc, Inc.

Warrant

January 16, 2020

December 15, 2025

Preferred Series A

589,275

$
0.51

$
40

$
1

Sun Basket, Inc.

Warrant

January 16, 2020

October 5, 2027

Preferred Series C-2

249,306

$
6.02

$
111

$
167

Warrant

December 31, 2020

December 29, 2032

Common Stock

118,678

$
0.89

545

499

656

666

Utility Associates, Inc.

Warrant

January 16, 2020

June 30, 2025

Preferred Series A

92,511

$
4.54

$
55

$
1

Warrant

January 16, 2020

May 1, 2026

Preferred Series A

60,000

$
4.54

36

—

Warrant

January 16, 2020

May 22, 2027

Preferred Series A

200,000

$
4.54

120

—
Total Utility Associates, Inc.





211

1

Sub-Total: Professional, Scientific, and Technical Services (2.8%)*

$
3,148

$
10,742

18

~~(5)~~(4)

Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or ~~any~~ additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair ~~market~~ value, ~~in certain cases~~generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt ~~securities~~securities.

~~(6)~~(5)

Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

~~(7)~~(6)

Except as noted, all investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.

(7)	The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.

(8)	~~Asset is valued using Level 2 inputs.~~

~~(9)~~

~~Investment has zero cost basis as it was purchased at a fair market value of zero as part of the Formation Transactions.~~

~~(10)~~

~~Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended. The Company’s~~ percentage of non-qualifying assets at fair value represents 9.9% of the Company’s total assets as of June 30, 2021. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Invenia, Inc. is a Canadian corporation, and Atieva, Inc. is a Cayman Island corporation.

~~(11)~~

The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was ~~3.25%~~4.75% and 1-month U.S. Dollar London Interbank Offered Rate (“LIBOR”) was 1.79% as of June 30, ~~2021.~~ 2022.

21

(19)	All of the Company’s debt securities are pledged as collateral supporting the amounts outstanding under the credit facility with KeyBank (see “Note 5 – Borrowings”), except as noted.

(20)

This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments are defined by the ~~Investment Company~~1940 Act, ~~of 1940,~~ as amended, as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the ~~Investment Company~~1940 Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of June 30, ~~2021,~~2022, along with transactions during the six months ended June 30, ~~2021~~2022 in these control or affiliated investments are as follows:


									Net change in
									Unrealized
	Fair Value at		Gross		Gross		Realized		(Depreciation)/		Fair Value at		Interest
	December 31, 2021		Additions ⁽¹⁾		Reductions ⁽²⁾		Gain/(Loss)		Appreciation		June 30, 2022		Income
For the Six Months Ended June 30, 2022
Control Investments
Edeniq, Inc.	$	5,522	$	1,237	$	—	$	—	$	(751)	$	6,008	$	1,527
Project Frog, Inc.		4,209		27		(3,878)		(228)		256		386		228
Vertical Communications, Inc.		17,382		252		—		—		(247)		17,387		983
WorkWell Prevention and Care Inc.		5,101		300		—		—		(4,394)		1,007		—
Total Control Investments	$	32,214	$	1,816	$	(3,878)	$	(228)	$	(5,136)	$	24,788	$	2,738

Affiliate Investments
FemTec Health, Inc.	$	27,748	$	28	$	—	$	—	$	(3,939)	$	23,837	$	862
Store Intelligence, Inc.		4,444		—		(2,400)		(9,633)		7,589		—		—
Total Affiliate Investments	$	32,192	$	28	$	(2,400)	$	(9,633)	$	3,650	$	23,837	$	862

Total Control and Affiliate Investments	$	64,406	$	1,844	$	(6,278)	$	(9,861)	$	(1,486)	$	48,625	$	3,600

Net change in

Unrealized

Fair Value at

Gross

Gross

Realized

(Depreciation)/

Fair Value at

Interest


December 31, 2020

Additions ⁽¹⁾

Reductions ⁽²⁾

Gain/(Loss)

Appreciation

June 30, 2021

Income

For the Six Months Ended June 30, 2021

Control Investments











Birchbox, Inc.

$
19,369

$
5,564

$
—

$
—

$
(10,624)

$
14,309

$
514

Edeniq, Inc.

1,507

178

(1,698)

—

356

343

557

Project Frog, Inc.

4,516

26

—

—

194

4,736

273

Vertical Communications, Inc.

16,953

447

(242)

—

(1,035)

16,123

1,049

WorkWell Prevention and Care Inc.

6,385

1,017

—

—

(975)

6,427

179

Total Control Investments

$
48,730

$
7,232

$
(1,940)

$
—

$
(12,084)

$
41,938

$
2,572















Affiliate Investments















Ology Bioservices, Inc.

$
15,072

$
—

$
(9,304)

$
1,491

$
(7,259)

$
—

$
—

Store Intelligence, Inc.

12,578

162

—

—

(945)

11,795

882

Total Affiliate Investments

$
27,650

$
162

$
(9,304)

$
1,491

$
(8,204)

$
11,795

$
882















Total Control and Affiliate Investments

$
76,380

$
7,394

$
(11,244)

$
1,491

$
(20,288)

$
53,733

$
3,454

(1)

Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one

22

~~Table of Contents~~

or more new securities and the movement of an existing portfolio company into this category from a different category.

(2)

Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

2328

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities

Administrative and Support and Waste Management and Remediation ⁽⁷⁾
Qwick, Inc.	Secured Loan⁽¹⁹⁾	December 31, 2021	January 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 5.0% ⁽⁸⁾	$	5,000	$	4,903	$	4,903

RTS Holding, Inc.	Secured Loan⁽¹⁹⁾	December 31, 2021	January 1, 2027	Fixed interest rate 10.5%; EOT 3.0%	$	23,000	$	22,711	$	22,711

SeaOn Environmental, LLC	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.0%; EOT 12.0%	$	1,115	$	1,490	$	1,474

Sub-total: Administrative and Support and Waste Management and Remediation (3.1%)*					$	29,115	$	29,104	$	29,088

Agriculture, Forestry, Fishing and Hunting ⁽⁷⁾
Bowery Farming, Inc.	Secured Loan⁽¹⁴⁾	September 10, 2021	January 1, 2026	Variable interest rate LIBOR + 11.0% or Floor rate 10.1% ⁽⁸⁾	$	10,000	$	9,253	$	9,300

Robotany, Inc.	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.6%; EOT 22.0%	$	1,186	$	1,458	$	1,492

Sub-total: Agriculture, Forestry, Fishing and Hunting (1.2%)*					$	11,186	$	10,711	$	10,792

Construction ⁽⁷⁾
Dandelion Energy, Inc.	Equipment Financing	March 17, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 12.5%	$	332	$	367	$	368
	Equipment Financing	October 27, 2020	November 1, 2024	Fixed interest rate 9.2%; EOT 12.5%		421		456		453
	Equipment Financing	November 19, 2020	December 1, 2024	Fixed interest rate 9.1%; EOT 12.5%		524		564		561
	Equipment Financing	December 29, 2020	January 1, 2025	Fixed interest rate 9.2%; EOT 12.5%		615		657		653
	Equipment Financing	March 25, 2021	April 1, 2025	Fixed interest rate 9.1%; EOT 12.5%		1,238		1,300		1,295
	Equipment Financing	December 1, 2021	January 1, 2026	Fixed interest rate 8.8%; EOT 12.5%		1,356		1,362		1,362
Total Dandelion Energy, Inc.						4,486		4,706		4,692

Project Frog, Inc. ⁽²²⁾	Secured Loan	April 30, 2020	May 1, 2023	Fixed interest rate 12.0%	$	4,128	$	4,080	$	3,754

Sub-total: Construction (0.9%)*					$	8,614	$	8,786	$	8,446

Educational Services ⁽⁷⁾
Medical Sales Training Holding Company	Secured Loan	March 18, 2021	April 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾	$	6,000	$	5,962	$	6,052
	Secured Loan	July 21, 2021	August 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾		2,000		1,973		2,013
Total Medical Sales Training Holding Company						8,000		7,935		8,065

Yellowbrick Learning, Inc.	Secured Loan	February 1, 2021	September 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾	$	7,500	$	7,579	$	7,630
	Secured Loan	August 10, 2021	March 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾		2,500		2,504		2,525
Total Yellowbrick Learning, Inc.						10,000		10,083		10,155

Sub-total: Educational Services (2.0%)*					$	18,000	$	18,018	$	18,220

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾
Debt Securities

Administrative and Support and Waste Management and Remediation ⁽²⁾










SeaOn Environmental, LLC

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 9.0%; EOT 12.0%

$
2,134

$
2,370

$
2,328

Sub-total: Administrative and Support and Waste Management and Remediation (1.0%)*


$
2,134

$
2,370

$
2,328

Agriculture, Forestry, Fishing and Hunting ⁽²⁾












Bowery Farming, Inc.

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 8.5%; EOT 8.5%

$
2,481

$
2,742

$
2,574

Equipment Financing

January 16, 2020

February 1, 2023

Fixed interest rate 8.7%; EOT 8.5%

2,453

2,650

2,684

Equipment Financing

January 16, 2020

May 1, 2023

Fixed interest rate 8.7%; EOT 8.5%

3,054

3,259

3,303

Equipment Financing

December 22, 2020

January 1, 2024

Fixed interest rate 7.5%; EOT 8.5%

10,000

9,912

9,912
Total Bowery Farming, Inc.



17,988

18,563

18,473

Robotany, Inc.

Equipment Financing

January 16, 2020

January 1, 2024

Fixed interest rate 7.6%; EOT 22.0%

$
1,667

$
1,720

$
1,709

Sub-total: Agriculture, Forestry, Fishing and Hunting (8.5%)*



$
19,655

$
20,283

$
20,182

Construction ⁽²⁾












Dandelion Energy, Inc.

Equipment Financing

March 17, 2020

April 1, 2024

Fixed interest rate 9.0%; EOT 12.5%

$
460

$
467

$
471

Equipment Financing

October 27, 2020

November 1, 2024

Fixed interest rate 9.2%; EOT 12.5%

545

551

551

Equipment Financing ⁽¹²⁾

November 19, 2020

December 1, 2024

Fixed interest rate 9.1%; EOT 12.5%

558

563

563

Equipment Financing

December 29, 2020

January 1, 2025

Fixed interest rate 9.2%; EOT 12.5%

791

791

791
Total Dandelion Energy, Inc.

2,354

2,372

2,376

Project Frog, Inc. ⁽¹⁹⁾

Secured Loan

April 30, 2020

May 1, 2023

Fixed interest rate 12.0%

$
4,128

$
4,045

$
4,029

Sub-total: Construction (2.7%)*



$
6,482

$
6,417

$
6,405

Educational Services ⁽²⁾

Examity, Inc.

Secured Loan

January 16, 2020

February 1, 2022

Fixed interest rate 11.5%; EOT 8.0%

$
3,280

$
4,028

$
3,994

Secured Loan

January 16, 2020

February 1, 2022

Fixed interest rate 11.5%; EOT 4.0%

3,516

1,775

1,775

Secured Loan

January 16, 2020

January 1, 2023

Fixed interest rate 12.25%; EOT 4.0%

1,658

1,005

1,004
Total Examity, Inc.



8,454

6,808

6,773

Qubed, Inc. dba Yellowbrick

Secured Loan

January 16, 2020

October 1, 2023

Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁹⁾

$
1,906

$
1,950

$
1,957

Secured Loan

January 16, 2020

October 1, 2023

Fixed interest rate 11.5%; EOT 4.0%

476

481

493
Total Qubed, Inc. dba Yellowbrick



2,382

2,431

2,450

Sub-total: Educational Services (3.9%)*



$
10,836

$
9,239

$
9,223

2429

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Finance and Insurance ⁽⁷⁾
BoardRE, Inc.	Secured Loan⁽¹⁹⁾	October 15, 2021	May 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾	$	5,000	$	4,973	$	4,973

DailyPay, Inc.	Secured Loan	September 30, 2020	November 1, 2024	Variable interest rate Prime + 5.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾	$	19,536	$	19,869	$	20,040
	Secured Loan	December 30, 2020	January 1, 2025	Variable interest rate Prime + 5.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾		5,000		5,076		5,101
Total DailyPay, Inc.						24,536		24,945		25,141

Petal Card, Inc.	Secured Loan	January 16, 2020	October 1, 2024	Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾	$	10,000	$	10,140	$	10,078
	Secured Loan ^(12)(14)	January 28, 2021	January 1, 2024	Variable interest rate Prime + 4.3% or Floor rate 11.5% ⁽⁸⁾		14,234		13,986		14,236
	Secured Loan	August 6, 2021	October 1, 2024	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾		7,000		6,855		6,908
Total Petal Card, Inc.						31,234		30,981		31,222

Sub-total: Finance and Insurance (6.6%)*					$	60,770	$	60,899	$	61,336

Health Care and Social Assistance ⁽⁷⁾
FemTec Health, Inc.	Secured Loan	December 1, 2021	July 1, 2026	Fixed interest rate 11.0%; EOT 7.5%	$	10,000	$	10,752	$	10,168
	Secured Loan	July 23, 2021	September 1, 2022	Fixed interest rate 11.0%		2,151		2,152		2,171
	Secured Loan	September 29, 2021	April 1, 2026	Fixed interest rate 11.0%; EOT 7.5%		3,000		3,019		3,040
Total FemTec Health, Inc. ⁽²²⁾						15,151		15,923		15,379

Lark Technologies, Inc.	Secured Loan	September 30, 2020	April 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	5,000	$	4,939	$	4,986
	Secured Loan	June 30, 2021	January 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		5,000		4,818		4,847
Total Lark Technologies, Inc.						10,000		9,757		9,833

WorkWell Prevention & Care Inc.	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%; EOT 10.0%	$	3,370	$	3,659	$	3,522
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%		700		718		676
Total WorkWell Prevention & Care Inc. ⁽²²⁾						4,070		4,377		4,198

Sub-total: Health Care and Social Assistance (3.1%)*					$	29,221	$	30,057	$	29,410

Information ⁽⁷⁾

Firefly Systems, Inc.	Equipment Financing	January 29, 2020	February 1, 2023	Fixed interest rate 9.0%; EOT 10.0%	$	2,144	$	2,579	$	2,549
	Equipment Financing	August 28, 2020	September 1, 2023	Fixed interest rate 8.9%; EOT 10.0%		2,094		2,356		2,338
	Equipment Financing	September 18, 2020	October 1, 2023	Fixed interest rate 8.8%; EOT 10.0%		256		286		284
Total Firefly Systems, Inc.						4,494		5,221		5,171

Gobiquity, Inc.	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 7.5%; EOT 20.0%	$	61	$	193	$	189

Group Nine Media, Inc.	Secured Loan⁽¹⁹⁾	September 17, 2021	October 1, 2026	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5% ⁽⁸⁾	$	20,000	$	19,962	$	20,108

Hut 8 Holdings, Inc. ⁽¹⁰⁾	Equipment Financing⁽¹⁹⁾	December 30, 2021	January 1, 2025	Fixed interest rate 9.5%; EOT 3.5%	$	30,000	$	29,705	$	29,705

Rigetti & Co, Inc.	Secured Loan	March 10, 2021	April 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾	$	12,000	$	11,891	$	11,977
	Secured Loan	May 18, 2021	June 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾		8,000		7,895		7,954
	Secured Loan	November 10, 2021	December 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾		7,000		6,848		6,848
Total Rigetti & Co, Inc.						27,000		26,634		26,779

Smule, Inc.	Secured Loan⁽¹⁵⁾	July 1, 2020	January 1, 2022	Fixed interest rate 0.0%	$	10	$	10	$	10

Stratifyd, Inc.	Secured Loan⁽¹⁹⁾	September 3, 2021	December 1, 2025	Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾	$	6,000	$	5,947	$	5,993

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾

Debt Securities, Continued

Finance and Insurance ⁽²⁾












DailyPay, Inc.

Secured Loan

September 30, 2020

November 1, 2024

Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁹⁾

$
20,000

$
19,800

$
20,062

Secured Loan

December 30, 2020

January 1, 2025

Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁹⁾

5,000

4,939

4,939
Total DailyPay, Inc.

25,000

24,739

25,001

Petal Card, Inc.

Secured Loan

January 16, 2020

December 1, 2023

Fixed interest rate 11.0%; EOT 3.0%

$
10,000

$
9,998

$
10,116

Sub-total: Finance and Insurance (14.7%)*



$
35,000

$
34,737

$
35,117

Health Care and Social Assistance ⁽²⁾










Lark Technologies, Inc.

Secured Loan

September 30, 2020

April 1, 2025

Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁹⁾

$
5,000

$
4,809

$
4,874

WorkWell Prevention & Care Inc.

Secured Loan

January 16, 2020

March 1, 2024

Fixed interest rate 8.0%; EOT 10.0%

$
3,370

$
3,608

$
3,493

Secured Loan

January 16, 2020

March 1, 2024

Fixed interest rate 8.0%; EOT 10.0%

700

734

693
Total WorkWell Prevention & Care Inc. ⁽¹⁹⁾



4,070

4,342

4,186

Sub-total: Health Care and Social Assistance (3.8%)*



$
9,070

$
9,151

$
9,060

Information ⁽²⁾










Firefly Systems, Inc.

Equipment Financing

January 29, 2020

February 1, 2023

Fixed interest rate 9.0%; EOT 10.0%

$
3,946

$
4,080

$
4,052

Equipment Financing

August 28, 2020

September 1, 2023

Fixed interest rate 9.0%; EOT 10.0%

3,208

3,308

3,307

Equipment Financing

September 18, 2020

October 1, 2023

Fixed interest rate 9.0%; EOT 10.0%

386

396

396
Total Firefly Systems, Inc.

7,540

7,784

7,755

Gobiquity, Inc.

Equipment Financing

January 16, 2020

April 1, 2022

Fixed interest rate 7.5%; EOT 20.0%

$
296

$
394

$
395

Hytrust, Inc.

Secured Loan

January 16, 2020

February 1, 2021

Fixed interest rate 11.1%; EOT 10.5%

$
194

$
717

$
621

Oto Analytics, Inc.

Secured Loan

January 16, 2020

March 1, 2023

Fixed interest rate 11.5%; EOT 6.0%

$
7,294

$
7,755

$
7,735

RapidMiner, Inc.

Secured Loan

January 16, 2020

April 1, 2024

Fixed interest rate 12.0%; EOT 7.5%

$
10,000

$
10,099

$
10,113

Smule, Inc.

Secured Loan

July 1, 2020

January 1, 2022

Fixed interest rate 0.0% ⁽¹⁵⁾

$
145

$
145

$
145

STS Media, Inc. ⁽¹¹⁾

Secured Loan

January 16, 2020

May 1, 2022

Fixed interest rate 11.9%; EOT 4.0%

$
7,811

$
737

$
100

Unitas Global, Inc.

Equipment Financing

January 16, 2020

July 1, 2021

Fixed interest rate 9.0%; EOT 12.0%

$
580

$
938

$
921

Equipment Financing

January 16, 2020

April 1, 2021

Fixed interest rate 7.8%; EOT 6.0%

53

76

74
Total Unitas Global, Inc.



633

1,014

995

Sub-total: Information (11.7%)*



$
33,913

$
28,645

$
27,859

2530

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾
Debt Securities, Continued

Manufacturing ⁽²⁾












AyDeeKay LLC

Secured Loan

January 16, 2020

August 1, 2024

Variable interest rate PRIME + 7.5% or Floor rate 10.8%; EOT 3.0% ⁽⁹⁾

$
12,000

$
11,893

$
11,779

BHCosmetics, LLC

Equipment Financing

January 16, 2020

March 1, 2021

Fixed interest rate 8.9%; EOT 5.0%

$
106

$
165

$
165

Equipment Financing

January 16, 2020

April 1, 2021

Fixed interest rate 8.7%; EOT 5.0%

159

217

218
Total BHCosmetics, LLC

265

382

383

Footprint International Holding, Inc.

Equipment Financing

February 14, 2020

March 1, 2024

Fixed interest rate 10.3%; EOT 8.0%

$
14,771

$
15,244

$
15,352

Secured Loan

June 22, 2020

July 1, 2024

Fixed interest rate 12.0%; EOT 9.0%

7,000

7,095

7,177
Total Footprint International Holding, Inc.

21,771

22,339

22,529

Happiest Baby, Inc.

Equipment Financing

January 16, 2020

September 1, 2022

Fixed interest rate 8.4%; EOT 9.5%

$
924

$
1,031

$
998

Equipment Financing

January 16, 2020

November 1, 2022

Fixed interest rate 8.6%; EOT 9.5%

748

822

830

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 8.6%; EOT 9.5%

719

775

786

Equipment Financing

February 7, 2020

June 1, 2023

Fixed interest rate 8.2%; EOT 9.5%

901

953

955

Equipment Financing

September 16, 2020

January 1, 2024

Fixed interest rate 7.8%; EOT 9.5%

1,248

1,270

1,278
Total Happiest Baby, Inc.



4,540

4,851

4,847

Health-Ade, LLC

Equipment Financing

January 16, 2020

February 1, 2022

Fixed interest rate 9.4%; EOT 15.0%

$
1,361

$
1,887

$
1,877

Equipment Financing

January 16, 2020

April 1, 2022

Fixed interest rate 8.6%; EOT 15.0%

784

1,031

1,030

Equipment Financing

January 16, 2020

July 1, 2022

Fixed interest rate 9.1%; EOT 15.0%

1,956

2,436

2,441
Total Health-Ade, LLC







4,101

5,354

5,348

Mainspring Energy, Inc.

Secured Loan

January 16, 2020

August 1, 2023

Fixed interest rate 11.0%; EOT 3.8%

$
8,592

$
8,759

$
8,801

Secured Loan

November 20, 2020

December 1, 2024

Fixed interest rate 11.0%; EOT 3.8%

5,500

5,267

5,267
Total Mainspring Energy, Inc.

14,092

14,026

14,068

Miyoko's Kitchen

Equipment Financing

February 19, 2020

September 1, 2022

Fixed interest rate 8.8%; EOT 9.0%

$
580

$
617

$
618

Equipment Financing

August 27, 2020

March 1, 2023

Fixed interest rate 8.9%; EOT 9.0%

867

889

896
Total Miyoko's Kitchen

1,447

1,506

1,514

Molekule, Inc.

Equipment Financing

June 19, 2020

January 1, 2024

Fixed interest rate 8.8%; EOT 10.0%

$
2,526

$
2,571

$
2,588

Equipment Financing

September 29, 2020

April 1, 2024

Fixed interest rate 9.0%; EOT 10.0%

542

550

554

Equipment Financing

December 18, 2020

July 1, 2024

Fixed interest rate 8.8%; EOT 10.0%

879

879

881
Total Molekule, Inc.

3,947

4,000

4,023

Second Nature Brands, Inc.

Equipment Financing

September 29, 2020

April 1, 2024

Fixed interest rate 9.7%; EOT 11.50%

$
2,196

$
2,157

$
2,144

Store Intelligence, Inc. ⁽¹⁹⁾

Secured Loan

May 2, 2020

June 1, 2024

Fixed interest rate 12.0%; EOT 7.8%

$
12,001

$
12,232

$
11,884

The Fynder Group, Inc.

Equipment Financing

October 14, 2020

May 1, 2024

Fixed interest rate 9.1%; EOT 10.0%

$
612

$
604

$
604

Vertical Communications, Inc.

Secured Loan

May 1, 2020

November 1, 2024

Fixed interest rate 9.5%; EOT 26.4%

$
12,000

$
12,937

$
12,787

Secured Loan

June 18, 2020

July 1, 2022

Fixed interest rate 9.5%

807

807

816
Total Vertical Communications, Inc. ⁽¹⁹⁾

12,807

13,744

13,603

Sub-total:  Manufacturing (38.9%)*







$
89,779

$
93,088

$
92,726


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Information, Continued ⁽⁷⁾
Whip Networks, Inc.	Secured Loan⁽¹⁹⁾	June 14, 2021	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾	$	5,000	$	4,992	$	5,029
	Secured Loan⁽¹⁹⁾	September 10, 2021	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾		1,000		995		1,003
Total Whip Networks, Inc.						6,000		5,987		6,032

Zuum Transportation, Inc.	Secured Loan⁽¹⁹⁾	December 17, 2021	January 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾	$	5,000	$	4,976	$	4,976

Sub-total: Information (10.6%)*					$	98,565	$	98,635	$	98,963

Management of Companies and Enterprises ⁽⁷⁾

Exer Holdings, LLC	Secured Loan⁽¹⁹⁾	November 19, 2021	December 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾	$	22,500	$	22,240	$	22,240

Sub-total: Management of Companies and Enterprises (2.4%)*					$	22,500	$	22,240	$	22,240

Manufacturing ⁽⁷⁾
Athletic Brewing Company, LLC	Equipment Financing⁽¹⁹⁾	December 7, 2021	December 1, 2025	Fixed interest rate 11.0%; EOT 7.0%	$	20,000	$	19,932	$	19,932

Bolb, Inc.	Equipment Financing⁽¹⁹⁾	October 12, 2021	November 1, 2024	Fixed interest rate 10.3%; EOT 6.0%	$	1,624	$	1,625	$	1,625

Daring Foods, Inc.	Equipment Financing⁽¹⁹⁾	April 8, 2021	May 1, 2024	Fixed interest rate 9.6%; EOT 7.5%	$	400	$	411	$	413
	Equipment Financing⁽¹⁹⁾	July 7, 2021	July 1, 2024	Fixed interest rate 9.5%; EOT 7.5%		1,917		1,938		1,937
	Equipment Financing⁽¹⁹⁾	August 17, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 7.5%		942		947		952
	Equipment Financing⁽¹⁹⁾	August 31, 2021	September 1, 2024	Fixed interest rate 10.0%; EOT 7.5%		546		548		552
	Equipment Financing⁽¹⁹⁾	November 1, 2021	December 1, 2024	Fixed interest rate 9.4%; EOT 7.5%		1,034		1,028		1,028
Total Daring Foods, Inc.						4,839		4,872		4,882

Eterneva, Inc.	Equipment Financing⁽¹⁴⁾	November 24, 2021	December 1, 2025	Fixed interest rate 10.6%; EOT 11.5%	$	544	$	546	$	546


Footprint International Holding, Inc.	Equipment Financing	February 14, 2020	March 1, 2024	Fixed interest rate 10.3%; EOT 8.0%	$	10,611	$	11,576	$	12,405
	Secured Loan	June 22, 2020	November 1, 2024	Fixed interest rate 12.0%; EOT 9.0%		6,837		7,162		6,837
Total Footprint International Holding, Inc.						17,448		18,738		19,242

Happiest Baby, Inc.	Equipment Financing	January 16, 2020	September 1, 2022	Fixed interest rate 8.4%; EOT 9.5%	$	385	$	538	$	527
	Equipment Financing	January 16, 2020	November 1, 2022	Fixed interest rate 8.6%; EOT 9.5%		355		469		464
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.6%; EOT 9.5%		375		469		469
	Equipment Financing	February 7, 2020	June 1, 2023	Fixed interest rate 8.2%; EOT 9.5%		550		640		640
	Equipment Financing	September 16, 2020	January 1, 2024	Fixed interest rate 8.4%; EOT 9.5%		866		945		947
	Equipment Financing	January 22, 2021	May 1, 2025	Fixed interest rate 8.4%; EOT 9.5%		745		790		792
Total Happiest Baby, Inc.						3,276		3,851		3,839

Health-Ade, LLC	Equipment Financing	January 16, 2020	February 1, 2022	Fixed interest rate 9.4%; EOT 15.0%	$	110	$	709	$	703
	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 8.6%; EOT 15.0%		163		462		454
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.1%; EOT 15.0%		682		1,295		1,270
Total Health-Ade, LLC						955		2,466		2,427

Hi-Power, LLC	Equipment Financing⁽¹⁹⁾	September 30, 2021	April 1, 2025	Fixed interest rate 12.4%; EOT 1.0%	$	6,529	$	6,524	$	6,598

2631

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Manufacturing, Continued ⁽⁷⁾
Mainspring Energy, Inc.	Secured Loan	January 16, 2020	August 1, 2023	Fixed interest rate 11.0%; EOT 3.8%	$	5,660	$	5,942	$	5,956
	Secured Loan	November 20, 2020	December 1, 2024	Fixed interest rate 11.0%; EOT 3.8%		5,500		5,436		5,539
Total Mainspring Energy, Inc.						11,160		11,378		11,495

Miyoko's Kitchen	Equipment Financing	February 19, 2020	September 1, 2022	Fixed interest rate 8.8%; EOT 9.0%	$	242	$	311	$	310
	Equipment Financing	August 27, 2020	March 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		488		558		556
	Equipment Financing	February 5, 2021	September 1, 2023	Fixed interest rate 8.5%; EOT 9.0%		450		484		483
	Equipment Financing	June 25, 2021	December 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		486		506		505
Total Miyoko's Kitchen						1,666		1,859		1,854

Molekule, Inc.	Equipment Financing	June 19, 2020	January 1, 2024	Fixed interest rate 8.8%; EOT 10.0%	$	1,756	$	1,931	$	1,918
	Equipment Financing	September 29, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 10.0%		391		425		421
	Equipment Financing	December 18, 2020	July 1, 2024	Fixed interest rate 8.8%; EOT 10.0%		652		695		688
	Equipment Financing	August 25, 2021	March 1, 2025	Fixed interest rate 8.9%; EOT 10.0%		494		504		500
Total Molekule, Inc.						3,293		3,555		3,527

Nexii Building Solutions, Inc. ⁽¹⁰⁾	Secured Loan⁽¹⁹⁾	August 27, 2021	September 1, 2025	Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾	$	10,000	$	9,575	$	9,648

Quip NYC, Inc.	Secured Loan	March 9, 2021	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾	$	17,500	$	17,319	$	17,448

Store Intelligence, Inc. ⁽²²⁾	Secured Loan ⁽¹⁸⁾	May 2, 2020	August 1, 2024	Fixed interest rate 12.0%; EOT 7.7%	$	11,641	$	12,033	$	4,444

Tarana Wireless, Inc.	Secured Loan⁽¹⁹⁾	June 30, 2021	July 1, 2025	Variable interest rate Prime + 8.0% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾	$	18,500	$	17,728	$	17,551

The Fynder Group, Inc.	Equipment Financing	October 14, 2020	May 1, 2024	Fixed interest rate 9.1%; EOT 10.0%	$	489	$	516	$	515

Vertical Communications, Inc.	Secured Loan	August 23, 2021	March 1, 2026	Fixed interest rate 11.0%; EOT 23.8%	$	13,300	$	15,016	$	13,656

VitaCup, Inc.	Secured Loan⁽¹⁹⁾	June 23, 2021	July 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 2.5% ⁽⁸⁾	$	5,500	$	5,471	$	5,519

Sub-total: Manufacturing (15.5%)*					$	148,264	$	153,004	$	144,748

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾
Debt Securities, Continued

Pharmaceutical ⁽²⁾












Zosano Pharma Corporation

Equipment Financing

January 16, 2020

April 1, 2022

Fixed interest rate 9.4%; EOT 12.0%

$
2,256

$
2,756

$
2,530

Equipment Financing

January 16, 2020

July 1, 2022

Fixed interest rate 9.7%; EOT 12.0%

1,501

1,757

1,642

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 9.9%; EOT 12.0%

1,608

1,769

1,710

Equipment Financing

January 16, 2020

April 1, 2023

Fixed interest rate 9.9%; EOT 12.0%

1,787

1,919

1,884

Equipment Financing

January 16, 2020

May 1, 2023

Fixed interest rate 10.5%; EOT 12.0%

1,316

1,420

1,384
Total Zosano Pharma Corporation







8,468

9,621

9,150

Sub-total:  Pharmaceutical (3.8%)*







$
8,468

$
9,621

$
9,150

Professional, Scientific, and Technical Services ⁽²⁾



��








Augmedix, Inc.

Secured Loan

January 16, 2020

April 1, 2023

Fixed interest rate 12.0%; EOT 6.5%

$
9,422

$
9,602

$
9,629

BackBlaze, Inc.

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 7.2%; EOT 11.5%

$
907

$
1,042

$
1,046

Equipment Financing

January 16, 2020

April 1, 2023

Fixed interest rate 7.4%; EOT 11.5%

117

131

132

Equipment Financing

January 16, 2020

June 1, 2023

Fixed interest rate 7.4%; EOT 11.5%

905

1,001

1,006

Equipment Financing

January 16, 2020

August 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

180

196

197

Equipment Financing

January 16, 2020

September 1, 2023

Fixed interest rate 7.7%; EOT 11.5%

185

201

201

Equipment Financing

January 16, 2020

October 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

186

200

201

Equipment Financing

January 16, 2020

November 1, 2023

Fixed interest rate 7.2%; EOT 11.5%

621

670

670

Equipment Financing

January 16, 2020

December 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

822

881

881

Equipment Financing

January 16, 2020

January 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

717

764

763

Equipment Financing

January 20, 2020

February 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

732

775

775

Equipment Financing

February 1, 2020

March 1, 2024

Fixed interest rate 7.2%; EOT 11.5%

636

673

672

Equipment Financing

March 26, 2020

April 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

192

201

206

Equipment Financing

April 17, 2020

May 1, 2024

Fixed interest rate 7.3%; EOT 11.5%

1,246

1,303

1,311

Equipment Financing

July 27, 2020

August 1, 2024

Fixed interest rate 7.5%; EOT 11.5%

1,336

1,374

1,378

Equipment Financing

September 4, 2020

October 1, 2024

Fixed interest rate 7.2%; EOT 11.5%

239

243

237
Total BackBlaze, Inc.







9,021

9,655

9,676

Cuebiq, Inc.

Secured Loan

March 4, 2020

April 1, 2024

Variable interest rate PRIME + 7.3% or Floor rate 12.0%; EOT 4.5% ⁽⁹⁾

$
5,000

$
5,030

$
4,963

Edeniq, Inc.

Secured Loan

January 16, 2020

September 1, 2021

Fixed interest rate 13.0%; EOT 9.5%

$
3,039

$
1,102

$
859

Secured Loan

January 16, 2020

September 1, 2021

Fixed interest rate 13.0%; EOT 9.5%

2,282

762

648
Total Edeniq, Inc. ⁽¹¹⁾ ⁽¹⁹⁾







5,321

1,864

1,507

2732

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Pharmaceutical ⁽⁷⁾
Zosano Pharma Corporation	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 9.4%; EOT 12.0%	$	473	$	1,070	$	1,038
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.7%; EOT 12.0%		525		853		822
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		844		1,091		1,059
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,042		1,273		1,245
	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 10.5%; EOT 12.0%		811		973		949
Total Zosano Pharma Corporation						3,695		5,260		5,113

Sub-total: Pharmaceutical (0.5%)*					$	3,695	$	5,260	$	5,113

Professional, Scientific, and Technical Services ⁽⁷⁾
BackBlaze, Inc.	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 7.2%; EOT 11.5%	$	470	$	650	$	645
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		67		87		87
	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		550		690		686
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		114		140		139
	Equipment Financing	January 16, 2020	September 1, 2023	Fixed interest rate 7.7%; EOT 11.5%		120		145		144
	Equipment Financing	January 16, 2020	October 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		123		146		145
	Equipment Financing	January 16, 2020	November 1, 2023	Fixed interest rate 7.2%; EOT 11.5%		416		493		489
	Equipment Financing	January 16, 2020	December 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		560		657		651
	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		495		575		570
	Equipment Financing	January 20, 2020	February 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		512		590		585
	Equipment Financing	February 1, 2020	March 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		451		515		512
	Equipment Financing	March 26, 2020	April 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		138		156		157
	Equipment Financing	April 17, 2020	May 1, 2024	Fixed interest rate 7.3%; EOT 11.5%		903		1,018		1,014
	Equipment Financing	July 27, 2020	August 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		998		1,100		1,093
	Equipment Financing	September 4, 2020	October 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		181		197		197
	Equipment Financing	March 29, 2021	April 1, 2025	Fixed interest rate 7.5%; EOT 11.5%		2,310		2,426		2,421
Total BackBlaze, Inc.						8,408		9,585		9,535

Commonwealth Fusion Systems, LLC	Equipment Financing⁽¹⁹⁾	September 10, 2021	October 1, 2024	Fixed interest rate 9.5%; EOT 8.5%	$	2,169	$	2,196	$	2,207
	Equipment Financing⁽¹⁹⁾	October 20, 2021	November 1, 2024	Fixed interest rate 9.7%; EOT 8.5%	$	644	$	648	$	648
Total Commonwealth Fusion Systems, LLC						2,813		2,844		2,855

Core Scientific, Inc.	Equipment Financing⁽¹⁹⁾	August 31, 2021	October 1, 2024	Fixed interest rate 10.3%; EOT 5.0%	$	928	$	938	$	964
	Equipment Financing⁽¹⁹⁾	August 31, 2021	December 1, 2024	Fixed interest rate 10.7%; EOT 5.0%	$	13,596	$	13,649	$	13,649
	Equipment Financing⁽¹⁹⁾	August 31, 2021	January 1, 2025	Fixed interest rate 10.5%; EOT 5.0%	$	5,000	$	5,008	$	5,008
Total Core Scientific, Inc.						19,524		19,595		19,621

Edeniq, Inc.	Secured Loan	November 30, 2021	June 1, 2025	Fixed interest rate 18.0%	$	5,267	$	469	$	5,074

Emerald Cloud Lab, Inc.	Equipment Financing⁽¹⁹⁾	July 13, 2021	August 1, 2024	Fixed interest rate 9.7%; EOT 7.0%	$	9,278	$	9,486	$	9,528

Emergy, Inc.	Equipment Financing⁽¹⁹⁾	January 8, 2021	May 1, 2024	Fixed interest rate 9.1%; EOT 8.5%	$	434	$	456	$	456
	Equipment Financing⁽¹⁹⁾	December 15, 2021	July 1, 2025	Fixed interest rate 9.3%; EOT 11.5%	$	10,419	$	10,396	$	10,396
Total Emergy, Inc.						10,853		10,852		10,852

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾
Debt Securities, Continued

Professional, Scientific, and Technical Services, Continued










Incontext Solutions, Inc.

Secured Loan

January 16, 2020

October 1, 2023

Fixed interest rate 11.75%; EOT 11.4%

$
7,149

$
7,401

$
6,998

Matterport, Inc.

Secured Loan

January 16, 2020

May 1, 2022

Fixed interest rate 11.5%; EOT 5.0%

$
4,870

$
5,560

$
5,599

Pendulum Therapeutics, Inc.

Equipment Financing

January 16, 2020

May 1, 2023

Fixed interest rate 7.7%; EOT 5.0%

$
347

$
338

$
338

Equipment Financing

January 17, 2020

August 1, 2023

Fixed interest rate 7.8%; EOT 5.0%

2,084

2,147

2,164

Equipment Financing

March 6, 2020

October 1, 2023

Fixed interest rate 7.7%; EOT 5.0%

616

620

626

Equipment Financing

July 15, 2020

February 1, 2024

Fixed interest rate 9.8%; EOT 6.0%

894

895

881
Total Pendulum Therapeutics, Inc.







3,941

4,000

4,009

Reciprocity, Inc.

Secured Loan

September 25, 2020

October 1, 2024

Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁹⁾

$
10,000

$
9,862

$
9,805

Sun Basket, Inc.

Secured Loan

December 31, 2020

December 1, 2024

Variable interest rate PRIME + 8.5% or Floor rate 11.8%; EOT 5.0% ⁽⁹⁾

18,375

17,831

17,831

Utility Associates, Inc. ⁽¹¹⁾

Secured Loan

January 16, 2020

October 1, 2023

Fixed interest rate 11.0%

$
750

$
830

$
604

Sub-total:  Professional, Scientific, and Technical Services (29.6%)*



$
73,849

$
71,635

$
70,621

2833

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Professional, Scientific, and Technical Services, Continued
Greenlight Biosciences Inc.	Equipment Financing	March 29, 2021	April 1, 2024	Fixed interest rate 9.7%; EOT 8.0%	$	2,575	$	2,656	$	2,667
	Equipment Financing	June 17, 2021	July 1, 2024	Fixed interest rate 9.5%; EOT 8.0%		3,716		3,774		3,808
	Equipment Financing	August 31, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 8.0%		2,003		2,008		2,011
	Equipment Financing	August 31, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 8.0%		1,160		1,163		1,157
Total Greenlight Biosciences Inc.						9,454		9,601		9,643

Incontext Solutions, Inc.	Secured Loan	January 16, 2020	October 1, 2024	Fixed interest rate 11.8%; EOT 16.4%	$	6,149	$	6,818	$	5,476

PebblePost, Inc.	Secured Loan⁽¹⁹⁾	May 7, 2021	June 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.8% ⁽⁸⁾	$	12,500	$	12,450	$	12,547

Pendulum Therapeutics, Inc.	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 7.7%; EOT 5.0%	$	206	$	220	$	220
	Equipment Financing	January 17, 2020	August 1, 2023	Fixed interest rate 7.8%; EOT 5.0%		1,326		1,436		1,445
	Equipment Financing	March 6, 2020	October 1, 2023	Fixed interest rate 7.7%; EOT 5.0%		407		431		433
	Equipment Financing	July 15, 2020	February 1, 2024	Fixed interest rate 9.8%; EOT 6.0%		633		665		671
	Secured Loan	December 31, 2021	January 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾		5,000		4,972		4,972
Total Pendulum Therapeutics, Inc.						7,572		7,724		7,741

Reciprocity, Inc.	Secured Loan	September 25, 2020	October 1, 2024	Variable interest rate Prime + 3.3% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾	$	10,000	$	9,984	$	10,200
	Secured Loan	April 29, 2021	May 1, 2025	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾		5,000		4,984		5,100
Total Reciprocity, Inc.						15,000		14,968		15,300

Sun Basket, Inc.	Secured Loan	December 31, 2020	December 1, 2024	Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 5.8% ⁽⁸⁾	$	16,905	$	16,984	$	16,882

Utility Associates, Inc.	Secured Loan⁽¹⁸⁾	January 16, 2020	September 30, 2023	PIK Fixed interest rate 11.0% ⁽²⁰⁾	$	750	$	830	$	697

ZenDrive, Inc.	Secured Loan⁽¹⁹⁾	July 16, 2021	August 1, 2026	Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 3.0% ⁽⁸⁾	$	15,000	$	14,899	$	15,006

Sub-total: Professional, Scientific, and Technical Services (15.1%)*					$	139,473	$	137,105	$	140,757

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾
Debt Securities, Continued

Real Estate ⁽²⁾












Knockaway, Inc.

Secured Loan

January 16, 2020

December 1, 2023

Fixed interest rate 11.0%; EOT 3.0%

$
10,000

$
10,103

$
10,112

Secured Loan

January 16, 2020

February 1 , 2024

Fixed interest rate 11.0%; EOT 3.0%

2,500

2,519

2,549

Secured Loan

January 16, 2020

March 1, 2024

Fixed interest rate 11.0%; EOT 3.0%

2,500

2,516

2,548
Total Knockaway, Inc.







15,000

15,138

15,209

Wanderjaunt, Inc.

Equipment Financing

January 16, 2020

June 1, 2023

Fixed interest rate 10.2%; EOT 12.0%

$
387

$
388

$
380

Equipment Financing

January 16, 2020

August 1, 2023

Fixed interest rate 10.2%; EOT 12.0%

1,230

1,313

1,296
Total Wanderjaunt, Inc.







1,617

1,701

1,676

Sub-total:  Real Estate (9.6%)*



$
16,617

$
16,839

$
16,885












Rental and Leasing Services⁽²⁾












EquipmentShare, Inc.

Equipment Financing

June 24, 2020

July 1, 2023

Fixed interest rate 10.7%; EOT 5.0%

$
7,538

$
7,685

$
7,730

Equipment Financing

July 2, 2020

August 1, 2023

Fixed interest rate 10.1%; EOT 5.0%

864

879

884

Equipment Financing

August 7, 2020

September 1, 2023

Fixed interest rate 10.2%; EOT 5.0%

1,908

1,935

1,944

Equipment Financing

September 18, 2020

October 1, 2023

Fixed interest rate 10.4%; EOT 5.0%

3,422

3,458

3,470

Equipment Financing

September 29, 2020

October 1, 2024

Fixed interest rate 8.3%; EOT 10.0%

429

435

435

Equipment Financing

October 2, 2020

November 1, 2023

Fixed interest rate 10.4%; EOT 5.0%

811

818

818

Equipment Financing

October 9, 2020

November 1, 2023

Fixed interest rate 10.5%; EOT 5.0%

2,560

2,581

2,581

Equipment Financing

November 4, 2020

December 1, 2023

Fixed interest rate 10.1%; EOT 5.0%

2,491

2,506

2,506

Equipment Financing

December 4, 2020

January 1, 2024

Fixed interest rate 10.1%; EOT 5.0%

1,995

2,002

2,002

Equipment Financing

December 21, 2020

January 1, 2024

Fixed interest rate 10.5%; EOT 5.0%

797

799

799
Total EquipmentShare, Inc.

22,815

23,098

23,169

Maxwell Financial Labs, Inc.

Secured Loan

October 7, 2020

November 1, 2024

Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% ⁽⁹⁾

$
3,000

$
2,964

$
2,964

Secured Loan

December 22, 2020

January 1, 2025

Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% ⁽⁹⁾

3,000

2,938

2,938
Total Maxwell Financial Labs, Inc.

6,000

5,902

5,902

Sub-total:  Rental and Leasing Services (12.2%)*



$
28,815

$
29,000

$
29,071

Retail Trade ⁽²⁾












Birchbox, Inc. ⁽¹⁹⁾

Secured Loan

January 16, 2020

July 1, 2024

Fixed interest rate 9.0%; EOT 7.5%

$
10,000

$
10,433

$
9,924

Boosted eCommerce, Inc. ⁽¹⁴⁾

Secured Loan

December 18, 2020

January 1, 2023

Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽⁹⁾

$
5,000

$
4,933

$
4,933

Gobble, Inc.

Secured Loan

January 16, 2020

July 1, 2023

Fixed interest rate 11.3%; EOT 6.0%

$
3,443

$
3,544

$
3,556

Secured Loan

January 16, 2020

July 1, 2023

Fixed interest rate 11.5%; EOT 6.0%

1,730

1,781

1,795
Total Gobble Inc.







5,173

5,325

5,351

Madison Reed, Inc.

Secured Loan

April 23, 2020

May 1, 2024

Variable interest rate PRIME + 6.0% or Floor rate 10.3%; EOT 4.0% ⁽⁹⁾

$
17,500

$
17,471

$
17,835

Portofino Labs, Inc. ⁽¹⁴⁾

Secured Loan

December 31, 2020

July 1, 2025

Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% ⁽⁹⁾

$
2,000

$
1,984

$
1,984

Super73, Inc. ⁽¹⁴⁾

Secured Loan

December 31, 2020

January 1, 2025

Variable interest rate PRIME + 7.3% or Floor rate 11.8%; EOT 4.0% ⁽⁹⁾

$
5,500

$
5,416

$
5,416

UnTuckIt, Inc.

Secured Loan

January 16, 2020

June 1, 2024

Fixed interest rate 12.0%; EOT 5.0%

$
20,000

$
21,098

$
19,230

Sub-total:  Retail Trade (27.1%)*







$
65,173

$
66,660

$
64,673

2934

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Real Estate ⁽⁷⁾
Knockaway, Inc.	Secured Loan	November 10, 2021	June 1, 2026	Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾	$	14,734	$	14,608	$	14,608
	Secured Loan	November 30, 2021	June 1, 2026	Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾		2,000		1,982		1,982
	Secured Loan	December 28, 2021	July 1, 2026	Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾		4,275		4,231		4,231
Total Knockaway, Inc.						21,009		20,821		20,821

Orchard Technologies, Inc.	Secured Loan	March 11, 2021	April 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾	$	5,000	$	5,030	$	5,064
	Secured Loan	July 23, 2021	April 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾		12,500		12,520		12,612
Total Orchard Technologies, Inc.						17,500		17,550		17,676

Wanderjaunt, Inc.	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 10.2%; EOT 12.0%	$	238	$	277	$	271
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 10.2%; EOT 12.0%		792		935		928
Total Wanderjaunt, Inc.						1,030		1,212		1,199

Sub-total: Real Estate (4.3%)*					$	39,539	$	39,583	$	39,696

Rental and Leasing Services⁽⁷⁾
EquipmentShare, Inc.	Equipment Financing	June 24, 2020	July 1, 2023	Fixed interest rate 11.0%; EOT 5.0%	$	3,269	$	3,501	$	3,532
	Equipment Financing	August 7, 2020	September 1, 2023	Fixed interest rate 10.2%; EOT 5.0%		1,252		1,328		1,335
	Equipment Financing	October 2, 2020	November 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		551		579		585
	Equipment Financing	October 9, 2020	November 1, 2023	Fixed interest rate 10.5%; EOT 5.0%		1,741		1,829		1,846
Total EquipmentShare, Inc.						6,813		7,237		7,298

Maxwell Financial Labs, Inc.	Secured Loan	September 30, 2021	April 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾	$	18,000	$	17,828	$	17,949

NextCar Holding Company, Inc.	Secured Loan⁽¹⁹⁾	December 14, 2021	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 12.0% ⁽⁸⁾	$	5,000	$	4,961	$	4,961
	Secured Loan⁽¹⁹⁾	December 15, 2021	January 1, 2026	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 12.0% ⁽⁸⁾		2,000		1,986		1,986
Total NextCar Holding Company, Inc.						7,000		6,947		6,947

Sub-total: Rental and Leasing Services (3.4%)*					$	31,813	$	32,012	$	32,194

Retail Trade ⁽⁷⁾
Fernished, Inc.	Equipment Financing⁽¹⁴⁾	October 29, 2021	November 1, 2024	Fixed interest rate 13.4%; EOT 3.0%	$	472	$	470	$	470

Gobble, Inc.	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.3%; EOT 6.0%	$	2,227	$	2,414	$	2,398
	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.5%; EOT 6.0%		1,120		1,214		1,206
Total Gobble Inc.						3,347		3,628		3,604

Portofino Labs, Inc.	Secured Loan⁽¹⁹⁾	December 31, 2020	July 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	2,000	$	2,014	$	2,023
	Secured Loan⁽¹⁹⁾	March 12, 2021	October 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		3,000		2,904		2,918
	Secured Loan⁽¹⁹⁾	April 1, 2021	November 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		2,000		1,860		1,873
Total Portofino Labs, Inc.						7,000		6,778		6,814

Super73, Inc.	Secured Loan	December 31, 2020	January 1, 2025	Variable interest rate Prime + 4.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	5,500	$	5,528	$	5,567
	Secured Loan	October 25, 2021	January 1, 2025	Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	4,500	$	4,456	$	4,456
Total Super73, Inc.						10,000		9,984		10,023

UnTuckIt, Inc.	Secured Loan	January 16, 2020	June 1, 2025	Fixed interest rate 12.0%; EOT 3.8%	$	15,000	$	15,796	$	15,200

Sub-total: Retail Trade (3.9%)*					$	35,819	$	36,656	$	36,111

Portfolio Company ⁽¹⁾

Type of Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Maturity Date

Interest Rate ⁽⁴⁾

Principal
Amount ⁽⁵⁾

Cost

Fair Value ⁽⁶⁾
Debt Securities, Continued

Utilities ⁽²⁾












Invenia, Inc.

Secured Loan

January 16, 2020

January 1, 2023

Fixed interest rate 11.5%; EOT 5.0%

$
6,570

$
7,042

$
6,991

Secured Loan

January 16, 2020

May 1, 2023

Fixed interest rate 11.5%; EOT 5.0%

3,326

3,537

3,550

Secured Loan

January 16, 2020

January 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

3,000

3,058

3,165

Secured Loan

January 17, 2020

February 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

4,000

4,103

4,200

Secured Loan

June 8, 2020

July 1, 2024

Fixed interest rate 11.5%: EOT 5.0%

4,000

4,043

4,160

Secured Loan

October 29, 2020

November 1, 2024

Fixed interest rate 11.5%: EOT 5.0%

5,000

5,017

5,017
Total Invenia, Inc. ⁽⁸⁾







25,896

26,800

27,083

Sub-total:  Utilities (11.4%)*







$
25,896

$
26,800

$
27,083












Wholesale Trade ⁽²⁾












BaubleBar, Inc.

Secured Loan

January 16, 2020

March 1, 2023

Fixed interest rate 11.5%; EOT 7.3%

$
5,752

$
6,576

$
6,148

Grandpad, Inc.

Equipment Financing

November 16, 2020

June 1, 2023

Fixed interest rate 10.6%; EOT 5.0%

$
2,899

$
2,907

$
2,907

Equipment Financing

December 23, 2020

July 1, 2023

Fixed interest rate 10.8%; EOT 5.0%

3,672

3,667

3,667
Total Grandpad, Inc. ⁽¹⁴⁾

6,571

6,574

6,574

GrubMarket, Inc.

Secured Loan

June 15, 2020

July 1, 2024

Fixed interest rate 10.5%; EOT 3.0%

$
10,000

$
9,875

$
10,114

Sub-total:  Wholesale Trade (9.6%)*







$
22,323

$
23,025

$
22,836

Total:  Debt Securities (186.0%)* ⁽¹³⁾







$
448,010

$
447,510

$
443,219

3035

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Space Research and Technology ⁽⁷⁾

Axiom Space, Inc.	Secured Loan⁽¹⁹⁾	May 28, 2021	June 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 9.3%; EOT 2.5% ⁽⁸⁾	$	30,000	$	29,819	$	30,015

Sub-total: Space Research and Technology (3.2%)*					$	30,000	$	29,819	$	30,015

Utilities ⁽⁷⁾
Invenia, Inc.	Secured Loan	January 16, 2020	January 1, 2023	Fixed interest rate 11.5%; EOT 5.0%	$	3,611	$	4,068	$	4,012
	Secured Loan	January 16, 2020	May 1, 2023	Fixed interest rate 11.5%; EOT 5.0%		2,060		2,264		2,240
	Secured Loan	January 16, 2020	January 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		2,190		2,297		2,308
	Secured Loan	January 17, 2020	February 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		3,023		3,183		3,177
	Secured Loan	June 8, 2020	July 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		3,523		3,638		3,669
	Secured Loan	October 29, 2020	November 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		4,883		4,995		5,030
Total Invenia, Inc. ⁽¹⁰⁾						19,290		20,445		20,436

Sub-total: Utilities (2.2%)*					$	19,290	$	20,445	$	20,436

Wholesale Trade ⁽⁷⁾
BaubleBar, Inc.	Secured Loan	January 16, 2020	March 1, 2023	Fixed interest rate 11.5%; EOT 7.3%	$	3,377	$	4,285	$	4,085

Grandpad, Inc.	Equipment Financing⁽¹⁹⁾	November 16, 2020	June 1, 2023	Fixed interest rate 10.6%; EOT 5.0%	$	1,789	$	1,887	$	1,893
	Equipment Financing⁽¹⁹⁾	December 23, 2020	July 1, 2023	Fixed interest rate 10.8%; EOT 5.0%		2,306		2,419		2,425
Total Grandpad, Inc.						4,095		4,306		4,318

Sub-total: Wholesale Trade (0.9%)*					$	7,472	$	8,591	$	8,403

Total: Debt Securities (78.8%)* ⁽¹³⁾					$	733,336	$	740,925	$	735,968

Portfolio Company ⁽¹⁾

Type of
Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Expiration Date

Series

Shares

Strike Price

Cost

Fair Value ⁽⁶⁾
Warrant Investments













Agriculture, Forestry, Fishing and Hunting ⁽²⁾














Bowery Farming, Inc.

Warrant

January 16, 2020

June 10, 2029

Common Stock

68,863

$
5.08

$
410

$
403

Warrant

December 22, 2020

December 22, 2030

Common Stock

29,925

$
6.24

$
160

$
160
Total Bowery Farming, Inc.

570

563

Robotany, Inc.

Warrant

January 16, 2020

July 19, 2029

Common Stock

262,870

$
0.26

$
128

$
92

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.3%)*



$
698

$
655

Construction ⁽²⁾










Project Frog, Inc. ⁽¹⁹⁾

Warrant

January 16, 2020

July 26, 2026

Preferred Series AA

391,990

$
0.19

$
18

$
2

Sub-Total: Construction (0.0%)*





$
18

$
2

Educational Services ⁽²⁾








Qubed, Inc. dba Yellowbrick

Warrant

January 16, 2020

September 28, 2028

Common Stock

222,222

$
0.90

$
120

$
593

Sub-Total: Educational Services (0.2%)*







$
120

$
593

Finance and Insurance ⁽²⁾










DailyPay, Inc.

Warrant

September 30, 2020

September 30, 2030

Common Stock

89,264

$
3.00

$
151

$
206

Petal Card, Inc.

Warrant

January 16, 2020

November 27, 2029

Preferred Series B

250,268

$
1.32

$
147

$
350

Realty Mogul, Co

Warrant

January 16, 2020

December 18, 2027

Preferred Series B

234,421

$
3.88

$
285

$
25

Sub-Total: Finance and Insurance (0.2%)*





$
583

$
581

Health Care and Social Assistance ⁽²⁾








Lark Technologies, Inc.

Warrant

September 30, 2020

September 30, 2030

Common Stock

76,231

$
1.76

$
177

$
163

Sub-Total: Health Care and Social Assistance (0.1%)*



$
177

$
163

Information ⁽²⁾








Convercent, Inc.

Warrant

January 16, 2020

November 30, 2025

Preferred Series 1

3,139,579

$
0.16

$
924

$
610

Figg, Inc. ⁽⁷⁾

Warrant

January 16, 2020

March 31, 2028

Common Stock

935,198

$
0.07

$
—

$
—

Everalbum, Inc.

Warrant

January 16, 2020

July 29, 2026

Preferred Series A

851,063

$
0.10

$
24

$
6

Firefly Systems, Inc.

Warrant

January 31, 2020

January 29, 2030

Common Stock

133,147

$
1.14

$
282

$
132

Gtxcel, Inc.

Warrant

January 16, 2020

September 24, 2025

Preferred Series C

1,000,000

$
0.21

$
83

$
4

Warrant

January 16, 2020

September 24, 2025

Preferred Series D

1,000,000

$
0.21

83

12
Total Gtxcel, Inc.





166

16

Hytrust, Inc.

Warrant

January 16, 2020

June 23, 2026

Preferred Series D2

424,808

$
0.82

$
172

$
—

Lucidworks, Inc.

Warrant

January 16, 2020

June 27, 2026

Preferred Series D

619,435

$
0.77

$
806

$
1,509

Oto Analytics, Inc.

Warrant

January 16, 2020

August 31, 2028

Preferred Series B

1,018,718

$
0.79

$
295

$
221

RapidMiner, Inc.

Warrant

January 16, 2020

March 25, 2029

Preferred Series C-1

11,624

$
60.22

$
528

$
357

STS Media, Inc.⁽⁷⁾

Warrant

January 16, 2020

March 15, 2028

Preferred Series C

20,210

$
24.74

$
—

$
—

Sub-Total: Information (1.2%)*







$
3,197

$
2,851

3136

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments

Administrative and Support and Waste Management and Remediation ⁽⁷⁾

Qwick, Inc.	Warrant⁽¹⁴⁾	December 31, 2021	December 31, 2031	Common Stock	16,956	$	2.79	$	96	$	96

RTS Holding, Inc.	Warrant⁽¹⁴⁾	December 10, 2021	December 10, 2031	Preferred Series C	3,857	$	205.28	$	153	$	153

Sub-Total: Administrative and Support and Waste Management and Remediation (0.0%)*								$	249	$	249

Agriculture, Forestry, Fishing and Hunting ⁽⁷⁾
Bowery Farming, Inc.	Warrant	January 16, 2020	June 10, 2029	Common Stock	68,863	$	5.08	$	410	$	1,419
	Warrant	December 22, 2020	December 22, 2030	Common Stock	29,925	$	6.24		160		594
	Warrant	September 10, 2021	September 10, 2028	Common Stock	21,577	$	0.01		617		518
Total Bowery Farming, Inc.									1,187		2,531


Robotany, Inc.	Warrant	January 16, 2020	July 19, 2029	Common Stock	262,870	$	0.26	$	127	$	73

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.3%)*								$	1,314	$	2,604

Construction ⁽⁷⁾
Project Frog, Inc. ⁽²²⁾	Warrant	January 16, 2020	July 26, 2026	Preferred Series AA	211,633	$	0.19	$	9	$	—
	Warrant	January 16, 2020	July 26, 2026	Common Stock	180,356	$	0.19		9		—
	Warrant	August 3, 2021	December 31, 2031	Preferred Series CC	250,000	$	0.01		20		31
Total Project Frog, Inc.									38		31

Sub-Total: Construction (0.0%)*								$	38	$	31

Educational Services ⁽⁷⁾
Medical Sales Training Holding Company	Warrant⁽¹⁴⁾	March 18, 2021	March 18, 2031	Common Stock	28,732	$	7.74	$	108	$	108

Yellowbrick Learning, Inc.	Warrant	January 16, 2020	September 28, 2028	Common Stock	222,222	$	0.90	$	120	$	485

Sub-Total: Educational Services (0.1%)*								$	228	$	593

Finance and Insurance ⁽⁷⁾
BoardRE, Inc.	Warrant⁽¹⁴⁾	October 15, 2021	October 15, 2031	Common Stock	105,347	$	1.94	$	9	$	8

DailyPay, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock	89,264	$	3.00	$	151	$	839

Petal Card, Inc.	Warrant	January 16, 2020	November 27, 2029	Preferred Series B	250,268	$	1.32	$	147	$	1,412
	Warrant⁽¹⁴⁾	January 11, 2021	January 11, 2031	Common Stock	135,835	$	0.01		312		908
	Warrant	August 6, 2021	August 6, 2031	Common Stock	111,555	$	1.60		197		605
Total Petal Card, Inc.									656		2,925

RealtyMogul, Co.	Warrant	January 16, 2020	December 18, 2027	Preferred Series B	234,421	$	3.88	$	285	$	1

Sub-Total: Finance and Insurance (0.4%)*								$	1,101	$	3,773

Health Care and Social Assistance ⁽⁷⁾
Lark Technologies, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock	76,231	$	1.76	$	177	$	674
	Warrant	June 30, 2021	June 30, 2031	Common Stock	79,325	$	1.76		258		701
Total Lark Technologies, Inc.									435		1,375

Sub-Total: Health Care and Social Assistance (0.1%)*								$	435	$	1,375

Information ⁽⁷⁾
Everalbum, Inc.	Warrant	January 16, 2020	July 29, 2026	Preferred Series A	851,063	$	0.10	$	25	$	—

Figg, Inc.	Warrant⁽¹¹⁾	January 16, 2020	March 31, 2028	Common Stock	935,198	$	0.10	$	—	$	—

Firefly Systems, Inc.	Warrant	January 31, 2020	January 29, 2030	Common Stock	133,147	$	1.14	$	282	$	477

Gtxcel, Inc.	Warrant	January 16, 2020	September 24, 2025	Preferred Series C	1,000,000	$	0.21	$	83	$	21
	Warrant	January 16, 2020	September 24, 2025	Preferred Series D	1,000,000	$	0.21		83		14
Total Gtxcel, Inc.									166		35

Lucidworks, Inc.	Warrant	January 16, 2020	June 27, 2026	Preferred Series D	619,435	$	0.77	$	805	$	2,302

RapidMiner, Inc.	Warrant	January 16, 2020	March 25, 2029	Preferred Series C-1	11,624	$	60.22	$	528	$	18

Rigetti & Co, Inc.	Warrant	May 18, 2021	May 18, 2031	Common Stock	995,099	$	0.21	$	506	$	5,830

Stratifyd, Inc.	Warrant	September 3, 2021	September 3, 2031	Preferred Series B-2	106,719	$	2.53	$	84	$	71

Sub-Total: Information (0.6%)*								$	2,396	$	8,733

37

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value ⁽⁶⁾		Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series		Shares		Strike Price			Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued
Management of Companies and Enterprises ⁽⁷⁾

Manufacturing ⁽²⁾
Atieva, Inc. ⁽¹³⁾	Warrant	January 16, 2020	March 31, 2027	Preferred Series D	390,016		$	5.13	$	3,067	$	1,053
Exer Holdings, LLC													Warrant⁽¹⁴⁾	November 19, 2021	November 19, 2031	Common Stock		281		$	479.25	⁽²¹⁾	$	93	$	92
	Warrant	January 16, 2020	September 8, 2027	Preferred Series D	195,008		$	5.13		1,533		526
Total Atieva, Inc.										4,600		1,579
Sub-Total: Management of Companies and Enterprises (0.0%)*																							$	93	$	92

AyDeeKay LLC	Warrant	January 16, 2020	March 30, 2028	Preferred Series G	6,250		$	35.42	$	31	$	32
Manufacturing ⁽⁷⁾
Bolb, Inc.													Warrant⁽¹⁴⁾	October 12, 2021	October 12, 2031	Common Stock		181,784		$	0.07		$	35	$	34

Daring Foods, Inc.													Warrant	April 8, 2021	April 8, 2031	Common Stock		68,100		$	0.27		$	106	$	431

Footprint International Holding, Inc.	Warrant	February 14, 2020	February 14, 2030	Common Stock	26,852		$	0.31	$	5	$	81	Warrant	February 14, 2020	February 14, 2030	Common Stock		38,171		$	0.31		$	9	$	2,137
	Warrant	June 22, 2020	June 22, 2030	Common Stock	10,836		$	0.31		4		33
Total Footprint International Holding, Inc.										9		114

Happiest Baby, Inc.	Warrant	January 16, 2020	May 16, 2029	Common Stock	182,554		$	0.33	$	193	$	126	Warrant	January 16, 2020	May 16, 2029	Common Stock		182,554		$	0.33		$	193	$	241

Hexatech, Inc. ⁽⁷⁾	Warrant	January 16, 2020	April 2, 2022	Preferred Series A	226		$	2.77	$	—	$	—

Lensvector, Inc.	Warrant	January 16, 2020	December 30, 2021	Preferred Series C	85,065		$	1.18	$	32	$	—

Mainspring Energy, Inc.	Warrant	January 16, 2020	July 9, 2029	Common Stock	140,186		$	1.15	$	283	$	394	Warrant	January 16, 2020	July 9, 2029	Common Stock	��	140,186		$	1.15		$	284	$	534
	Warrant	November 20, 2020	November 20, 2030	Common Stock	81,294		$	1.15		226		229	Warrant	November 20, 2020	November 20, 2030	Common Stock		81,294		$	1.15			226		310
Total Mainspring Energy, Inc.										509		623												510		844

Molekule, Inc.	Warrant	June 19, 2020	June 19, 2030	Preferred Series C-1	32,051			3.12	$	16	$	23	Warrant	June 19, 2020	June 19, 2030	Preferred Series C-1		32,051		$	3.12		$	16	$	23

Nexii Building Solutions, Inc. ⁽¹⁰⁾													Warrant⁽¹⁴⁾	August 27, 2021	August 27, 2026	Common Stock		63,071	⁽²¹⁾	$	15.86	⁽²¹⁾	$	410	$	421

Quip NYC, Inc.													Warrant	March 9, 2021	March 9, 2031	Preferred Series A-1		10,833		$	48.46		$	203	$	311

SBG Labs, Inc.	Warrant	January 16, 2020	June 29, 2023	Preferred Series A-1	42,857		$	0.70	$	13	$	10	Warrant	January 16, 2020	July 29, 2023	Preferred Series A-1		42,857		$	0.70		$	13	$	—
	Warrant	January 16, 2020	September 18, 2024	Preferred Series A-1	25,714		$	0.70		8		6	Warrant	January 16, 2020	September 18, 2024	Preferred Series A-1		25,714		$	0.70			8		—
	Warrant	January 16, 2020	January 14, 2024	Preferred Series A-1	21,492		$	0.70		7		5	Warrant	January 16, 2020	January 14, 2024	Preferred Series A-1		21,492		$	0.70			7		—
	Warrant	January 16, 2020	March 24, 2025	Preferred Series A-1	12,155		$	0.70		4		3	Warrant	January 16, 2020	March 24, 2025	Preferred Series A-1		12,155		$	0.70			4		—
	Warrant	January 16, 2020	October 10, 2023	Preferred Series A-1	11,150		$	0.70		4		3	Warrant	January 16, 2020	October 10, 2023	Preferred Series A-1		11,150		$	0.70			4		—
	Warrant	January 16, 2020	May 6, 2024	Preferred Series A-1	11,145		$	0.70		4		3	Warrant	January 16, 2020	May 6, 2024	Preferred Series A-1		11,145		$	0.70			4		—
	Warrant	January 16, 2020	June 9, 2024	Preferred Series A-1	7,085		$	0.70		2		2	Warrant	January 16, 2020	June 9, 2024	Preferred Series A-1		7,085		$	0.70			2		—
	Warrant	January 16, 2020	May 20, 2024	Preferred Series A-1	342,857		$	0.70		110		80	Warrant	January 16, 2020	May 20, 2024	Preferred Series A-1		342,857		$	0.70			110		—
	Warrant	January 16, 2020	March 26, 2025	Preferred Series A-1	200,000	��	$	0.70		65		48	Warrant	January 16, 2020	March 26, 2025	Preferred Series A-1		200,000		$	0.70			65		—
Total SBG Labs, Inc.										217		160												217		—

Tarana Wireless, Inc.													Warrant⁽¹⁴⁾	June 30, 2021	June 30, 2031	Common Stock		5,027,629		$	0.19		$	967	$	641

The Fynder Group, Inc.	Warrant	October 14, 2020	October 14, 2030	Common Stock	107,190		$	0.49	$	201	$	282	Warrant	October 14, 2020	October 14, 2030	Common Stock		36,445		$	0.49		$	68	$	337

Vertical Communications, Inc. ^{(7) (19)}	Warrant	January 16, 2020	July 11, 2026	Preferred Series A	828,479		$	1.00	$	—	$	—
Vertical Communications, Inc. ⁽²²⁾													Warrant⁽¹¹⁾	January 16, 2020	July 11, 2026	Preferred Series A		828,479		$	1.00		$	—	$	—

Sub-Total: Manufacturing (1.2%)*									$	5,808	$	2,939
VitaCup, Inc.													Warrant⁽¹⁴⁾	June 23, 2021	June 23, 2031	Preferred Series C		68,996		$	2.79		$	9	$	5

Sub-Total: Manufacturing (0.6%)*																							$	2,743	$	5,425

3238

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾		Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Pharmaceutical ⁽²⁾⁽⁷⁾
Ology Bioservices, Inc. ⁽¹⁹⁾	Warrant	January 16, 2020	November 14, 2021	Common Stock	67,961	$	1.03	$	1,122	$	2,216

Zosano Pharma Corporation	Warrant	January 16, 2020	September 25, 2025	Common Stock	75,000	$	3.59	$	69	$	18	Warrant ⁽⁹⁾	January 16, 2020	September 25, 2025	Common Stock	75,000	$	3.59	$	69	$	17

Sub-Total: Pharmaceutical (0.9%)*								$	1,191	$	2,234
Sub-Total: Pharmaceutical (0.0%)*																			$	69	$	17

Professional, Scientific, and Technical Services ⁽²⁾
Augmedix, Inc.	Warrant	January 16, 2020	September 3, 2029	Preferred Series B	580,383	$	2.88	$	449	$	379

Professional, Scientific, and Technical Services ⁽⁷⁾
Continuity, Inc.	Warrant	January 16, 2020	March 29, 2026	Preferred Series C	1,588,806	$	0.25	$	21	$	45	Warrant	January 16, 2020	March 29, 2026	Preferred Series C	1,588,806	$	0.25	$	21	$	17

Crowdtap, Inc.	Warrant	January 16, 2020	December 16, 2025	Preferred Series B	442,233	$	1.09	$	42	$	140	Warrant	January 16, 2020	December 16, 2025	Preferred Series B	442,233	$	1.09	$	41	$	240
	Warrant	January 16, 2020	November 30, 2027	Preferred Series B	100,000	$	1.09		9		32	Warrant	January 16, 2020	December 11, 2027	Preferred Series B	100,000	$	1.09		9		54
Total Crowdtap, Inc.									51		172									50		294

Dynamics, Inc.	Warrant	January 16, 2020	March 10, 2024	Common Stock	17,000	$	10.59	$	86	$	—	Warrant	January 16, 2020	March 10, 2024	Common Stock	17,000	$	10.59	$	86	$	—

E La Carte, Inc.	Warrant	January 16, 2020	July 28, 2027	Common Stock	497,183	$	0.30	$	186	$	123	Warrant	January 16, 2020	April 27, 2027	Preferred Series A	497,183	$	0.30	$	185	$	861
	Warrant	January 16, 2020	July 28, 2027	Preferred Series A	104,284	$	7.49		15		34	Warrant	January 16, 2020	July 28, 2027	Common Stock	104,284	$	7.49		14		156
	Warrant	January 16, 2020	July 28, 2027	Preferred Series AA-1	106,841	$	7.49		15		1	Warrant	January 16, 2020	April 28, 2027	Preferred Series AA-1	106,841	$	7.49		14		43
Total E La Carte, Inc.									216		158									213		1,060

Edeniq, Inc.	Warrant	January 16, 2020	December 23, 2026	Preferred Series B	2,685,501	$	0.22	$	—	$	—	Warrant⁽¹¹⁾	January 16, 2020	December 23, 2026	Preferred Series B	2,685,501	$	0.22	$	—	$	2
	Warrant	January 16, 2020	December 23, 2026	Preferred Series B	2,184,672	$	0.01		—		—	Warrant⁽¹¹⁾	January 16, 2020	December 23, 2026	Preferred Series B	2,184,672	$	0.01		—		5
	Warrant	January 16, 2020	March 12, 2028	Preferred Series C	5,106,972	$	0.44		—		—	Warrant⁽¹¹⁾	January 16, 2020	June 29, 2027	Preferred Series C	5,106,972	$	0.44		—		—
	Warrant	January 16, 2020	October 15, 2028	Preferred Series C	3,850,294	$	0.01		—		—	Warrant⁽¹¹⁾	January 16, 2020	November 2, 2028	Preferred Series C	3,850,294	$	0.01		—		12
Total Edeniq, Inc. ^(7)(19)									—		—
												Warrant	November 29, 2021	November 29, 2031	Preferred Series D	154,906,320	$	0.01		7		34
Fingerprint Digital, Inc.	Warrant	January 16, 2020	April 29, 2026	Preferred Series B	48,102	$	10.39	$	165	$	84
Total Edeniq, Inc. ⁽²²⁾																				7		53

Greenlight Biosciences Inc.												Warrant⁽¹⁴⁾	March 29, 2021	March 29, 2031	Common Stock	219,839	$	0.82	$	139	$	857

Hologram, Inc.	Warrant	January 31, 2020	January 27, 2030	Common Stock	193,054	$	0.26	$	49	$	33	Warrant	January 31, 2020	January 27, 2030	Common Stock	193,054	$	0.26	$	49	$	914

Hospitalists Now, Inc.	Warrant	January 16, 2020	March 30, 2026	Preferred Series D2	135,807	$	5.89	$	71	$	272	Warrant	January 16, 2020	March 30, 2026	Preferred Series D-2	135,807	$	5.89	$	71	$	1,840
	Warrant	January 16, 2020	December 6, 2026	Preferred Series D2	750,000	$	5.89		391		1,505	Warrant	January 16, 2020	December 6, 2026	Preferred Series D-2	750,000	$	5.89		391		333
Total Hospitalists Now, Inc.									462		1,777									462		2,173

Incontext Solutions, Inc.	Warrant	January 16, 2020	September 28, 2028	Preferred Series AA-1	332,858	$	1.47	$	34	$	47	Warrant	January 16, 2020	September 28, 2028	Common Stock	2,219	$	220.82	$	34	$	—

Matterport, Inc.	Warrant	January 16, 2020	April 20, 2028	Common Stock	143,813	$	1.43	$	434	$	603
PebblePost, Inc.												Warrant⁽¹⁴⁾	May 7, 2021	May 7, 2031	Common Stock	657,343	$	0.75	$	68	$	379

Pendulum Therapeutics, Inc.	Warrant	January 16, 2020	October 9, 2029	Preferred Series B	55,263	$	1.90	$	44	$	65	Warrant	January 16, 2020	October 9, 2029	Preferred Series B	55,263	$	1.90	$	44	$	46
												Warrant	June 1, 2020	July 15, 2030	Preferred Series B	36,842	$	1.90		36		31
	Warrant	June 1, 2020	July 15, 2030	Preferred Series B	36,842	$	1.90		36		43	Warrant⁽¹⁴⁾	December 31, 2021	December 31, 2021	Preferred Series C	322,251	$	3.24		118		118
Total Pendulum Therapeutics, Inc.									80		108									198		195

Reciprocity, Inc.	Warrant	September 25, 2020	September 25, 2030	Common Stock	114,678	$	4.17	$	99	$	145	Warrant	September 25, 2020	September 25, 2030	Common Stock	114,678	$	4.17	$	99	$	656
												Warrant	April 29, 2021	April 29, 2031	Common Stock	57,195	$	4.17		54		327
Total Reciprocity, Inc.																				153		983

Resilinc, Inc.	Warrant	January 16, 2020	December 15, 2025	Preferred Series A	589,275	$	0.51	$	40	$	100	Warrant	January 16, 2020	December 15, 2025	Preferred Series A	589,275	$	0.51	$	40	$	—


Saylent Technologies, Inc.	Warrant	January 16, 2020	March 31, 2027	Preferred Series C	24,096	$	9.96	$	108	$	94

Sun Basket, Inc.	Warrant	January 16, 2020	October 5, 2027	Preferred Series C-2	249,306	$	6.02	$	111	$	343	Warrant	January 16, 2020	October 5, 2027	Common Stock	103,636	$	14.47	$	111	$	1,172
	Warrant	December 31, 2020	December 31, 2030	Common Stock	118,678	$	0.89		545		546	Warrant	December 31, 2020	December 29, 2032	Common Stock	33,348	$	3.17		546		81
									656		889

Utility Associates, Inc.	Warrant	January 16, 2020	June 30, 2025	Preferred Series A	92,511	$	4.54	$	55	$	4
	Warrant	January 16, 2020	May 1, 2026	Preferred Series A	60,000	$	4.54		36		3
	Warrant	January 16, 2020	May 22, 2027	Preferred Series A	200,000	$	4.54		120		8
Total Utility Associates, Inc.									211		15

Sub-Total: Professional, Scientific, and Technical Services (2.0%)*								$	3,161	$	4,649
Total Sun Basket, Inc.																				657		1,253

3339

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾			Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares		Strike Price			Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Real Estate ⁽²⁾
Professional, Scientific, and Technical Services, Continued ⁽⁷⁾
Utility Associates, Inc.													Warrant	January 16, 2020	June 30, 2025	Preferred Series A	92,511		$	4.54		$	55	$	—
													Warrant	January 16, 2020	May 1, 2026	Preferred Series A	60,000		$	4.54			36		—
													Warrant	January 16, 2020	May 22, 2027	Preferred Series A	200,000		$	4.54			120		—
Total Utility Associates, Inc.																							211		—

ZenDrive, Inc.													Warrant⁽¹⁴⁾	July 16, 2021	July 16, 2031	Common Stock	30,466		$	2.46		$	29	$	55

Sub-Total: Professional, Scientific, and Technical Services (0.9%)*												Sub-Total: Professional, Scientific, and Technical Services (0.9%)*										$	2,417	$	8,233

Real Estate ⁽⁷⁾
Egomotion Corporation	Warrant	January 16, 2020	December 10, 2028	Preferred Series A ⁽⁷⁾	60,786	$	1.32	$	—	$	53		Warrant⁽¹¹⁾	January 16, 2020	December 10, 2028	Preferred Series A	60,786		$	1.32		$	—	$	47
	Warrant	January 16, 2020	June 29, 2028	Preferred Series A	121,571	$	1.32		219		106		Warrant	January 16, 2020	June 29, 2028	Preferred Series A	121,571		$	1.32			219		94
Total Egomotion Corporation									219		159												219		141

Knockaway, Inc.	Warrant	January 16, 2020	May 24, 2029	Preferred Series B	87,955	$	8.53	$	209	$	272		Warrant	January 16, 2020	May 24, 2029	Preferred Series B	87,955		$	8.53		$	209	$	458
													Warrant	November 10, 2021	November 10, 2031	Common Stock	148,730	⁽²¹⁾	$	7.74	⁽²¹⁾	$	265	$	557
Sub-Total: Real Estate (0.2%)*								$	428	$	431
Total Knockaway, Inc.																							474		1,015

Rental and Leasing Services ⁽²⁾
Sub-Total: Real Estate (0.1%)*																						$	693	$	1,156

Rental and Leasing Services ⁽⁷⁾

Maxwell Financial Labs, Inc.	Warrant	October 7, 2020	October 7, 2030	Common Stock	106,735	$	0.29	$	21	$	33		Warrant	October 7, 2020	October 7, 2030	Common Stock	106,735		$	0.29		$	20	$	283
	Warrant	December 22, 2020	December 22, 2030	Common Stock	110,860	$	0.29		34		34		Warrant	December 22, 2020	December 22, 2030	Common Stock	110,860		$	0.29			34		273
													Warrant	September 30, 2021	September 30, 2031	Common Stock	79,135		$	1.04			148		174
Total Maxwell Financial Labs, Inc.									55		67												202		730

Sub-Total: Rental and Leasing Services (0.0%)*								$	55	$	67
NextCar Holding Company, Inc.													Warrant	December 14, 2021	December 14, 2026	Preferred Series A	167,543	⁽²¹⁾	$	2.62	⁽²¹⁾	$	35	$	80

Retail Trade ⁽²⁾
Boosted eCommerce, Inc. ⁽¹⁴⁾	Warrant	December 18, 2020	December 14, 2030	Preferred Series A-1	759,263	$	0.84	$	259	$	259
Sub-Total: Rental and Leasing Services (0.1%)*																						$	237	$	810

Retail Trade ⁽⁷⁾
Boosted eCommerce, Inc.													Warrant	December 18, 2020	December 14, 2030	Preferred Series A-1	759,263		$	0.84		$	259	$	154

Fernished, Inc.													Warrant⁽¹⁴⁾	May 5, 2021	May 5, 2031	Common Stock	54,427		$	0.15		$	39	$	39

Gobble, Inc.	Warrant	January 16, 2020	May 9, 2028	Common Stock	74,635	$	1.20	$	73	$	63		Warrant	January 16, 2020	May 9, 2028	Common Stock	74,635		$	1.20		$	73	$	101
	Warrant	January 16, 2020	December 27, 2029	Common Stock	10,000	$	1.22		617		467		Warrant	January 16, 2020	December 27, 2029	Common Stock	10,000		$	1.22			617		754
Total Gobble, Inc.									690		530												690		855

Madison Reed, Inc.	Warrant	January 16, 2020	March 23, 2027	Preferred Series C	194,553	$	2.57	$	185	$	241		Warrant	January 16, 2020	March 23, 2027	Preferred Series C	194,553		$	2.57		$	185	$	398
	Warrant	January 16, 2020	July 18, 2028	Common Stock	43,158	$	0.99		71		78		Warrant	January 16, 2020	July 18, 2028	Common Stock	43,158		$	0.99			71		131
	Warrant	January 16, 2020	May 19, 2029	Common Stock	36,585	$	1.23		56		62		Warrant	January 16, 2020	June 30, 2029	Common Stock	36,585		$	1.23			56		105
Total Madison Reed, Inc.									312		381												312		634

Portofino Labs, Inc. ⁽¹⁴⁾	Warrant	December 31, 2020	December 31, 2030	Common Stock	39,659	$	1.53	$	15	$	15
Portofino Labs, Inc.													Warrant⁽¹⁴⁾	December 31, 2020	December 31, 2030	Common Stock	39,659		$	1.53		$	160	$	107
													Warrant⁽¹⁴⁾	April 1, 2021	April 1, 2031	Common Stock	39,912		$	1.46			99		44
Super73, Inc. ⁽¹⁴⁾	Warrant	December 31, 2020	December 31, 2030	Common Stock	177,305	$	3.16	$	105	$	105
Total Portofino Labs, Inc.																							259		151

Super73, Inc.													Warrant⁽¹⁴⁾	December 31, 2020	December 31, 2030	Common Stock	177,305		$	3.16		$	105	$	132

Trendly, Inc.	Warrant	January 16, 2020	August 10, 2026	Preferred Series A	245,506	$	1.14	$	222	$	256		Warrant	January 16, 2020	August 10, 2026	Preferred Series A	245,506		$	1.14		$	222	$	86

Sub-Total: Retail Trade (0.6%)*								$	1,603	$	1,546

Wholesale Trade ⁽²⁾
BaubleBar, Inc.	Warrant	January 16, 2020	March 29, 2027	Preferred Series C	531,806	$	1.96	$	638	$	207
	Warrant	January 16, 2020	April 20, 2028	Preferred Series C	60,000	$	1.96		72		23
Total BaubleBar, Inc.									710		230

GrubMarket, Inc.	Warrant	June 15, 2020	June 15, 2030	Common Stock	405,000	$	1.10	$	116	$	837

Sub-Total: Wholesale Trade (0.4%)*								$	826	$	1,067

Total: Warrant Investments (7.4%)*⁽¹³⁾								$	17,865	$	17,778
Sub-Total: Retail Trade (0.2%)*																						$	1,886	$	2,051

3440

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~2021

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Space Research and Technology ⁽⁷⁾
Axiom Space, Inc.	Warrant	May 28, 2021	May 28, 2031	Common Stock	1,773	$	169.24	$	121	$	146
	Warrant	May 28, 2021	May 28, 2031	Common Stock	882	$	340.11		39		37
Total Axiom Space, Inc.									160		183

Sub-Total: Space Research and Technology (0.0%)*								$	160	$	183

Wholesale Trade ⁽⁷⁾
BaubleBar, Inc.	Warrant	January 16, 2020	March 29, 2027	Preferred Series C	531,806	$	1.96	$	639	$	788
	Warrant	January 16, 2020	April 20, 2028	Preferred Series C	60,000	$	1.96		72		89
Total BaubleBar, Inc.									711		877

GrubMarket, Inc.	Warrant	June 15, 2020	June 15, 2030	Common Stock	405,000	$	1.10	$	115	$	568

Sub-Total: Wholesale Trade (0.2%)*								$	826	$	1,445

Total: Warrant Investments (3.6%)*⁽¹³⁾								$	14,885	$	36,770

Portfolio Company ⁽¹⁾

Type of
Investment ⁽³⁾

Investment Date ⁽¹⁷⁾

Shares / Principal

Series

Cost

Fair Value ⁽⁶⁾
Equity Investments











Construction ⁽²⁾











Project Frog, Inc.

Equity

January 16, 2020

8,118,527

Preferred Series AA-1 ⁽¹⁸⁾

$
702

$
36

Equity

January 16, 2020

6,300,134

Preferred  Series BB ⁽¹⁸⁾

2,667

449
Total Project Frog, Inc. ⁽¹⁹⁾





3,369

485








Sub-Total:  Construction (0.2%)*





$
3,369

$
485








Health Care and Social Assistance ⁽²⁾








WorkWell Prevention & Care Inc.

Equity

January 16, 2020

7,000,000

Common Stock

$
51

$
—

Equity

January 16, 2020

3,450

Preferred Series P ⁽¹⁸⁾

3,450

657

Equity

January 16, 2020

$
1,470

Convertible Notes ⁽¹⁰⁾

1,519

1,542
Total WorkWell Prevention & Care Inc. ⁽¹⁹⁾





5,020

2,199








Sub-Total:  Health Care and Social Assistance (0.9%)*





$
5,020

$
2,199








Manufacturing ⁽²⁾








Store Intelligence, Inc. ⁽¹⁹⁾

Equity

May 2, 2020

1,430,000

Preferred Series A ⁽¹⁸⁾

$
608

$
694








Vertical Communications, Inc.

Equity

January 16, 2020

3,892,485

Preferred Series 1 ^(7)(18)

$
—

$
—

Equity

January 16, 2020

$
5,500,000

Convertible Notes⁽¹⁰⁾

3,966

3,350
Total Vertical Communications, Inc. ⁽¹⁹⁾





3,966

3,350








Sub-Total:  Manufacturing (1.7%)*





$
4,574

$
4,044








Pharmaceutical ⁽²⁾








Ology Bioservices, Inc. ⁽¹⁹⁾

Equity

January 16, 2020

382,277

Common Stock ⁽¹⁶⁾

$
6,691

$
12,856

Sub-Total:  Pharmaceutical (5.4%)*





$
6,691

$
12,856








Professional, Scientific, and Technical Services ⁽²⁾








Dynamics, Inc.

Equity

January 16, 2020

17,726

Preferred  Series A ⁽¹⁸⁾

$
390

$
—

Equity

January 16, 2020

15,000

Common Stock ⁽⁷⁾

—

—
Total Dynamics, Inc.

390

—








Edeniq, Inc.

Equity

January 16, 2020

7,807,499

Preferred Series B ^(7)(18)

$
—

$
—

Equity

January 16, 2020

2,441,082

Preferred Series C ^(7)(18)

—

—

Equity

January 16, 2020

$
1,303,373

Convertible Notes ^(7)(10)

—

—
Total Edeniq, Inc. ⁽¹⁹⁾





—

—








Instart Logic, Inc.

Equity

January 16, 2020

$
2,600,000

Convertible Notes ⁽¹⁰⁾

$
2,646

$
3,625








Sub-Total: Professional, Scientific, and Technical Services (1.5%)*

$
3,036

$
3,625

Retail Trade ⁽²⁾

Birchbox, Inc. ⁽¹⁹⁾

Equity

April 20, 2020

3,140,927

Preferred Series D ⁽¹⁸⁾

$
10,271

$
9,445







Sub-Total: Retail Trade (4.0%)*

$
10,271

$
9,445

Total:  Equity Investments (13.7%)*⁽¹³⁾







$
32,961

$
32,654










Total Investment in Securities (207.2%)*







$
498,336

$
493,651










Cash, Cash Equivalents, and Restricted Cash










Goldman Sachs Financial Square Government Institutional Fund





$
60,284

$
60,284
Other cash accounts







817

817
Cash, Cash Equivalents, and Restricted Cash (25.6%)*







61,101

61,101










Total Portfolio Investments and Cash and Cash Equivalents (232.9% of net assets)







$
559,437

$
554,752

3541

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, ~~2020~~
2021

(In thousands, except share and per share data)

Portfolio Company ⁽¹⁾

Type of
Investment ⁽²⁾

Investment Date ⁽³⁾

Shares / Principal

Series

Cost

Fair Value ⁽⁶⁾
Equity Investments











Construction ⁽⁷⁾











Project Frog, Inc.

Equity

January 16, 2020

4,383,173

Preferred Series AA-1⁽¹⁷⁾

$
351

$
—

Equity

January 16, 2020

3,401,427

Preferred Series BB⁽¹⁷⁾

1,333

—

Equity

August 3, 2021

6,634,061

Common Stock

1,684

—

Equity

August 3, 2021

3,129,887

Preferred Series CC⁽¹⁷⁾

1,253

426
Total Project Frog, Inc. ⁽²²⁾





4,621

426








Sub-Total:  Construction (0.0%)*





$
4,621

$
426








Health Care and Social Assistance ⁽⁷⁾








FemTec, Inc. ⁽²²⁾

Equity

July 22, 2021

1,098,093

Common Stock

$
13,046

$
12,369








Lark Technologies, Inc.

Equity⁽¹⁴⁾

August 19, 2021

32,416

Preferred Series D⁽¹⁷⁾

$
500

$
461








WorkWell Prevention & Care Inc.

Equity

January 16, 2020

7,000,000

Common Stock

$
51

$
—

Equity

January 16, 2020

3,450

Preferred Series P⁽¹⁷⁾

3,450

—

Equity

January 16, 2020

$
2,870

Convertible Note⁽¹⁶⁾

2,919

903
Total WorkWell Prevention & Care Inc. ⁽²²⁾





6,420

903








Sub-Total:  Health Care and Social Assistance (1.5%)*





$
19,966

$
13,733








Manufacturing ⁽⁷⁾








Lucid Motors, Inc.

Equity ⁽⁹⁾

July 26, 2021

1,867,973

Common Stock

$
8,560

$
67,620

Quip NYC, Inc.

Equity⁽¹⁴⁾

August 17, 2021

3,321

Preferred Series B-1⁽¹⁷⁾

$
500

$
493

Store Intelligence, Inc. ⁽²²⁾

Equity

May 2, 2020

1,430,000

Preferred Series A⁽¹⁷⁾

$
608

$
—








Vertical Communications, Inc.

Equity⁽¹¹⁾

January 16, 2020

3,892,485

Preferred Series 1⁽¹⁷⁾

$
—

$
—

Equity

January 16, 2020

$
5,500

Convertible Note⁽¹⁶⁾

3,966

3,725
Total Vertical Communications, Inc. ⁽²²⁾



3,966

3,725






Sub-Total:  Manufacturing (7.7%)*



$
13,634

$
71,838






Professional, Scientific, and Technical Services ⁽⁷⁾






Dynamics, Inc.

Equity

January 16, 2020

17,726

Preferred Series A⁽¹⁷⁾

$
391

$
—








Matterport, Inc.

Equity ⁽⁹⁾

July 23, 2021

571,941

Common Stock

$
434

$
11,324








Edeniq, Inc.

Equity⁽¹¹⁾

January 16, 2020

7,807,499

Preferred Series B⁽¹⁷⁾

$
—

$
19

Equity⁽¹¹⁾

January 16, 2020

3,657,487

Preferred Series C⁽¹⁷⁾

—

34

Equity⁽¹¹⁾

November 29, 2021

133,766,138

Preferred Series D⁽¹⁷⁾

—

343
Total Edeniq, Inc. ⁽²²⁾





—

396

Emergy, Inc.

Equity

June 28, 2021

75,958

Preferred Series B⁽¹⁷⁾

$
500

$
507

Sub-Total: Professional, Scientific, and Technical Services (1.3%)*

$
1,325

$
12,227

42

TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2021
(In thousands, except share and per share data)

Portfolio Company ⁽¹⁾

Type of
Investment ⁽²⁾

Investment Date ⁽³⁾

Shares / Principal

Series

Cost

Fair Value ⁽⁶⁾
Equity Investments, Continued











Real Estate ⁽⁷⁾

Orchard Technologies, Inc.

Equity⁽¹⁴⁾

August 6, 2021

74,406

Preferred Series D⁽¹⁷⁾

$
500

$
499

Sub-Total:  Real Estate (0.1%)*

$
500

$
499

Rental and Leasing Services ⁽⁷⁾








Maxwell Financial Labs, Inc

Equity⁽¹⁴⁾

January 22, 2021

135,641

Preferred Series B⁽¹⁷⁾

$
500

$
509

Sub-Total:  Rental and Leasing Services (0.1%)*





$
500

$
509

Retail Trade ⁽⁷⁾

Fernished, Inc.

Equity⁽¹¹⁾⁽¹⁴⁾

October 6, 2021

454,905

Preferred Series B-1⁽¹⁷⁾

$
500

$
500

Portofino Labs, Inc.

Equity⁽¹¹⁾⁽¹⁴⁾

November 1, 2021

256,291

Preferred Series B-1⁽¹⁷⁾

$
500

$
500

Sub-Total:  Retail Trade (0.1%)*





$
1,000

$
1,000








Space Research and Technology ⁽⁷⁾

Axiom Space, Inc.

Equity⁽¹⁴⁾

August 11, 2021

$
500

Convertible Note⁽¹⁶⁾

$
500

$
500

Sub-Total:  Rental and Leasing Services (0.1%)*

$
500

$
500

Total:  Equity Investments (10.8%)*⁽¹³⁾







$
42,046

$
100,732










Total Investment in Securities (93.2%)*







$
797,856

$
873,470










Cash, Cash Equivalents, and Restricted Cash





��




Goldman Sachs Financial Square Government Institutional Fund





$
43,428

$
43,428
Other cash accounts







3,314

3,314
Cash, Cash Equivalents, and Restricted Cash (4.7%)*







46,742

46,742










Total Portfolio Investments and Cash and Cash Equivalents (97.8% of net assets)







$
844,598

$
920,212
(1) All portfolio companies are located in North America. As of December 31, ~~2020,~~2021, the Company had ~~two~~three foreign domiciled portfolio companies, ~~- one~~which are based in Canada ~~(11.3%~~and, in total, represent 13.5% of ~~NAV) and one in Cayman Islands (0.7% of NAV).~~total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.
(2) ~~The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.~~
~~(3)~~ All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.
(3) Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds (as defined below) as part of the Formation Transactions (as defined below), investment date is January 16, 2020, the date of the Formation Transactions.
(4) Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or ~~any~~ additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair market value, ~~in certain cases~~generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt ~~securities~~securities.
(5) Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

43

(6)	~~All~~Except as noted, all investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.

(7)	~~Investment has zero cost basis as it was purchased at a fair market value~~The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of ~~zero as part of the Formation Transaction.~~ its portfolio companies.

(8)

~~Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended. The Company’s~~ percentage of non-qualifying assets represents 5.1% of the Company’s total assets as of December 31, 2020. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Invenia, Inc. is a Canadian corporation, and Atieva, Inc. is a Cayman Island corporation.

~~(9)~~

The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 3.25% and 1-month U.S. Dollar London Interbank Offered Rate (“LIBOR”) was 0.10% as of December ~~30, 2020.~~ 31, 2021.

(9)	Asset is valued using Level 2 inputs.

(10)

~~Convertible notes~~Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended (the “1940 Act”). The Company’s percentage of non-qualifying assets at fair value represents 6.4% of the Company’s total assets as of December 31, 2021. Qualifying assets must represent ~~investments through which~~at least 70% of the ~~Company will participate in future equity rounds~~Company’s total assets at ~~preferential rates. There~~the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Hut 8 Holdings, Inc., Invenia, Inc. and Nexii, Inc. are ~~no principal or interest payments made against the note unless conversion does not take place.~~ Canadian corporations.

(11)	~~Debt is on non-accrual status~~Investment has zero cost basis as it was purchased at a fair market value of ~~December 30, 2020 and is therefore considered non-income producing.~~zero as part of the Formation Transactions.

36

(12)

Investment ~~has an unfunded commitment as of December 31, 2020 (see “Note 6 – Commitments and Contingencies”). The fair value~~is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the ~~investment includes~~facility will occur over the ~~impact of the fair value of any unfunded commitments.~~ amortizing period unless otherwise prepaid.

(13)	All of the Company’s debt, warrant and equity securities are pledged as collateral supporting the amounts outstanding under the credit facility with Credit Suisse AG (see “Note 5 – Borrowings”), except as noted.

(14)	Investment is not pledged as collateral supporting amounts outstanding under the credit facility with Credit Suisse AG.

(15)	Investment is considered non-income producing.

(16)

~~Certain third parties have rights to 17,485 shares of Ology Bioservices common stock~~Convertible notes represent investments through which the Company will participate in future equity rounds at ~~a fair value of approximately $0.6 million as of December 31, 2020.~~preferential rates. There are no principal or interest payments made against the note unless conversion does not occur.

(17)	Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions, investment date is January 16, 2020, the date of the Formation Transactions.

~~(18)~~

Preferred stock ~~represent~~represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

37

(18)	Investment is on non-accrual status as of December 31, 2021, and is therefore considered non-income producing.

(19)	Investment is pledged as collateral supporting amounts outstanding under the credit facility with KeyBank.

(20)

Interest on this loan includes a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected.

(21)	Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.

(22)

This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the ~~Investment Company~~1940 Act ~~of 1940, as amended,~~ as investments in companies in which the Company owns more than 25% of the voting securities or

44

maintains greater than 50% of ~~the~~ board representation. Affiliate Investments are defined by the ~~Investment Company~~1940 Act ~~of 1940, as amended,~~ as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the ~~Investment Company~~1940 Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of December 31, ~~2020~~2021, along with transactions during the year ended December 31, ~~2020~~2021, in these control or affiliated investments are as follows:

Net change in

Unrealized

Fair Value at

Gross

Gross

Realized

(Depreciation)/

Fair Value at

Interest

December 31, 2020

Additions ⁽¹⁾

Reductions ⁽²⁾

Gain/(Loss)

Appreciation

December 31, 2021

Income

For the Year Ended December 31, 2021

Control Investments











Birchbox, Inc.

$
19,369

$
5,569

$
(23,548)

$
(2,725)

$
1,335

$
—

$
576

Edeniq, Inc.

1,507

914

(2,301)

—

5,402

5,522

1,675

Project Frog, Inc.

4,516

1,318

(20)

—

(1,605)

4,209

549

Vertical Communications, Inc.

16,953

1,597

(325)

—

(843)

17,382

2,082

WorkWell Prevention and Care Inc.

6,385

1,435

—

—

(2,719)

5,101

360

Total Control Investments

$
48,730

$
10,833

$
(26,194)

$
(2,725)

$
1,570

$
32,214

$
5,242

Affiliate Investments















FemTec Health, Inc.

$
—

$
29,499

$
(531)

$
—

$
(1,220)

$
27,748

$
725

Ology Bioservices, Inc.

15,072

—

(9,972)

2,159

(7,259)

—

—

Store Intelligence, Inc.

12,578

162

(360)

—

(7,936)

4,444

882

Total Affiliate Investments

$
27,650

$
29,661

$
(10,863)

$
2,159

$
(16,415)

$
32,192

$
1,607

Total Control and Affiliate Investments

$
76,380

$
40,494

$
(37,057)

$
(566)

$
(14,845)

$
64,406

$
6,849

Net change in

Unrealized

Fair Value at

Gross

Gross

Realized

(Depreciation)/

Fair Value at

Interest

December 31, 2019

Additions ⁽¹⁾

Reductions ⁽²⁾

Gain/(Loss)

Appreciation

December 31, 2020

Income

For the Year Ended December 31, 2020

Control Investments











Birchbox, Inc.

$
—

$
20,704

$

$
—

$
(1,335)

$
19,369

$
1,289

Edeniq, Inc.

—

3,278

(1,414)

—

(357)

1,507

—

Project Frog, Inc.

—

7,432

—

(2,916)

4,516

552

Vertical Communications, Inc.

—

17,904

(194)

—

(757)

16,953

1,425

WorkWell Prevention and Care Inc.

—

9,362

—

(2,977)

6,385

395

Total Control Investments

$
—

$
58,680

$
(1,608)

$
—

$
(8,342)

$
48,730

$
3,661















Affiliate Investments















Ology Bioservices, Inc.

$
—

$
7,813

$

$
—

$
7,259

$
15,072

$
—

Store Intelligence, Inc.

—

12,840

—

(262)

12,578

1,191

Total Affiliate Investments

$
—

$
20,653

$
—

$
—

$
6,997

$
27,650

$
1,191















Total Control and Affiliate Investments

$
—

$
79,333

$
(1,608)

$
—

$
(1,345)

$
76,380

$
4,852

(1) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

3845

TRINITY CAPITAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)
Note 1. Organization and Basis of Presentation
Trinity Capital Inc., (“Trinity Capital” and, together with its ~~subsidiary,~~subsidiaries, the “Company”) is a specialty lending company focused on providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company (“BDC”).
Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Trinity Capital ~~intends to elect~~has elected to be treated, and intends to continue to qualify annually, ~~thereafter,~~ as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), for U.S. federal income tax purposes. ~~This election will be made in conjunction with the filing of the Company’s 2020 tax return.~~
On September 27, 2019, Trinity Capital was initially capitalized with the issuance of 10 shares of its common stock for $150 to its sole stockholder. On January 16, 2020, Trinity Capital completed a series of transactions, including a private equity offering, a private debt offering, and the acquisition of Trinity Capital Investment, LLC, ~~(“TCI”),~~ Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P. ~~(“Fund III”)~~, Trinity Capital Fund IV, L.P. ~~(“Fund IV”)~~, and Trinity Sidecar Income Fund, L.P. ~~(“Sidecar Fund”)~~ (collectively the “Legacy Funds”) through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital’s acquisition of Trinity Capital Holdings, LLC (“Trinity Capital Holdings”) (collectively, the “Formation Transactions”).
Trinity Capital’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN” in connection with its initial public offering of shares of its common stock (“IPO”).
Basis of Presentation
The Company’s interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period’s consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021, as filed with the Securities and Exchange Commission (“SEC”). on March 3, 2022. As an investment company, the Company follows accounting and reporting guidance determined by the Financial Accounting Standards Board (“FASB”), in Accounting Standards Codification, as amended (“ASC”) ~~Topic~~ 946 - Financial Services – Investment Companies (“ASC 946”).
~~Formation Transactions~~
~~The Formation Transactions were accounted for as a business combination in accordance with FASB ASC 805,~~ ~~Business Combinations~~ ~~(“ASC 805”)~~, and as a result the assets acquired, and liabilities assumed were recorded at fair values as of January 16, 2020. Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of the consideration transferred.

39

On January 16, 2020, the Company completed a private offering of shares of its common stock (the “Private Common Stock Offering”) in reliance upon the available exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to which the Company issued and sold 7,000,000 shares of its common stock for aggregate gross proceeds of approximately $105.0 million. Keefe, Bruyette & Woods, Inc. (“KBW”) acted as the initial purchaser and placement agent in connection with the Private Common Stock Offering pursuant to a purchase/placement agreement, dated January 8, 2020, by and between the Company and KBW. KBW exercised in full its option to purchase or place additional shares and on January 29, 2020 the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million.

On January 16, 2020, concurrent with the initial closing of the Private Common Stock Offering, the Company completed a private debt offering (the “144A Note Offering” and together with the Private Common Stock Offering, the “Private Offerings”) of $105.0 million in aggregate principal amount of the Company’s unsecured 7.00% Notes due 2025 (the “2025 Notes”). On January 29, 2020, an over-allotment option related to the 144A Note Offering was exercised in full and on the Company issued and sold an additional $20.0 million in aggregate principal amount of the Notes. As a result, the Company issued and sold $125.0 million in aggregate principal amount of the Notes. See “Note 5 - Borrowings” and “Note 7 – Stockholder’s Equity.”

On January 16, 2020, immediately following the consummation of the Private Offerings, the Company used a portion of the proceeds of the Private Offerings to acquire, through the Formation Transactions, the Legacy Funds and Trinity Capital Holdings. Each member/limited partner of the Legacy Funds was given the option to elect to receive cash and or shares of the Company’s common stock in exchange for its limited partner interests or membership interests, as applicable. The general partners, managers or managing members of the Legacy Funds received only shares in exchange for their interests held in such capacities. As a result of the Formation Transactions, the Legacy Funds were merged with and into the Company and Trinity Capital Holdings became a wholly owned subsidiary of the Company.

As consideration for the partnership and membership interests in the Legacy Funds, the Company issued 9,183,185 shares of its common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners/managers of the Legacy Funds (the “Legacy Investors”). The acquisition consideration of the Formation Transactions was based on valuations as of September 30, 2019, as adjusted for assets that were disposed of by the Legacy Funds, as well as earnings, capital contributions and distributions paid to the general partners, managers or managing members, and material events affecting the portfolio companies of the Legacy Funds subsequent to September 30, 2019 and through the closing date of the Formation Transactions.

~~A summary of the fair value of the assets acquired and liabilities assumed from the Legacy Funds as of the acquisition date is as follows (in thousands):~~

Investments acquired

$
417,023
Interest receivable and other assets acquired

1,191
Accounts payable and accrued liabilities assumed

(680)
Customer deposits assumed

(4,250)
Credit facility assumed

(190,000)
Financing fees related to credit facility acquired

1,900
Cash acquired

19,183
Total net assets acquired

$
244,367

The total merger consideration of the Legacy Funds of approximately $246.4 million exceeded the fair value of the net assets acquired as of the acquisition date, and as a result, the Company included a loss of approximately $2.1 million in Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. During the quarter ended December 31, 2020, upon filing the final tax returns for the Legacy Funds, the Company reversed approximately $0.4 million of accrued liabilities assumed related to expected tax expense of the Legacy Funds.

40

Additionally, as part of the Formation Transactions, the Company also used a portion of the proceeds of the Private Offerings to acquire 100% of the equity interests of Trinity Capital Holdings, the sole member of Trinity Management IV, LLC, the investment manager to Fund IV and the sub-adviser to Fund II and Fund III, the Company issued 533,332 shares of common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash. In connection with the acquisition of Trinity Capital Holdings, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. Prior to the completion of the Formation Transactions, Trinity Capital Holdings acquired approximately $0.2 million of certain net assets from Trinity SBIC Management, LLC, the investment manager to Fund II and Fund III.

In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. Under ASC 805, such amount represents the settlement price, based on the estimated fair value of the future profits and cash flows that would otherwise have been contractually due to Trinity Capital Holdings, had the underlying management agreements with each of the Legacy Funds not been canceled in order to enter into the Formation Transactions and operate the Company as an internally managed BDC.

Principles of Consolidation

Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 3 - Investments,” with any

46

adjustments to fair value recognized as "Net unrealized ~~appreciation~~ appreciation/(depreciation) from investments" on the Consolidated Statements of Operations.

The Company’s consolidated operations include the activities of its wholly owned ~~subsidiary,~~subsidiaries, Trinity Funding 1, LLC (“TF1”)~~. On January 16, 2020, in connection with the Formation Transactions, the Company acquired TF1 through Fund II~~, and ~~became a party to, and assumed, a $300 million credit agreement (as amended, the “Credit Facility”~~TrinCap Funding, LLC (“TCF”) ~~with Credit Suisse AG (“Credit Suisse”) through TF1.~~. TF1 was formed on August 14, 2019, as a Delaware limited liability company with Fund II as its sole equity member. On January 16, 2020, in connection with the Formation Transactions, Trinity Capital acquired TF1 isthrough Fund II and became a party to, and assumed, a $300 million credit agreement with Credit Suisse AG (the “Credit Suisse Credit Facility”) through TF1 which matured on January 8, 2022 in accordance with its terms. TCF was formed on August 5, 2021, as a Delaware limited liability company with Trinity Capital as its sole equity member for purposes of securing lending in conjunction with a $300 million credit agreement, as amended, with KeyBank National Association (“KeyBank”) (such credit facility, the “KeyBank Credit Facility”). TF1 and TCF are special purpose bankruptcy-remote ~~entity~~entities and ~~is a~~are separate legal ~~entity~~entities from ~~the Company.~~Trinity Capital. Any assets conveyed to TF1 or TCF are not available to creditors of the Company or any other entity other than ~~TF1’s~~TF1 or TCF’s respective lenders. TF1 isand TCF are consolidated for financial reporting purposes and in accordance with GAAP, and the portfolio investments held by ~~this subsidiary~~these subsidiaries, if any, are included in the Company’s consolidated financial statements and recorded at fair value. All intercompany balances and transactions have been eliminated. As part of the Formation Transactions, Trinity Capital acquired 100% of the equity interests of Trinity Capital Holdings. There has been no activity in Trinity Capital Holdings since acquisition.

In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, ~~Trinity Capital~~the Company must determine which of its unconsolidated controlled portfolio companies, if any, are considered “significant subsidiaries.” In evaluating these unconsolidated controlled portfolio companies, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of ~~Trinity Capital’s~~the Company’s Control Investments (as defined in “Note 2 - Summary of Significant Accounting Policies”) are considered significant subsidiaries: the investment test, and the income test. As of June 30, ~~2021~~2022 and December 31, ~~2020, Trinity Capital~~2021, the Company had no single investment that met either of these two tests.

41

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from those estimates.

Investment Transactions

Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.

The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs

47

used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in ~~valuing.~~valuing such investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on the Company’s Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

42

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth stage companies, ~~substantially all~~99.7%, based on fair value, of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or ~~exchanges.~~exchanged. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Debt Securities

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

48

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method analysis also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

~~Equity-Related~~Equity Securities and Warrants

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company ~~usually~~generally utilizes a combination of one or several forms of the market approach as well as contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement ~~date.~~date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio ~~company, and, if~~company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

43

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the ~~Net Asset Value~~net asset value (“NAV”) per share of the money market fund. As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, cash, cash equivalents and restricted cash consisted of ~~$34.5~~$13.2 million and ~~$61.1~~$46.7 million, respectively, of which ~~$34.1~~$12.5 million and ~~$60.3~~$43.4 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, ~~2021 and~~2022, we did not have any restricted cash. As of December 31, ~~2020,~~2021, restricted cash consisted of approximately ~~$15.3~~$15.1 million ~~and $15.7 million, respectively,~~ related to the Credit Suisse Credit Facility covenants (See “Note 5 – Borrowings”),. In conjunction with the maturity of the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

49

Table of ~~fixed assets net~~Contents

Escrow Receivables

Escrow receivables are collected in accordance with the terms and ~~an additional~~conditions of the escrow agreement. Escrow balances are typically distributed over a period of one year and may accrue interest during the escrow period. Escrow balances are measured for collectability on at least a quarterly basis and fair value is determined based on the amount of ~~approximately $0.7 million~~the estimated recoverable balances and the contractual maturity date. As of June 30, 2022 and December 31, 2021, there were no material past due escrow receivables. The escrow receivable balance as of June 30, 2022 and December 31, ~~2020~~2021 was measured at fair value and held in ~~escrow related to the payout of a severance related liability assumed as part of the Formation Transactions~~accordance with ~~respect to a former member of certain general partners of certain Legacy Funds.~~ASC 820.

~~Other Assets~~Debt Securities

~~Other assets~~The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally ~~consist~~estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

48

In its application of ~~accumulated depreciation, right~~the income approach to determine the fair value of ~~use asset,~~debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security ~~deposits~~will likely generate, including analyzing the discounted cash flows of interest and ~~other assets.~~

~~Equity Offering Costs~~

~~Equity offering costs consist~~principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of ~~fees and expenses incurred in connection with~~ the ~~sale~~portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s ~~common stock,~~investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method analysis also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Deferred costs are periodically reviewed and expensed if the related registration is no longer active.

~~Debt Financing Costs~~

~~The Company records costs related~~but not limited to, the ~~issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using~~value attributable to the ~~straight-line method over~~security from the ~~stated maturity life~~enterprise value of the ~~obligations.~~portfolio company or the proceeds that would most likely be received in a liquidation analysis.

~~Security Deposits~~Equity Securities and Warrants

~~Security deposits~~Often the Company is issued warrants by issuers as yield enhancements. These warrants are ~~collected upon funding equipment financings and are applied in lieu of regular payments~~recorded as assets at ~~the end of the term.~~

~~Income Recognition~~

~~Interest Income~~

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value ~~of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based~~ on the ~~effective yield method. In addition, the~~grant date. The Company ~~may also be entitled to an end-of-term (“EOT”) fee. EOT fees to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt~~

44

~~based on the effective yield method. As of June 30, 2021 and December 31, 2020, the EOT payment receivable of approximately $37.0 million and $37.9 million, respectively, is~~ ~~included as a component of~~determines the cost basis of the ~~Company’s current debt securities. When a portfolio company pre-pays~~warrants or other equity securities received based upon their ~~indebtedness prior~~respective fair values on the date of receipt in proportion to ~~the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.~~

The Company had a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. No PIK interest income was recorded during the three and six months ended June 30, 2021. The Company recorded approximately $0.4 million and $0.5 million in PIK interest income during the three and six months ended June 30, 2020, respectively.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

~~Fee Income~~

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

~~Non-Accrual Policy~~

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $1.2 million, and a total fair market value of approximately $0.9 million, or 0.2%, of the fair value of the Company’s investment portfolio. As of December 31, 2020, loans to three portfolio companies were on non-accrual status with a total cost of approximately $3.4 million, and a total fair value of approximately $2.2 million, or 0.5%, of the total fair value of the ~~Company’s investment portfolio.~~

~~Net Realized Gains / (Losses)~~

~~Realized gains / (losses) are measured by~~debt and warrants or other equity securities received. Depending on the ~~difference between~~facts and circumstances, the ~~net proceeds from the sale~~Company generally utilizes a combination of one or ~~redemption of an investment or a financial instrument and the cost basis~~several forms of the ~~investment or financial instrument, without regard~~market approach as well as contingent claim analyses (a form of option analysis) to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds excludes any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statement of Operations.

45

~~Net Unrealized Appreciation / (Depreciation)~~

~~Net change in unrealized appreciation / (depreciation) reflects the net change in~~estimate the fair value of the ~~investment~~securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value (“NAV”) per share of the money market fund. As of June 30, 2022 and December 31, 2021, cash, cash equivalents and restricted cash consisted of $13.2 million and $46.7 million, respectively, of which $12.5 million and $43.4 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, 2022, we did not have any restricted cash. As of December 31, 2021, restricted cash consisted of approximately $15.1 million related to the Credit Suisse Credit Facility covenants (See “Note 5 – Borrowings”). In conjunction with the maturity of the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

49

Escrow Receivables

Escrow receivables are collected in accordance with the terms and conditions of the escrow agreement. Escrow balances are typically distributed over a period of one year and may accrue interest during the escrow period. Escrow balances are measured for collectability on at least a quarterly basis and fair value is determined based on the amount of the estimated recoverable balances and the ~~reclassification~~contractual maturity date. As of ~~any prior period unrealized appreciation or depreciation on exited investments~~June 30, 2022 and ~~financial instruments to realized gains or losses.~~

~~Earnings Per Share~~

~~Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number~~December 31, 2021, there were no material past due escrow receivables. The escrow receivable balance as of ~~common shares outstanding for the period. Other potentially dilutive common shares,~~June 30, 2022 and the related impact to earnings are considered when calculating earnings per share on a diluted basis. Potential common shares associated with the conversion option embedded in the Convertible Notes are anti-dilutive when the Company’s average NAV is below the conversion price.

~~Income Taxes~~

~~The Company intends to elect to be treated for U.S. federal tax purposes as a RIC under Subchapter M of the Code~~December 31, 2021 was measured at fair value and operate in a manner so as to qualify annually thereafter for the tax treatment applicable to RICs. As a RIC, the Company generally will not pay corporate-level income tax on the portion of its taxable income distributed to stockholders, generally required to be at least 90% of its investment company taxable income (which is generally its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its tax-exempt income to maintain its RIC status (pass-through tax treatment for amounts distributed).

The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authorityheld in accordance with ASC ~~Topic 740,~~ ~~Income Taxes~~ ~~(“ASC 740”)~~, as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of June 30, 2021 and December 31, 2020. All the Company’s tax returns remain subject to examination by U.S. federal and state tax authorities.820.

In order for the Company not to be subject to federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its ordinary income (taking into account certain deferrals and elections), (ii) 98.2% of its net capital gains from the current year and (iii) any undistributed ordinary income and net capital gains from preceding year on which it paid corporate-level U.S. federal income tax. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income as required on an annual basis.

~~Distributions~~

Distributions to common stockholders are recorded on the record date. The amount to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Net realized capital gains, if any, are distributed at least annually, although the Company may decide to retain such capital gains for investment.

46

~~Reclassification~~

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. Included in interest income for the three and six months ended June 30, 2020 is the acceleration of OID and EOT of approximately $1.0 million and $1.4 million, respectively, which was reclassified from net realized gain/(loss) on investments. Included in fee income for the three and six months ended June 30, 2020 is non-recurring fees of approximately $0.4 million and $1.8 million, respectively, of which $0.1 million and $1.0 million, respectively, were reclassified from net realized gain/(loss) on investment and $0.3 million and $0.8 million, respectively, were reclassified from interest income. These reclassifications had no effect on the previously reported net increase (decrease) in net assets.

~~Note 3. Investments~~

The Company provides debt, including loans and equipment financings, to growth stage companies, including venture capital-backed companies and companies with institutional equity investors, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of the portfolio companies.

Debt Securities

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

48

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method analysis also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

Equity Securities and Warrants

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company generally utilizes a combination of one or several forms of the market approach as well as contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value (“NAV”) per share of the money market fund. As of June 30, 2022 and December 31, 2021, cash, cash equivalents and restricted cash consisted of $13.2 million and $46.7 million, respectively, of which $12.5 million and $43.4 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, 2022, we did not have any restricted cash. As of December 31, 2021, restricted cash consisted of approximately $15.1 million related to the Credit Suisse Credit Facility covenants (See “Note 5 – Borrowings”). In conjunction with the maturity of the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

49

Escrow Receivables

Escrow receivables are collected in accordance with the terms and conditions of the escrow agreement. Escrow balances are typically distributed over a period of one year and may accrue interest during the escrow period. Escrow balances are measured for collectability on at least a quarterly basis and fair value is determined based on the amount of the estimated recoverable balances and the contractual maturity date. As of June 30, 2022 and December 31, 2021, there were no material past due escrow receivables. The escrow receivable balance as of June 30, 2022 and December 31, 2021 was measured at fair value and held in accordance with ASC 820.

Other Assets

Other assets generally consist of fixed assets net of accumulated depreciation, right of use assets, prepaid expenses, escrow receivables, security deposits and other assets.

Equity Offering Costs

Equity offering costs consist of fees and costs incurred in connection with the sale of the Company’s common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Equity offering costs are periodically reviewed and expensed if the related registration is no longer active.

Security Deposits

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

Debt Financing Costs

The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations. Debt financing costs related to secured or unsecured notes are netted with the outstanding principal balance on the Company’s Consolidated Statements of Assets and Liabilities. Debt financing costs related to the KeyBank Credit Facility are recorded as a separate asset on the Company’s Consolidated Statements of Assets and Liabilities.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. EOT fees to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. As of June 30, 2022 and December 31, 2021, the EOT payments receivable of approximately $53.2 million and $46.7 million, respectively, is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT is recognized as interest income.

The Company has a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support

50

the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. No PIK interest income was recorded during the three and six months ended June 30, 2022 and 2021.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Non-Accrual Policy

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2022, loans to three portfolio companies and an equipment financing to one portfolio company were on non-accrual status with a total cost of approximately $20.5 million, and a total fair value of approximately $5.9 million, or 0.6% of the fair value of the Company’s debt investment portfolio. As of December 31, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $12.9 million, and a total fair value of approximately $5.1 million, or 0.7%, of the fair value of the Company’s debt investment portfolio.

Net Realized Gains / (Losses)

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statement of Operations.

Net Unrealized Appreciation / (Depreciation)

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Stock Based Compensation

The Company has issued and may, from time to time, issue restricted stock to its officers and employees under the 2019 Trinity Capital Inc. Long Term Incentive Plan and to its non-employee directors under the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan. The Company accounts for its share-based compensation plans using the fair value method, as prescribed by ASC 718, Compensation – Stock Compensation. Accordingly, for restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the

51

date of the grant and amortizes the fair value of the awards as share-based compensation expense over the requisite service period, which is generally the vesting term.

The Company has also adopted Accounting Standards Update (“ASU”) 2016-09, Compensation—Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which requires that all excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) be recognized as income tax expense or benefit in the income statement and not delay recognition of a tax benefit until the tax benefit is realized through a reduction to taxes payable. Accordingly, the tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. Additionally, the Company has elected to account for forfeitures as they occur.

Earnings Per Share

The Company's earnings per share ("EPS") amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of common shares outstanding for the period. In accordance with ASC 260, Earnings Per Share, the unvested shares of restricted stock awarded pursuant to Trinity Capital’s equity compensation plans are participating securities and, therefore, are included in the basic earnings per share calculation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued and the additional shares of common stock were dilutive. Diluted EPS, if any, reflects the potential dilution from the assumed conversion of the Company’s 6.00% Convertible Notes due 2025 (the “Convertible Notes”).

Income Taxes

The Company has elected to be treated, and to intends to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least 90% of the sum of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and its net tax-exempt income (if any). The Company generally will not pay corporate-level income tax on these distributed amounts but will pay corporate-level income tax on any retained amounts.

The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC 740, Income Taxes (“ASC 740”), as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of June 30, 2022 and December 31, 2021. All the Company’s tax returns remain subject to examination by U.S. federal and state tax authorities.

Based on federal excise distribution requirements applicable to RICs, the Company will be subject to a 4% nondeductible federal excise tax on undistributed taxable income and gains unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income or gain realized, but not distributed, in the preceding years. For this purpose, however, any ordinary income or capital gain net income retained by the Company and on which the Company paid corporate income tax is considered to have been distributed. The Company, at its discretion, may determine to carry forward taxable income or gain and pay a 4% excise tax on the amount by which it falls short of this calendar-year distribution requirement. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income and gain as required on an annual basis.

52

Distributions

Distributions to common stockholders are recorded on the record date. The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay corporate-level income taxes on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders.

Note 3. Investments
The Company provides debt, including loans and equipment financings, to growth stage companies, including venture capital-backed companies and companies with institutional equity investors, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of its portfolio companies.
Debt Securities
The Company’s debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between three and five years from the original investment date. Certain of the debt securities are “covenant-lite” loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower’s financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The loans in the investment portfolio generally have fixed interest rates or floating interest rates subject to interest rate floors. Both equipment financings and loans generally include an EOT payment.
The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company’s second lien positions.
Warrant Investments
In connection with the Company’s debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.

47

Equity Investments

In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in the portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

53

Portfolio ~~Industry Classification~~Composition

The Company’s portfolio investments are in companies conducting business in a variety of industries. The following table summarizes the composition of the Company’s portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 (dollars in thousands):


	June 30, 2021						December 31, 2020						June 30, 2022						December 31, 2021
	Cost			Fair Value			Cost			Fair Value			Cost			Fair Value			Cost			Fair Value
Industry	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%
Manufacturing	$	136,246	23.7%		167,170	28.0%	$	103,471	20.8%	$	99,709	20.2%	$	268,030	25.1%	$	268,338	25.4%	$	169,381	21.1%	$	222,011	25.4%
Professional, Scientific, and Technical Services		83,523	14.5%		89,394	15.0%		77,831	15.6%		78,893	16.0%		244,771	22.9%		255,633	24.3%		140,847	17.6%		161,217	18.5%
Information														81,235	7.6%		83,737	8.0%		101,031	12.7%		107,696	12.3%
Finance and Insurance														68,184	6.4%		70,121	6.7%		62,000	7.8%		65,109	7.5%
Management of Companies and Enterprises														69,723	6.5%		69,033	6.6%		22,333	2.8%		22,332	2.6%
Rental and Leasing Services														49,135	4.6%		50,559	4.8%		32,749	4.1%		33,513	3.8%
Real Estate														45,977	4.3%		39,597	3.8%		40,776	5.1%		41,351	4.7%
Health Care and Social Assistance														50,688	4.8%		36,097	3.4%		50,458	6.3%		44,518	5.1%
Administrative and Support and Waste Management and Remediation Services														34,818	3.3%		34,812	3.3%		29,353	3.7%		29,337	3.4%
Retail Trade		90,430	15.7%		78,374	13.1%		78,534	15.7%		75,664	15.4%		34,905	3.3%		33,695	3.2%		39,542	5.0%		39,162	4.5%
Finance and Insurance		41,007	7.1%		42,316	7.1%		35,320	7.0%		35,699	7.2%
Information		34,102	5.9%		34,208	5.7%		31,843	6.4%		30,709	6.2%
Rental and Leasing Services		30,936	5.4%		31,578	5.3%		29,055	5.8%		29,138	5.9%
Space Research and Technology		29,830	5.2%		29,811	5.0%		—	0.0%		—	0.0%		30,635	2.9%		31,327	3.0%		30,479	3.8%		30,698	3.5%
Educational Services														18,429	1.7%		17,070	1.6%		18,246	2.3%		18,813	2.2%
Utilities		24,128	4.2%		24,378	4.1%		26,800	5.4%		27,083	5.5%		15,795	1.5%		15,725	1.5%		20,445	2.6%		20,436	2.3%
Agriculture, Forestry, Fishing and Hunting		18,032	3.1%		20,855	3.5%		20,981	4.2%		20,837	4.2%		12,000	1.1%		13,061	1.2%		12,025	1.5%		13,396	1.5%
Real Estate		20,249	3.5%		20,152	3.4%		17,267	3.5%		17,316	3.5%
Health Care and Social Assistance		20,427	3.6%		16,606	2.8%		14,348	2.9%		11,422	2.3%
Educational Services		13,614	2.4%		14,147	2.4%		9,359	1.9%		9,816	2.0%
Construction														13,538	1.3%		9,198	0.9%		13,445	1.7%		8,903	1.0%
Wholesale Trade		11,763	2.0%		11,482	1.9%		23,850	4.8%		23,903	4.8%		6,887	0.6%		7,180	0.7%		9,417	1.2%		9,848	1.1%
Construction		10,711	1.9%		8,000	1.3%		9,804	2.0%		6,894	1.4%
Other Services (except Public Administration)														5,013	0.5%		5,015	0.5%		—	—		—	—
Accommodation and Food Services														3,915	0.4%		3,915	0.4%		—	—		—	—
Transportation and Warehousing														9,765	0.9%		3,838	0.4%		—	—		—	—
Arts, Entertainment, and Recreation														3,086	0.3%		3,123	0.3%		—	—		—	—
Pharmaceutical		7,606	1.3%		7,278	1.2%		17,503	3.5%		24,240	4.9%		69	0.0%		—	0.0%		5,329	0.7%		5,130	0.6%
Administrative and Support and Waste Management and Remediation Services		1,951	0.5%		1,947	0.2%		2,370	0.5%		2,328	0.5%
Total	$	574,555	100.0%	$	597,696	100.0%	$	498,336	100.0%	$	493,651	100.0%	$	1,066,598	100.0%	$	1,051,074	100.0%	$	797,856	100.0%	$	873,470	100.0%

4854

The geographic composition is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Company’s portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 (dollars in thousands):


	June 30, 2021						December 31, 2020						June 30, 2022						December 31, 2021
	Cost			Fair Value			Cost			Fair Value			Cost			Fair Value			Cost			Fair Value
Geographic Region	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%	Amount		%
United States:
West	$	279,721	48.7%	$	315,133	52.7%	$	247,204	49.6%	$	241,096	48.8%	$	470,496	44.1%	$	474,055	45.1%	$	370,791	46.5%	$	442,659	50.7%
Northeast		153,156	26.7%		143,474	24.0%		131,692	26.4%		127,801	25.9%		233,518	21.9%		232,688	22.1%		210,302	26.4%		213,823	24.5%
South														103,050	9.7%		103,885	9.9%		60,455	7.6%		61,166	7.0%
Mountain														105,724	9.9%		102,428	9.7%		65,223	8.2%		70,886	8.1%
Midwest		47,815	8.3%		43,561	7.3%		47,324	9.5%		44,092	8.9%		62,784	5.9%		52,854	5.0%		29,825	3.7%		23,958	2.7%
Mountain		38,401	6.7%		39,555	6.6%		33,842	6.8%		33,969	6.9%
Southeast		1,041	0.2%		606	0.1%		11,011	2.2%		17,834	3.6%		6,262	0.6%		6,066	0.6%		1,125	0.1%		768	0.1%
South		30,293	5.2%		30,989	5.2%		463	0.1%		1,777	0.4%
International:
Canada		24,128	4.2%		24,378	4.1%		26,800	5.4%		27,082	5.5%		66,600	6.2%		60,637	5.8%		60,135	7.5%		60,210	6.9%
Western Europe														18,164	1.7%		18,461	1.8%		—	—		—	—
Total	$	574,555	100.0%	$	597,696	100.0%	$	498,336	100.0%	$	493,651	100.0%	$	1,066,598	100.0%	$	1,051,074	100.0%	$	797,856	100.0%	$	873,470	100.0%

The following table summarizes the composition of the Company’s portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 (dollars in thousands):

June 30, 2022

December 31, 2021

Cost

Fair Value

Cost

Fair Value

Investment

Amount

%

Amount

%

Amount

%

Amount

%

Secured Loan

$
776,524

72.9%

$
769,659

73.2%

$
557,627

69.8%

$
551,894

63.2%

Equipment Financing

231,475

21.7%

224,934

21.4%

183,298

23.0%

184,074

21.1%

Warrants

20,741

1.9%

33,192

3.2%

14,885

1.9%

36,770

4.2%

Equity

37,858

3.5%

23,289

2.2%

42,046

5.3%

100,732

11.5%

Total

$
1,066,598

100.0%

$
1,051,074

100.0%

$
797,856

100.0%

$
873,470

100.0%

June 30, 2021

December 31, 2020

Cost

Fair Value

Cost

Fair Value

Investment

Amount

%

Amount

%

Amount

%

Amount

%

Secured Loan

$
400,944

69.8%

$
397,530

66.4%

$
324,544

65.1%

$
320,718

65.0%

Equipment Financing

120,078

20.9%

120,903

20.2%

122,966

24.7%

122,501

24.8%

Equity

39,715

6.9%

52,515

8.8%

32,961

6.6%

32,654

6.6%

Warrants

13,818

2.4%

26,748

4.6%

17,865

3.6%

17,778

3.6%

Total

$
574,555

100.0%

$
597,696

100.0%

$
498,336

100.0%

$
493,651

100.0%

55

Certain Risk Factors

In the ordinary course of business, the Company manages a variety of risks including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including trading limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

The Company’s investments may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Company’s investments consist of growth stage companies, many of which have relatively limited operating histories and also may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by ~~the~~ changes in government regulations. Most of the Company’s borrowers will need

49

additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.

56

Note 4. Fair Value of Financial Instruments
ASC 820 defines fair value, establishes a framework for measuring fair value, and establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. The Company accounts for its investments at fair ~~value.~~value in accordance with ASC 820. As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company’s portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts ~~reported~~reported.
In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See “Note 2 - Summary of Significant Accounting Policies.”
As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
The fair value determination of each portfolio investment categorized as Level 3 required one or more of the following unobservable inputs:
● Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;
● Current and projected financial condition of the portfolio company;
● Current and projected ability of the portfolio company to service its debt obligations;
● Type and amount of collateral, if any, underlying the investment;
● Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;
● Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);
● Pending debt or capital restructuring of the portfolio company;
● Projected operating results of the portfolio company;
● Current information regarding any offers to purchase the investment;
● Current ability of the portfolio company to raise any additional financing as needed;
● Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;
● Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;
● Qualitative assessment of key management;

5057

●

~~Qualitative assessment of key management;~~

●

Contractual rights, obligations or restrictions associated with the investment; and

●

Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company’s investments, are (i) earnings before interest, tax, depreciation, and amortization (“EBITDA”) and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. ~~On the contrary,~~Conversely, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

The Company’s assets measured at fair value by investment type on a recurring basis as of June 30, ~~2021~~2022 were as follows:

Fair Value Measurements at Reporting Date Using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Assets

(Level 1)

(Level 2)

(Level 3)

Total
Secured Loans

$
—

$
—

$
769,659

$
769,659
Equipment Financings

—

—

224,934

224,934
Warrants

—

—

33,192

33,192
Equity

184

2,670

20,435

23,289
Total Investments at fair value

184

2,670

1,048,220

1,051,074
Escrow Receivable ⁽¹⁾

—

—

2,441

2,441
Cash, cash equivalents and restricted cash

13,226

—

—

13,226
Total

$
13,410

$
2,670

$
1,050,661

$
1,066,741

Fair Value Measurements at Reporting Date Using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Assets

(Level 1)

(Level 2)

(Level 3)

Total
Secured Loans

$
—

$
—

$
397,530

$
397,530
Equipment Financings

—

—

120,903

120,903
Equity

—

1,534

50,981

52,515
Warrants

—

36

26,712

26,748
Total Investments at fair value

—

1,570

596,126

597,696
Cash, cash equivalents and restricted cash

34,465

—

—

34,465

$
34,465

$
1,570

$
596,126

$
632,161
(1) Escrow receivable is included in other assets on the Consolidated Statement of Assets and Liabilities.

The Company’s assets measured at fair value by investment type on a recurring basis as of December 31, ~~2020~~2021 were as follows:

Fair Value Measurements at Reporting Date Using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Assets

(Level 1)

(Level 2)

(Level 3)

Total
Secured Loans

$
—

$
—

$
551,894

$
551,894
Equipment Financings

—

—

184,074

184,074
Equity

—

78,944

21,788

100,732
Warrants

—

17

36,753

36,770
Total Investments at fair value

—

78,961

794,509

873,470
Escrow Receivable ⁽¹⁾

—

—

4,152

4,152
Cash, cash equivalents and restricted cash

46,742

—

—

46,742
Total

$
46,742

$
78,961

$
798,661

$
924,364

Fair Value Measurements at Reporting Date Using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Assets

(Level 1)

(Level 2)

(Level 3)

Total
Secured Loans

$
—

$
—

$
320,718

$
320,718
Equipment Financings

—

—

122,501

122,501
Equity

—

—

32,654

32,654
Warrants

—

—

17,778

17,778
Total Investments at fair value

—

—

493,651

493,651
Cash, cash equivalents and restricted cash

61,101

—

—

61,101

$
61,101

$
—

$
493,651

$
554,752

(1) Escrow receivable is included in other assets on the Consolidated Statement of Assets and Liabilities.

5158

~~Debt~~

The methodology for determining the fair value of the Company’s investments ~~include both secured loans and equipment financing securities.~~is discussed in “Note 2 – Summary of Significant Accounting Policies”. The significant unobservable input used in the fair value measurement of the Company’s escrow receivables is the amount recoverable at the contractual maturity date of the escrow receivable. The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of June 30, ~~2021 (dollars in thousands):~~2022.

Fair Value as of








June 30, 2022

Valuation Techniques/

Unobservable

Weighted

Investment Type

(in thousands)

Methodologies

Inputs ⁽¹⁾

Range

Average ⁽²⁾

Debt investments

$
814,887

Discounted Cash Flows

Hypothetical Market Yield

11.4% - 32.3%

15.0
%









154,689

Originated within the past three months

Origination Market Yield

11.0% - 21.3%

13.5
%

19,890

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

5,127

Liquidation Scenario

Probability Weighting of Alternative Outcomes

10.0% - 80.0%

n/a







Equity investments

17,435

Market Approach

Revenue Multiple Only ⁽³⁾

n/a

0.8
x

Revenue Multiple ⁽³⁾

0.9x - 2.3x

1.8
x

Volatility ⁽⁵⁾

45.1% - 76.7%

61.3
%

Risk-Free Interest Rate

2.9% - 3.0%

3.0
%





Estimated Time to Exit (in years)

2.3 - 4.5

3.0



Discount for Lack of Marketability ⁽⁸⁾

26.1% - 27.6%

4.6
%

3,000

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

Warrants

26,786

Market Approach

Revenue Multiple ⁽³⁾

0.2x - 11.9x

1.2
x

Company Specific Adjustment ⁽⁴⁾

6.1% - 34.4%

15.1
%

Volatility ⁽⁵⁾

23.7% - 107.6%

51.7
%



Risk-Free Interest Rate

1.2% - 3.2%

2.8
%



Estimated Time to Exit (in years)

0.1 - 4.5

2.0

679

Black Scholes Option Pricing Model

Volatility ⁽⁵⁾

42.6% - 65.4%

62.4
%

Discount for Lack of Marketability

19.6% - 27.2%

26.2
%

Risk-Free Interest Rate

1.8% - 3.4%

3.1
%

Estimated Time to Exit (in years)

4.2 - 9.8

4.9

5,727

Other⁽⁷⁾

Probability Weighting of Alternative Outcomes

10.0% - 90.0%

n/a

Total Level 3 Investments

$
1,048,220










Fair Value as of








June 30,

Valuation Techniques/

Unobservable

Weighted

Investment Type

2021

Methodologies

Inputs ⁽¹⁾

Range

Average ⁽²⁾

Debt investments

$
382,482

Discounted Cash Flows

Hypothetical Market Yield

9.2% - 31.1%

15.1
%











114,368

Originated within the past three months

Origination Market Yield

10.2% - 16.0%

12.9
%

20,637

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

��

946

Liquidation Scenario

Probability Weighting of Alternative Outcomes

60.0% - 90.0%

n/a









Equity investments

4,542

Market Approach

Revenue Multiple Only ⁽³⁾

0.7x - 1.1x

0.8
x

6,789

Market Approach

Revenue Multiple ⁽³⁾

0.4x - 0.7x

0.4
x

Volatility ⁽⁵⁾

37.6% - 82.1%

43.7
%





Risk-Free Interest Rate

0.1% - 0.5%

0.1
%



Estimated Time to Exit (in years)

0.7 - 3.3

2.7

Discount for Lack of Marketability ⁽⁸⁾

16.5% - 26.7%

23.3
%

500

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

39,150

Other⁽⁷⁾

Discount for Lack of Marketability ⁽⁸⁾

20.6%

n/a









Warrants

18,764

Market Approach

Revenue Multiple ⁽³⁾

0.3x - 30.0x

2.7
x

Company Specific Adjustment ⁽⁴⁾

8.6% - 32.2%

12.8
%

Volatility ⁽⁵⁾

38.4% - 103.7%

66.2
%





Risk-Free Interest Rate

0.1% - 0.8%

0.3
%





Estimated Time to Exit (in years)

0.1 - 4.5

2.4

7,948

Other⁽⁷⁾

Discount for Lack of Marketability ⁽⁸⁾

18.2% - 32.3%

20.5
%

Total Level 3 Investments

$
596,126









(1) The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.
(2) Weighted averages are calculated based on the fair ~~market~~ value of each investment.
(3) Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.
(4) Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.
(5) Represents the range of industry volatility used by market participants when pricing the investment.
59

(6)

Represents investments where there is an observable transaction or pending event for the investment.

52

(7)

The fair ~~market~~ value of these investments is derived based on recent private market and merger and acquisition transaction prices.

(8)

Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, ~~2020 (dollars in thousands):~~2021.

Fair Value as of








December 31, 2021

Valuation Techniques/

Unobservable

Weighted

Investment Type

(in thousands)

Methodologies

Inputs ⁽¹⁾

Range

Average ⁽²⁾

Debt investments

$
508,756

Discounted Cash Flows

Hypothetical Market Yield

10.8% - 33.2%

14.6
%











188,226

Originated within the past three months

Origination Market Yield

11.3% - 16.2%

13.0
%

34,542

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

4,444

Liquidation Scenario

Probability Weighting of Alternative Outcomes

20.0% - 80.0%

n/a









Equity investments

20,788

Market Approach

Revenue Multiple Only⁽³⁾

0.8x - 2.3x

1.9
x

Revenue Multiple ⁽³⁾

0.2x - 6.8x

3.5
x

Volatility ⁽⁵⁾

47.0% - 85.0%

65.1
%

Risk-Free Interest Rate

0.1% - 1.1%

0.9
%





Estimated Time to Exit (in years)

0.2 - 3.8

2.9



Discount for Lack of Marketability⁽⁸⁾

9.0% - 32.3%

24.5
%

1,000

Transactions Precedent(6)

Transaction Price

n/a

n/a

Warrants

23,573

Market Approach

Revenue Multiple⁽³⁾

0.2x - 30.0x

1.5
x

Company Specific Adjustment ⁽⁴⁾

7.9% - 34.5%

9.9
%

Volatility ⁽⁵⁾

35.1% - 111.3%

63.7
%





Risk-Free Interest Rate

0.1% - 1.3%

0.8
%





Estimated Time to Exit (in years)

0.2 - 5.0

2.3

2,312

Black Scholes Option Pricing Model

Volatility ⁽⁵⁾

42.1% - 83.5%

56.8
%

Discount for Lack of Marketability

27.2% - 30.3%

27.7
%

Risk-Free Interest Rate

0.4% - 1.3%

0.7
%

Estimated Time to Exit (in years)

1.0 - 5.0

2.3

984

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

9,884

Other⁽⁷⁾

Probability Weighting of Alternative Outcomes

10.0% - 90.0%

n/a

Total Level 3 Investments

$
794,509










Fair Value as of








December 31,

Valuation Techniques/

Unobservable

Weighted

Investment Type

2020

Methodologies

Inputs ⁽¹⁾

Range

Average ⁽²⁾

Debt investments

$
330,184

Discounted Cash Flows

Hypothetical Market Yield

9.5% - 31.2%

15.1
%











99,053

Originated within the past three months

Origination Market Yield

12.9% - 15.2%

14.2
%

11,771

Transactions Precedent⁽⁶⁾

Transaction Price

n/a

n/a

2,211

Liquidation Scenario

Probability Weighting of Alternative Outcomes

60.0% - 90.0%

n/a









Equity investments

3,623

Liquidation Scenario

Probability Weighting of Alternative Outcomes

30.0% - 70.0%

n/a

5,550

Market Approach

Revenue Multiple Only ⁽³⁾

0.5x - 0.9x

0.7
x

23,481

Market Approach

Revenue Multiple ⁽³⁾

0.36x - 3.0x

1.8
x





Company Specific Adjustment ⁽⁴⁾

(17.5)% - 150.0%

74.9
%

Volatility ⁽⁵⁾

45.0% - 80.0%

59.8
%





Risk-Free Interest Rate

0.1% - 0.2%

0.1
%





Estimated Time to Exit (in years)

0.5 - 2.0

1.1

Warrants

15,133

Market Approach

Revenue Multiple ⁽³⁾

0.3x - 20.75x

3.2
x

EBITDA Multiple

n/a

10.9
x





Company Specific Adjustment ⁽⁴⁾

(50.0)% - 10.0%

(13.1)
%



Volatility ⁽⁵⁾

20.0% - 104.7%

53.4
%

Risk-Free Interest Rate

0.1% - 3.0%

0.9
%

Estimated Time to Exit (in years)

0.2 - 10.0

3.3

2,645

Black Scholes Option Pricing Model

Volatility ⁽⁵⁾

46.8% - 132.3%

52.0
%



Risk-Free Interest Rate

0.1% - 0.7%

0.1
%

Estimated Time to Exit (in years)

0.5 - 7.3

0.8

Total Level 3 Investments

$
493,651









(1) The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.
(2) Weighted averages are calculated based on the fair ~~market~~ value of each investment.
60

(3)

Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

53

(4)

Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5)

Represents the range of industry volatility used by market participants when pricing the investment.

(6)

Represents investments where there is an observable transaction or pending event for the investment.

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the six months ended June 30, ~~2021~~2022 (in thousands):

Debt

Equity

Warrants

Escrow Receivable

Total
Fair Value as of December 31, 2021

$
735,968

$
21,788

$
36,753

$
4,152

$
798,661
Purchases, net of deferred fees

401,886

3,800

6,929

—

412,615
Transfers out of Level 3 ⁽¹⁾

—

—

(6,687)

—

(6,687)
Proceeds from sales and paydowns

(140,898)

(664)

(731)

(1,711)

(144,004)
Accretion of OID and EOT payments

15,516

—

—

—

15,516
Net realized gain/(loss)

(9,429)

(68)

303

—

(9,194)
Change in unrealized appreciation/(depreciation)

(8,450)

(4,421)

(3,375)

—

(16,246)
Fair Value as of June 30, 2022

$
994,593

$
20,435

$
33,192

$
2,441

$
1,050,661

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of June 30, 2022

$
(16,005)

$
(5,152)

$
(3,380)

$
—

$
(24,537)

Type of Investment


Debt

Equity

Warrants

Total
Fair Value as of December 31, 2020

$
443,219

$
32,654

$
17,778

$
493,651
Purchases, net of deferred fees

193,696

11,460

3,076

208,232
Non-cash conversion ⁽¹⁾

—

1,579

(1,579)

—
Transfer out of Level 3 ⁽²⁾

—

—

(50)

(50)
Proceeds from sales and paydowns

(130,251)

(13,536)

(3,092)

(146,879)
Accretion of OID and EOT payments

10,279

—

—

10,279
Net realized gain/(loss)

(210)

4,200

600

4,590
Third party participation ⁽³⁾

—

(283)

—

(283)
Change in unrealized appreciation/(depreciation)

1,700

14,907

9,979

26,586
Fair Value as of June 30, 2021

$
518,433

$
50,981

$
26,712

$
596,126

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of June 30, 2021

$
1,363

$
23,270

$
10,509

$
35,142
(1) ~~The non-cash conversion includes the non-cash exercise of warrants held in one portfolio company to equity instruments during the period.~~
~~(2)~~ Transfers out of Level 3 during the six months ended June 30, ~~2021~~2022 primarily relates to the exercise of ~~the~~ warrants held in ~~one~~two portfolio ~~company to equity investments during the period~~companies and the corresponding ~~company’s~~companies’ public offering ~~transaction.~~transactions during the period. During the six months ended June 30, ~~2021,~~2022, there were no transfers into Level 3.
~~(3)~~ ~~Certain third parties had rights to 17,485 shares of Ology Bioservices common stock~~at a fair value of approximately $0.6 million as of December 31, 2020. In March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

5461

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the year ended December 31, ~~2020~~2021 (in thousands):

Type of Investment


Debt

Equity

Warrants

Escrow Receivable

Total
Fair Value as of December 31, 2020

$
443,219

$
32,654

$
17,778

$
—

$
493,651
Purchases, net of deferred fees ⁽¹⁾

533,146

12,153

5,573

4,152

555,024
Non-cash conversion ⁽²⁾

916

—

—

—

916
Transfers out of Level 3 ⁽³⁾

—

—

(2,611)

—

(2,611)
Proceeds from sales and paydowns

(264,386)

(14,098)

(9,100)

—

(287,584)
Accretion of OID and EOT payments

21,238

—

—

—

21,238
Net realized gain/(loss)

2,501

2,038

6,061

—

10,600
Third party participation ⁽⁴⁾

—

(283)

—

—

(283)
Change in unrealized appreciation/(depreciation)

(666)

(10,676)

19,052

—

7,710
Fair Value as of December 31, 2021

$
735,968

$
21,788

$
36,753

$
4,152

$
798,661

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of December 31, 2021

$
(1,473)

$
(4,641)

$
19,458

$
—

$
13,344

Type of Investment


Debt

Equity

Warrants

Total

Fair Value as of January 1, 2020

$
—

$
—

$
—

$
—

Formation Transactions acquisitions

375,858

24,066

17,099

417,023

Purchases, net of deferred fees

234,418

2,170

1,976

238,564

Non-cash conversion⁽¹⁾

(10,148)

10,879

532

1,263

Proceeds from sales and paydowns

(157,046)

(3,855)

—

(160,901)

Accretion of OID and EOT payments

11,788

—

—

11,788

Net realized gain/(loss)

(7,361)

(300)

(1,742)

(9,403)

Third party participation ⁽²⁾

—

283

—

283

Change in unrealized appreciation/(depreciation)

(4,290)

(589)

(87)

(4,966)

Fair Value as of December 31, 2020 ⁽³⁾

$
443,219

$
32,654

$
17,778

$
493,651

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of December 31, 2020

$
(4,290)

$
(589)

$
(87)

$
(4,966)

(1) Escrow receivable purchases may include additions due to proceeds held in escrow from the liquidation of level 3 investments.
(2) The non-cash conversion includes non-cash restructuring ~~transactions~~resulting in an increase in cost basis or the recognition of ~~two portfolio companies in which our outstanding loan investments were converted to equity instruments during the period.~~PIK interest income.
~~(2)~~ (3) Transfers out of Level 3 during the year ended December 31, 2021 primarily relates to the exercise of warrants held in four portfolio companies to equity investments during the period, and the corresponding company’s public offering transaction. During the year ended December 31, 2021, there were no transfers into Level 3.
(4) Certain third parties had rights to 17,485 shares of Ology Bioservices common stockat a fair value of approximately $0.6 million as of December 31, 2020. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).
~~(3)~~ ~~During the year ended December 31, 2020, there were no transfers into or out of Level 3.~~

Fair Value of Financial Instruments Carried at Cost
As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the carrying value of the KeyBank Credit Facility iswas approximately ~~$68.9~~$220.0 million and ~~$132.9 million, net of unamortized deferred financing costs of $1.1 million and $2.1 million, respectively.~~$81.0 million. The carrying value of the ~~Company’s~~KeyBank Credit Facility as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 approximates the fair value, which was estimated using a market yield approach with Level 3 inputs.
As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the carrying value of the 7.00% Notes due 2025 ~~Notes is~~(the “2025 Notes”) was approximately ~~$120.8~~$122.0 million and ~~$120.3~~$121.4 million, respectively, net of unamortized deferred financing costs of ~~$4.2~~$3.0 million and ~~$4.7~~$3.6 million, respectively. The 2025 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the 2025 Notes as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 was approximately ~~$130.0~~$130.6 million and ~~$131.4~~$139.0 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.
As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the carrying value of the Convertible Notes iswas approximately ~~$47.2~~$47.8 million and ~~$46.6~~$47.5 million, respectively, net of unamortized deferred financing costs and discount of ~~$2.8~~$2.2 million and ~~$3.4~~$2.5 million, respectively. The Convertible Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s Convertible Notes as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 was approximately ~~$48.1~~$49.2 million and ~~$46.6~~$55.8 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of June 30, 2022 and December 31, 2021, the carrying value of the Company’s 4.375% Notes due 2026 (the “August 2026 Notes”) was approximately $122.6 million and $122.3 million, respectively, net of unamortized deferred financing costs and discount of $2.4 million and $2.7 million, respectively. The August 2026 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s August 2026 Notes as of June 30, 2022 and
5562

December 31, 2021, was approximately $110.7 million and $138.4 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of June 30, 2022, and December 31, 2021, the carrying value of the Company’s 4.25% Notes due 2026 (the “December 2026 Notes”) was approximately $73.3 million, and $73.2 million, respectively, net of unamortized deferred financing fees of $1.7 million and $1.8 million, respectively. The fair value of the Company’s December 2026 Notes as of June 30, 2022 was approximately $65.8 million, which was estimated using a relative market yield approach with Level 3 inputs. The fair value of the Company’s December 2026 Notes as of December 31, 2021 was approximately $73.2 million, which was based on the recent funding.

Note 5. Borrowings
Credit Suisse Credit Facility
On January 9, 2020, TF1 and its affiliates borrowed $190.0 million under the Credit Suisse Credit Facility. On January 16, 2020, in connection with the Formation Transactions, through its wholly owned subsidiary, TF1, the Company became a party to, and assumed, the ~~Credit Facility~~credit facility with Credit Suisse. ~~The Credit Facility matures on January 8, 2022, unless extended.~~
Borrowings under the Credit Suisse Credit Facility ~~bear~~bore interest at a rate of the three-month London Interbank Offered Rate (“LIBOR”) plus 3.25%. The Credit Suisse Credit Facility iswas collateralized by all investments held by TF1 and ~~permits~~permitted an advance rate of up to 65% of eligible investments. The ~~Credit Facility contains covenants that, among other things, require the~~ Company ~~to maintain minimum tangible net worth and leverage ratios, minimum cash balance of $15.0 million, and a cash reserve of 60 days for interest. The Company has~~had the ability to borrow up to an aggregate of $300.0 million, and the Credit Suisse Credit Facility borrowing base ~~contains~~contained certain criteria for eligible investments and includes concentration limits as defined in the Credit Suisse Credit Facility. As
On January 8, 2022, the Credit Suisse Credit Facility matured in accordance with its terms, and all outstanding indebtedness thereunder was repaid. Additionally, in conjunction with the maturity of ~~June 30,~~the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.
The summary information regarding the Credit Suisse Credit Facility is as follows (dollars in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

June 30, 2022

June 30, 2021

June 30, 2022

June 30, 2021

Stated interest expense

$
n/a

$
482

$
9

$
1,159

Amortization of deferred financing costs

n/a

527

—

1,054

Total interest and amortization of deferred financing costs

$
n/a

$
1,009

$
9

$
2,213

Weighted average effective interest rate

n/a

7.2
%

3.9
%

6.6
%
Weighted average outstanding balance

$
n/a

$
55,769

$
442

$
66,823

KeyBank Credit Facility
On October 27, 2021, ~~and December 31, 2020,~~TCF, a wholly owned subsidiary of the Company, ~~had $70.0~~as borrower, and the Company, as servicer, entered into a credit agreement (as amended, the “KeyBank Credit Agreement”) with the lenders from time-to-time party thereto, KeyBank, as administrative agent and syndication agent, and Wells Fargo, National Association, as collateral custodian and paying agent.
The KeyBank Credit Facility includes a commitment of $300.0 million from KeyBank and ~~$135.0 million, respectively, in borrowings outstanding~~other banks and allows the Company, through TCF, to borrow up to $400 million. Borrowings under the KeyBank Credit Agreement bear interest at a rate equal to Adjusted Term Secured Overnight Financing Rate (“SOFR”) plus 2.85%, subject to the number of eligible loans in the collateral pool. The KeyBank Credit Facility provides for a variable advance rate of up to 60% on eligible term loans and up to 64% on eligible equipment finance loans.

63

The KeyBank Credit Facility includes a three-year revolving period and a ~~borrowing availability~~two-year amortization period and matures on October 27, 2026, unless extended. Such credit facility is collateralized by all investment assets held by TCF. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of ~~approximately $88.6 million~~this type, including certain financial covenants such as a consolidated tangible net worth requirement and ~~$42.0 million, respectively.~~a required asset coverage ratio.

The KeyBank Credit Agreement also contains customary events of defaults (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.

During the three months ended June 30, ~~2021,~~2022, the Company borrowed $116.0 million and ~~additional $25.0~~made repayments of $30.0 million onunder the KeyBank Credit ~~Facility and did not make any repayments.~~Facility. During the six months ended June 30, ~~2021,~~2022, the Company borrowed ~~an additional $25.0~~$184 million and made repayments of ~~$90.0 million. During~~$45 million under the ~~year ended December 31, 2020, the~~KeyBank Credit Facility. The Company ~~borrowed an additional $30.0 million and made repayments of $85.0 million and~~ incurred approximately ~~$4.0~~$3.2 million of financing costs in connection with the KeyBank Credit Facility that ~~are~~were capitalized and deferred using the straight-line method over the life of the facility. As of June 30, ~~2021~~2022, and December 31, ~~2020,~~2021, unamortized deferred financing costs related to the KeyBank Credit Facility were ~~$1.1~~$2.8 million and ~~$2.1~~$2.3 million, ~~respectively~~respectively. As of June 30, 2022 and ~~presented as~~December 31, 2021, the Company had a ~~direct deduction from the carrying amount~~borrowing availability of ~~the debt liability on the Consolidated Statements of Assets~~approximately $80.0 million and ~~Liabilities.~~

$38.1 million. See “Note 14 – Subsequent Events.”

The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended


June 30, 2022

June 30, 2021


June 30, 2022

June 30, 2021

Stated interest expense

$
1,791

$
n/a

$
2,643

$
n/a

Amortization of deferred financing costs

173

n/a

331

n/a

Total interest and amortization of deferred financing costs

$
1,964

$
n/a

$
2,974

$
n/a

Weighted average effective interest rate

4.4
%

n/a

4.5
%

n/a

Weighted average outstanding balance

$
180,271

$
n/a

$
131,357

$
n/a

Three Months Ended

Six Months Ended


June 30, 2021

June 30, 2020


June 30, 2021

June 30, 2020

Stated interest expense

$
482

$
1,287

$
1,159

$
3,000

Amortization of deferred financing costs

527

473

1,054

907

Total interest and amortization of deferred financing costs

$
1,009

$
1,760

$
2,213

$
3,907

Weighted average effective interest rate

7.2
%

5.5
%

6.6
%

5.6
%
Weighted average outstanding balance

$
55,769

$
128,626

$
66,823

$
138,592

2025 Notes
Concurrent with the completion of a private common stock offering (the “Private Common Stock Offering”), on January 16, 2020, the Company completed ~~the 144A Note Offering~~its offering of $105.0 million in aggregate principal amount of the unsecured 2025 Notes in reliance upon the available exemptions from the registration requirements of the Securities ~~Act. KBW,~~Act (the “144A Note Offering”). Keefe, Bruyette & Woods, Inc. (“KBW”), as the initial purchaser, exercised in full its option to purchase or place additional Notes and on January 29, 2020, the Company issued and sold an additional $20.0 million in aggregate principal amount of the 2025 Notes. As a result, the Company issued and sold a total of $125.0 million in aggregate principal amount of the 2025 Notes pursuant to the 144A Note Offering.
The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee ~~(the~~(together with its successor in interest, U.S. Bank Trust Company, National Association, the “Trustee”), and a First Supplemental Indenture, dated as of January 16, 2020 (the “First Supplemental Indenture” and together with the Base Indenture, the “2025 Notes Indenture”), between the Company and the Trustee. The 2025 Notes mature on January 16, 2025 (the “Maturity Date”), unless repurchased or redeemed in accordance with their terms prior to such date. The 2025 Notes are redeemable, in

56

whole or in part, at any time, or from time to time, at the Company’s option, on or after January 16, 2023 at a redemption price equal to 100% of the outstanding principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of redemption. The holders of the 2025 Notes do not have the option to have the notes repaid or repurchased by the Company prior to the Maturity Date.

64

The 2025 Notes bear interest at a fixed rate of 7.00% per year payable quarterly on March 15, June 15, September 15, and December 15 of each year, commencing on March 15, 2020. The 2025 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.

Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriter’s discount and commissions, were approximately ~~$5.8~~$5.9 million, which were capitalized and deferred. As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, unamortized deferred financing costs related to the 2025 Notes were ~~$4.2~~$3.0 million and ~~$4.7~~$3.6 million, respectively.

The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):


	Three Months Ended						Six Months Ended						Three Months Ended			Three Months Ended				Six Months Ended			Six Months Ended
	June 30, 2021			June 30, 2020			June 30, 2021			June 30, 2020			June 30, 2022			June 30, 2021			June 30, 2022			June 30, 2021
Stated interest expense	$	2,188		$	2,212		$	4,375		$	4,059		$	2,188		$	2,188		$	4,375		$	4,375
Amortization of deferred financing costs		292			277			583			509			298			292			595			583
Total interest and amortization of deferred financing costs	$	2,480		$	2,489		$	4,958		$	4,568		$	2,486		$	2,480		$	4,970		$	4,958

Weighted average effective interest rate		7.9	%		8.0	%		7.9	%		7.3	%		8.0	%		7.9	%		8.0	%		7.9	%

August 2026 Notes

On August 24, 2021, the Company issued and sold $125.0 million in aggregate principal amount of its unsecured August 2026 Notes under its shelf Registration Statement on Form N-2. The August 2026 Notes were issued pursuant to the Base Indenture and a Third Supplemental Indenture, dated as of August 24, 2021 (together with the Base Indenture, the “August 2026 Notes Indenture”), between the Company and the Trustee. The August 2026 Notes mature on August 24, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The August 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the August 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the August 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any August 2026 Notes on or after July 24, 2026, the redemption price for the August 2026 Notes will be equal to 100% of the principal amount of the August 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the August 2026 Notes Indenture) occurs prior to the maturity date of the August 2026 Notes or the Company’s redemption of all outstanding August 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the August 2026 Notes at a repurchase price equal to 100% of the principal amount of the August 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The August 2026 Notes bear interest at a fixed rate of 4.375% per year payable semiannually on February 15 and August 15 of each year, commencing on February 15, 2022. The August 2026 Notes are direct, general unsecured

65

obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the August 2026 Notes issuance, including the underwriter’s discount and commissions, were approximately $2.9 million, which were capitalized and deferred. As of June 30, 2022 and December 31, 2021, unamortized deferred financing costs related to the August 2026 Notes were $2.4 million and $2.7 million, respectively.

The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended


June 30, 2022


June 30, 2021


June 30, 2022


June 30, 2021

Stated interest expense

$
1,367

$
n/a

$
2,719

$
n/a

Amortization of deferred financing costs

144

n/a

288

n/a

Total interest and amortization of deferred financing costs

$
1,511

$
n/a

$
3,007

$
n/a

Weighted average effective interest rate

4.8
%

n/a

4.8
%

n/a

December 2026 Notes
On December 15, 2021, the Company issued and sold $75.0 million in aggregate principal amount of its unsecured December 2026 Notes under its shelf Registration Statement on Form N-2. The December 2026 Notes were issued pursuant to the Base Indenture and a Fourth Supplemental Indenture, dated as of December 15, 2021 (together with the Base Indenture, the “December 2026 Notes Indenture”), between the Company and the Trustee. The December 2026 Notes mature on December 15, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The December 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the December 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the December 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any December 2026 Notes on or after November 15, 2026, the redemption price for the December 2026 Notes will be equal to 100% of the principal amount of the December 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the December 2026 Notes Indenture) occurs prior to the maturity date of the December 2026 Notes or the Company’s redemption of all outstanding December 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the December 2026 Notes at a repurchase price equal to 100% of the principal amount of the December 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.
The December 2026 Notes bear interest at a fixed rate of 4.25% per year payable semiannually on June 15 and December 15 of each year, commencing on June 15, 2022. The December 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.
Aggregate offering costs in connection with the December 2026 Notes issuance, including the underwriter’s discount and commissions, were approximately $1.9 million, which were capitalized and deferred. As of June 30, 2022 and December 31, 2021, unamortized deferred financing costs related to the December 2026 Notes were $1.7 million and $1.8 million, respectively.

66

The components of interest expense and related fees for the December 2026 Notes are as follows (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended


June 30, 2022


June 30, 2021


June 30, 2022


June 30, 2021

Stated interest expense

$
797

$
n/a

$
1,594

$
n/a

Amortization of deferred financing costs

93

n/a

186

n/a

Total interest and amortization of deferred financing costs

$
890

$
n/a

$
1,780

$
n/a

Weighted average effective interest rate

4.7
%

n/a

4.7
%

n/a

6.00% Convertible Notes due 2025
On December 11, 2020, the Company completed a private offering (the “Private Convertible Note Offering”) of ~~$50~~$50.0 million in aggregate principal amount of its unsecured ~~6.00%~~ Convertible Notes ~~due 2025 (the “Convertible Notes”)~~ in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW acted as the initial purchaser and placement agent in connection with the Private Convertible Note Offering pursuant to a purchase/placement agreement dated December 4, 2020, by and between the Company and KBW.
The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the “Second Supplemental Indenture” and together with the Base Indenture, the “Convertible Notes Indenture”), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof. Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.9 million which were capitalized and deferred.
The Convertible Notes bear interest at a fixed rate of 6.00% per year, subject to additional interest upon certain events, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2021. If an investment grade rating is not maintained with respect to the Convertible Notes, additional interest of 0.75% per annum will accrue on the Convertible Notes until such time as the Convertible Notes have received an investment grade rating of “BBB-” (or its equivalent) or better. The rating remained ~~unchanged~~at investment grade as of June 30, ~~2021 and December 31, 2020.~~2022. The Convertible Notes mature on December 11, 2025 (the “Convertible Notes Maturity Date”), unless earlier converted or repurchased in accordance with their terms.

57

Holders may convert their Convertible Notes, at their option, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date. The conversion rate iswas initially 66.6667 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $15.00 per share of common stock). Effective immediately after the close of business on June 30, 2022, the conversion rate changed to 68.7855 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to a conversion price of approximately $14.54 per share of common stock) as a result of a certain cash dividend of the Company. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events, further described in the Convertible Note Indenture, that occur prior to the Convertible Notes Maturity Date, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Upon conversion of the Convertible Notes, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate.

At the Company’s option, it may cause holders to convert all or a portion of the then outstanding principal amount of the Convertible Notes plus accrued but unpaid interest, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date, if the closing sale price of the Company’s common stock for any 30 consecutive trading days exceeds 120% of the conversion price, as may be adjusted. Upon such conversion, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of

67

cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate, and a forced conversion make-whole payment (as defined in the Second Supplemental Indenture), if any, in cash.
The Company may not redeem the Convertible Notes at its option prior to maturity. In addition, if the Company undergoes a fundamental change (as defined in the Second Supplemental Indenture), holders may require the Company to repurchase for cash all or part of such holders’ Convertible Notes at a repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
The Convertible Notes are direct unsecured obligations of the Company and rank pari passu, or equal, in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated, including, without limitation, the 2025 Notes, and senior in right of payment to all of the Company’s future indebtedness or other obligations that are expressly subordinated, or junior, in right of payment to the Convertible Notes.
Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.8 million which were capitalized and deferred. As of June 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the Convertible Notes were $1.6 million and $1.7 million, respectively.
The Convertible Notes are accounted for in accordance with ASC 470-20, Debt Instruments with Conversion and Other Options. In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately 99.1% and 0.9%, respectively. The original issue discount of 0.9%, or approximately $0.5 million, attributable to the conversion feature of the Convertible Notes was recorded in “capital in excess of par value” in the Consolidated Statements of Assets and Liabilities as of December 31, 2020. ~~The estimated effective interest rate of the Convertible Notes was approximately 7.2% annualized.~~
In January 2021, the Company early adopted Accounting Standard Update (“ASU”) No. 2020-06, Debt – Debt with Conversion and Other Options (“ASU 2020-06”), under which the accounting for convertible instruments was simplified by removing the separate accounting for embedded conversion features. As such, approximately $0.5 million was reversed out of net assets and reduced the original issue discount for the Convertible Notes.

58

The components of the carrying value of the Convertible Notes were as follows (in thousands):


	June 30, 2021		December 31, 2020		June 30, 2022		December 31, 2021
Principal amount of debt	$	50,000	$	50,000	$	50,000	$	50,000
Unamortized debt issuance cost		(1,619)		(1,672)
Original issue discount related to equity component, net of accretion		—		(468)
Unamortized debt financing cost						(1,297)		(1,480)
Original issue discount, net of accretion		(1,167)		(1,308)		(904)		(1,035)
Carrying value of Convertible Notes	$	47,214	$	46,552	$	47,799	$	47,485

The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):


	Three Months Ended					Six Months Ended					Three Months Ended			Three Months Ended				Six Months Ended			Six Months Ended
	June 30, 2021			June 30, 2020		June 30, 2021			June 30, 2020		June 30, 2022			June 30, 2021			June 30, 2022			June 30, 2021
Stated interest expense	$	750		$	—	$	1,492		$	—	$	750		$	750		$	1,500		$	1,492
Amortization of deferred financing costs and original issue discount		155			—		311			—		160			155			319			311
Total interest and amortization of deferred financing costs and original issue discount	$	905		$	—	$	1,803		$	—	$	910		$	905		$	1,819		$	1,803

Weighted average effective interest rate		7.2	%		n/a		7.2	%		n/a		7.3	%		7.2	%		7.3	%		7.2	%

As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company was in compliance with the terms of the KeyBank Credit Facility, the 2025 Notes Indenture, the August 2026 Notes Indenture, the December 2026 Notes Indenture and the Convertible Notes Indenture.

68

Note 6. Commitments and Contingencies
Unfunded Commitments
The Company’s commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 includes only those commitments ~~which~~that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.
As of June 30, 2022 and December 31, 2021 the Company had ~~an aggregate of approximately $4.0 million of unfunded commitments to two portfolio companies, Dandelion, Inc. and Greenlight Biosciences, Inc. As of December 31, 2020, the Company had~~no outstanding unfunded commitments of approximately $0.1 million to one portfolio company, Dandelion, Inc. These unfunded commitments are available at the request of such portfolio companies and unencumbered by milestones. The fair value of these unfunded commitments is considered to approximate the cost of such commitments as the yields determined at the time of underwriting are expected to be materially consistent with the yields upon funding.commitments. The Company will fund its unfunded commitments, if any, from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under ~~the Credit Facility)~~its credit facilities) and maintains adequate liquidity to fund its unfunded commitments through these sources.

59

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Leases

FASB ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) requires that a lessee evaluate its leases to determine whether they should be classified as operating or financing leases. The Company identified two significant operating leases for its office space in Chandler, AZ and its ~~new~~ headquarters in Phoenix, AZ. The lease for the Chandler office commenced February 21, 2017, and expires July 31, 2022. The Chandler lease contains a five-year extension option for a final expiration date of July 31, 2027, which the company will not exercise. The Company has also entered into a lease for ~~new~~ office space in downtown Phoenix, Arizona (“PHX”), which commenced on ~~June 4,~~July 10, 2021, and expires on December 31, 2028. The PHX lease contains two ~~five-years~~five-year extension options for a final expiration date of December 31, 2038.

The total lease expense incurred ~~related to the Chandler office lease~~ for the three months ended June 30, ~~2021~~2022 and ~~2020~~2021 was approximately $0.1 million for each period. The total lease expense ~~related to the Chandler office lease~~incurred for the six months ended June 30, ~~2021~~2022 and ~~2020~~2021 was approximately ~~$0.1 million for each period. As of June 30, 2021 and December 31, 2020, the right of use asset related to the Chandler office operating lease was~~ $0.2 million and ~~$0.4 million, respectively, and the lease liability was $0.2 million and $0.4 million,~~$30,000, respectively. As of June 30, ~~2021, the remaining lease term was 1.1 years~~2022 and ~~the discount rate was 3.25%. As of June 30,~~December 31, 2021, the right of use asset related to the ~~PHX~~ office operating ~~lease~~leases was ~~$2.4~~$2.3 million and $2.5 million, respectively, and the lease liability was ~~$2.4~~$2.5 million and $2.7 million, respectively. As of June 30, 2022, the remaining lease term for the Chandler office was 0.1 years. As of June 30, 2022, the remaining lease term for the Phoenix office was 6.5 years. The discount rate ~~was 3.75%. The total~~is determined at the commencement of the lease, ~~expense related to the PHX office~~and is 3.25% for the ~~three~~Chandler lease and ~~six months ended June 30, 2021 was approximately $30,000.~~is 3.75% for the Phoenix lease.

69

The following table shows future minimum payments under the Company’s operating leases as of June 30, ~~2021~~2022 (in thousands):


For the Years Ended December 31,		Total		Total
2021	$	112
2022		484	$	208
2023		361		383
2023		371
2024		380		382
2025				386
2026				396
Thereafter		1,619		821
Total	$	3,327	$	2,576

Legal Proceedings

The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of June 30, ~~2021,~~2022, there are no material legal matters or material litigation pending of which the Company is aware.

Note 7. Stockholder’s Equity
The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. On September 27, 2019, the Company was initially capitalized with the issuance of 10 shares of its common stock for an aggregate purchase price of $150 to its sole shareholder.

60

Private Common Stock Offerings

On January 16, 2020, the Company completed the Private Common Stock ~~Offering.~~Offering in reliance upon the available exemptions from the registration requirements of the Securities Act. As a result, the Company issued and sold a total of 7,000,000 shares of its common stock for aggregate net proceeds of approximately $105.0 million. The related overallotment option was exercised in full on January 29, 2020, pursuant to which the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million. ~~Refer to “Note 1 – Organization and Basis of Presentation” for further details.~~

Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the Legacy Investors that received shares of its common stock in connection with the Formation Transactions that were not the Company’s directors, officers and affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.

Formation Transactions

On January 16, 2020, immediately following the initial closings of the Private ~~Offerings,~~Common Stock Offering and the Private Convertible Note Offering (together, the “Private Offerings”), the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. In consideration for the Legacy Funds, the Company issued 9,183,185 shares of common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to certain of the Legacy Investors. As consideration for all of the equity interests in Trinity Capital Holdings, the Company

70

~~Table~~par value $0.001 per share, at a public offering price of ~~Contents~~

issued 533,332 shares of its common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash. ~~Refer to “Note 1 – Organization and Basis of Presentation” for further details regarding the Formation Transactions.~~

Initial Public Offering

~~The Company’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.”~~ On February 2, 2021, the Company completed its initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. The Company’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN.”Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Suisse Credit Facility.

~~2019 Long-Term Incentive Plan~~ATM Program

On November 9, 2021, the Company entered into an open market sale agreement (the “2021 Sales Agreement”) with Jefferies LLC, as sales agent and/or principal thereunder, pursuant to which the Company can issue and sell, from time to time, up to $50 million in aggregate offering price of shares of its common stock by any method permitted by law and deemed to be part of an “at-the-market” offering (as defined in Rule 415 under the Securities Act) (the “ATM Program”). During the six months ended June 30, 2022, the Company issued and sold 176,148 shares of its common stock at a weighted-average price of $16.56 per share and raised $2.9 million of net proceeds after deducting commissions to the sales agent on shares sold under the ATM Program. During the year ended December 31, 2021, the Company issued and sold 35,714 shares of its common stock at a weighted-average price of $16.55 per share and raised $0.6 million of net proceeds after deducting commissions to the sales agent on shares sold under the ATM Program. The ~~Company’s Board adopted and approved~~Company did not have the ~~2019 Trinity Capital Inc. Long-Term Incentive Plan (the “2019 Long-Term Incentive Plan”) on October 17, 2019 and~~ATM Program prior to November 9, 2021. The Company generally uses net proceeds from the Company’s stockholders approved the 2019 Long-Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long-Term Incentive Plan becoming effective on June 17, 2021. Under the 2019 Long-Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be grantedATM Program to ~~certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”)~~make investments in accordance with ~~the SEC exemptive order~~its investment objective and investment strategy and for general corporate purposes.
Equity Offering
On April 7, 2022, the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long-Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long-Term Incentive Plan.
~~Subject to certain adjustments under the 2019 Long-Term Incentive Plan, the maximum aggregate number of~~issued 2,754,840 shares of the Company’s common stock, ~~authorized for issuance under the 2019 Long-Term Incentive Plan is 3,600,000 shares. The 2019 Long-Term Incentive Plan is to be administered by the Board, unless the Board delegates its administrative~~

61

~~authority~~$18.15 per share, resulting in net proceeds to the ~~Compensation Committee~~Company of approximately $47.9 million, after deducting discounts and commissions and offering expenses. In addition, the ~~Board (the “Compensation Committee”)~~underwriters exercised their option to purchase an additional 413,226 shares of common stock, resulting in ~~accordance with the terms of the 2019 Long-Term Incentive Plan. The 2019 Long-Term Incentive Plan will terminate on the day prior~~additional net proceeds to the ~~tenth anniversary~~Company of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable. As of June 30, 2021, no securities have been issued under the 2019 Long-Term Incentive Plan.

~~For additional information regarding the 2019 Long-Term Incentive Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2021,~~$7.2 million, after deduction discounts and ~~the Company’s definitive proxy statement filed with the SEC on April 28, 2021.~~

~~2019 Restricted Stock Plan~~

~~The Company’s Board adopted~~commissions and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders. The 2019 Restricted Stock Plan became effective on June 17, 2021 and provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act)in accordance with the SEC Exemptive Order.

Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is 60,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company’s stockholders, unless terminated sooner by action of the Board. As of June 30, 2021, no restricted stock has been issued under the 2019 Restricted Stock Plan.

For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Report on Form 8-K, filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 28, 2021.offering expenses.

Distribution Reinvestment Plan

The Company’s amended and restated distribution reinvestment plan (“DRIP”) provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not “opted out” of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company’s common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company’s common stock on the valuation date determined for each distribution by the Board.

The Company’s DRIP is administered by its transfer agent on behalf of the Company’s record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company’s DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended June 30, ~~2021,~~2022, the Company issued ~~75,999~~30,800 shares of common stock for a total of approximately ~~$1.1~~$0.6 million under the DRIP. During the six months ended June 30, ~~2021,~~2022, the Company issued ~~163,709~~90,334 shares of common stock for a total of approximately ~~$2.3~~$1.6 million under the DRIP. During the year ended December 31, ~~2020,~~2021, the Company issued ~~271,414~~281,149 shares of common stock for a total of approximately ~~$3.4~~$4.1 million under the DRIP.

6271

Distributions

The following table summarizes distributions declared and/or paid by the Company since inception:

Declaration Date

Record Date

Payment Date

Per Share Amount

Type

Record Date

Payment Date

Per Share Amount

May 7, 2020

May 29, 2020

June 5, 2020

$

0.22

Quarterly

May 29, 2020

June 5, 2020

$

0.22

August 10, 2020

August 21, 2020

September 4, 2020

0.27

Quarterly

August 21, 2020

September 4, 2020

0.27

November 9, 2020

November 20, 2020

December 4, 2020

0.27

Quarterly

November 20, 2020

December 4, 2020

0.27

December 22, 2020

December 30, 2020

January 15, 2021

0.27

Quarterly

December 30, 2020

January 15, 2021

0.27

March 23, 2021

March 31, 2021

April 16, 2021

0.28

Quarterly

March 31, 2021

April 16, 2021

0.28

June 15, 2021

June 30, 2021

July 15, 2021

0.29

Quarterly

June 30, 2021

July 15, 2021

0.29

September 13, 2021

Quarterly

September 30, 2021

October 15, 2021

0.33

December 16, 2021

Quarterly

December 31, 2021

January 14, 2022

0.36

March 15, 2022

Quarterly

March 31, 2022

April 15, 2022

0.40

March 15, 2022

Supplemental

March 31, 2022

April 15, 2022

0.15

June 15, 2022

Quarterly

June 30, 2022

July 15, 2022

0.42

June 15, 2022

Supplemental

June 30, 2022

July 15, 2022

0.15

Total

$

1.60

Total

$

3.41

Note 8. Equity Incentive Plans
2019 Long Term Incentive Plan
8.The Company’s Board adopted and approved the 2019 Trinity Capital Inc. Long Term Incentive Plan (the “2019 Long Term Incentive Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Long Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long Term Incentive Plan becoming effective on June 17, 2021. Under the 2019 Long Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be granted to certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”) in accordance with the SEC exemptive order the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long Term Incentive Plan. The Employee Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.
Subject to certain adjustments under the 2019 Long Term Incentive Plan, the maximum aggregate number of shares of the Company’s common stock authorized for issuance under the 2019 Long Term Incentive Plan is 3,600,000 shares. The 2019 Long Term Incentive Plan is to be administered by the Compensation Committee of the Board (the “Compensation Committee”) in accordance with the terms of the 2019 Long Term Incentive Plan. The 2019 Long Term Incentive Plan will terminate on the day prior to the tenth anniversary of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable.
For additional information regarding the 2019 Long Term Incentive Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 27, 2022. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three and six months ended June 30, 2022 and 2021 and the twelve months ended December 31, 2021 (dollars in thousands).

72

Six Months Ended

Weighted Average

Six Months Ended

Weighted Average

June 30, 2022


Grant Date Fair Value


June 30, 2021


Grant Date Fair Value
Unvested as of December 31, 2021

536,552

16.48

-

-
Shares Granted

698,943

17.30

-

-
Shares Vested

(96,727)

16.54

-

-
Shares Forfeited

(3,218)

16.85

-

-
Unvested as of June 30, 2022

1,135,550

16.98

-

-

Fair Value of Granted Stock
$
12,092

$
-

Compensation cost recognized
$
2,464

$
-

As of June 30, 2022, there was approximately $18.2 million of total unrecognized compensation costs related to the non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 3.8 years. As of June 30, 2021, there was no stock based compensation costs or unrecognized compensation costs as no restricted stock has been issued under the plan. As of December 31, 2021, there was approximately $8.7 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 2.8 years.
2019 Restricted Stock Plan
The Company’s Board adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders. The 2019 Restricted Stock Plan became effective on June 17, 2021 and provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act) in accordance with the SEC Exemptive Order. The Non-Employee Director Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.
Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is 60,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company’s stockholders, unless terminated sooner by action of the Board.
For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Report on Form 8-K, filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 27, 2022. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three and six months ended June 30, 2022 and 2021 and the twelve months ended December 31, 2021 (dollars in thousands).

Six Months Ended

Weighted Average

Six Months Ended

Weighted Average

June 30, 2022


Grant Date Fair Value


June 30, 2021


Grant Date Fair Value
Unvested as of December 31, 2021

6,066

16.48

-

-
Shares Granted

19,320

15.53

-

-
Shares Vested

(11,846)

16.88

-

-
Shares Forfeited

-

-

-

-
Unvested as of June 30, 2022

13,540

14.77

-

-

Fair Value of Granted Stock
$
300

$
-

Compensation cost recognized
$
169

$
-

73

As of June 30, 2022, there was approximately $0.2 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a twelve-month period. As of June 30, 2021, there were no unrecognized compensation costs as no restricted stock had been issued under the plan. As of December 31, 2021, there was approximately $0.1 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a six-month period.

Note 9. Earnings Per Share
In accordance with the provisions of ASC Topic 260 – Earnings per Share (“ASC 260”), basic earnings per share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Other potentially dilutive common shares, and the related impact to earnings are considered when calculating earnings per share on a diluted basis. Potential common shares associated with the conversion option embedded in the Convertible Notes are anti-dilutive when the Company’s average NAV per share / market price per share is below the conversion price. The following table sets forth the computation of the ~~weighted average~~ basic and diluted ~~net increase (decrease) in net assets~~earnings per common share ~~from operations~~ for the three and six months ended June 30, ~~2021~~2022 and ~~2020~~2021 (in thousands except shares and per share information):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended


June 30, 2022

June 30, 2021

June 30, 2022

June 30, 2021
Earnings per common share - basic

Numerator for basic earnings per share

$
(7,723)

$
24,705

$
(16,787)

$
50,030
Denominator for basic weighted average shares

30,955,022

26,478,747

29,188,790

25,024,925
Earnings/(Loss) per common share - basic

$
(0.25)

$
0.93

$
(0.58)

$
2.00
Earnings per common share - diluted

Numerator for increase in net assets per share

$
(7,723)

$
24,705

$
(16,787)

$
50,030
Adjustment for interest expense and deferred financing costs on Convertible Notes⁽¹⁾

—

—

—

—
Numerator for diluted earnings per share

(7,723)

24,705

(16,787)

50,030
Denominator for basic weighted average shares

30,955,022

26,478,747

29,188,790

25,024,925
Adjustment for dilutive effect of Convertible Notes⁽¹⁾

—

—

—

—
Denominator for diluted weighted average shares

30,955,022

26,478,747

29,188,790

25,024,925
Earnings/(Loss) per common share - diluted

$
(0.25)

$
0.93

$
(0.58)

$
2.00

Three Months Ended

Six Months Ended


June 30, 2021

June 30, 2020

June 30, 2021

June 30, 2020
Net increase/(decrease) in net assets resulting from operations

$
24,705

$
6,882

$
50,030

$
(28,169)
Weighted average common shares outstanding

26,478,747

18,074,929

25,024,925

17,959,728
Net increase/(decrease) in net assets resulting from operations per common share - basic and diluted

$
0.93

$
0.38

$
2.00

$
(1.57)
(1) No adjustments for interest or incremental shares were included for the three and six months ended June 30, 2022 and 2021, because the effect would be antidilutive.

~~For the three and six months ended June 30, 2021, the effect of~~In certain circumstances, the Convertible Notes ~~was anti-dilutive~~will be convertible into cash, shares of the Company’s common stock or a combination of cash and ~~accordingly, was excluded from~~shares of the ~~calculation~~Company’s common stock, at the Company’s election which can be dilutive to common stockholders. Diluted earnings (loss) available to each share of common stock outstanding during the reporting period included any additional shares of common stock that would be issued if all potentially dilutive securities were exercised. In accordance with ASU 2020-06, the Company is required to disclose diluted ~~earnings per share.~~EPS using the if-converted method that assumes conversion of convertible securities at the beginning of the reporting period and is intended to show the maximum dilution effect to common stockholders regardless of how the conversion can occur.

Note 9.10. Income Taxes
~~When filing its 2020 tax return, the Company intends to elect to be treated for U.S. federal tax purposes as a RIC under Subchapter M~~The amount of the Code and operate in a manner so as to qualify annually thereafter for the tax treatment applicable to RICs. As a RIC, the Company generally will not pay corporate-level income tax on the portion of its taxable income distributed to stockholders, generally required to be at least 90% of its investment company taxable income (which is generally its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its tax-exempt income to maintain its RIC status (pass-through tax treatment for amounts distributed). The amount to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by ~~the~~ management of the Company. ToNet capital gains, if any, are

74

distributed at least annually, although the ~~extent~~Company may decide to retain all or some of those capital gains for investment and pay corporate-level income taxes on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. In the event the Company’s ~~earnings~~taxable income (including any net capital gains) for a fiscal year fall below the amount of ~~dividend~~ distributions declared and paid with respect to that year, however, a portion of the total amount of ~~the Company’s~~those distributions ~~for the fiscal year~~ may be deemed a return of capital for tax purposes to the Company’s stockholders.

63

Because federal income tax regulations differ from accounting principles generally accepted in the United States, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future. ~~Also, recent~~

For the three and six months ended June 30, 2022, $0.7 million and $1.3 million, respectively, was recorded for U.S. federal excise tax. There was no U.S. federal excise tax ~~legislation requires that income be recognized~~recorded for the three months ended June 30, 2021, and there was $0.1 million recorded for U.S. federal excise tax ~~purposes no later than when recognized for financial reporting purposes.~~in the six months ended June 30, 2021.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of and for the ~~period~~six months ended June 30, ~~2021~~2022 and December 31, ~~2020~~2021 (in thousands):

June 30, 2022

December 31, 2021
Tax Cost of Investments ⁽¹⁾

$
1,083,460

$
849,402

June 30, 2022

December 31, 2021
Unrealized appreciation

$
29,775

$
97,569
Unrealized depreciation

(48,935)

(26,759)
Net unrealized appreciation/(depreciation) from investments

$
(19,160)

$
70,810

June 30, 2021

December 31, 2020
Tax Cost of Investments ⁽¹⁾

$
609,020

$
559,437

June 30, 2021

December 31, 2020
Unrealized appreciation

$
55,415

$
14,879
Unrealized depreciation

(32,274)

(19,845)
Net unrealized appreciation/(depreciation) from investments

$
23,141

$
(4,966)
(1) Includes cost of short-term investments, including cash and cash equivalents.

6475

Note ~~10.~~11. Financial Highlights
The following presents financial highlights (in thousands except share and per share information):

Six Months Ended

Six Months Ended

June 30, 2022

June 30, 2021

Per Share Data: ⁽¹⁾





Net asset value, beginning of period

$
16.40

$
13.03

Net investment income

1.07

0.69

Net realized and unrealized gains/(losses) on investments ⁽²⁾

(1.65)

1.31

Net increase/(decrease) in net assets resulting from operations

(0.58)

2.00

Offering costs

(0.08)

(0.30)

Effect of shares issued ⁽³⁾

—

0.19

Equity component of convertible notes

—

(0.02)

Distributions ⁽⁴⁾

(1.12)

(0.57)

Total increase/(decrease) in net assets

(1.78)

1.30

Net asset value, end of period

$
14.62

$
14.33

Shares outstanding, end of period

31,355,832

26,491,274

Weighted average shares outstanding

29,188,790

25,024,925

Total return based on net asset value ⁽⁵⁾⁽⁶⁾

(4.0)
%

14.4
%
⁽⁹⁾
Total return based on market value ⁽⁷⁾⁽⁶⁾

(13.6)
%

7.5
%

Ratio/Supplemental Data:





Per share market value at end of period

$
14.47

$
14.48

Net assets, end of period

$
458,343

$
379,720

Ratio of total expenses to average net assets⁽⁸⁾

15.6
%

11.7
%

Ratio of net investment income to average net assets⁽⁸⁾

14.4
%

10.4
%

Ratio of interest and credit facility expenses to average net assets⁽⁸⁾

6.7
%

5.4
%

Portfolio turnover rate⁽⁶⁾⁽⁹⁾

21.7
%

27.9
%

Asset coverage ratio ⁽¹⁰⁾

177.0
%

255.0
%

Six Months Ended

June 30, 2021

June 30, 2020

Per Share Data: ⁽¹⁾





Net asset value, beginning of period

$
13.03

$
14.97
⁽²⁾

Net investment income

0.69

0.69
⁽³⁾
Net realized and unrealized gains/(losses) on investments ⁽⁴⁾

1.31

(1.37)

Costs related to acquisition of Trinity Capital Holdings and Legacy Funds

—

(0.87)

Net increase/(decrease) in net assets resulting from operations

2.00

(1.55)

Offering costs

(0.30)

(0.58)

Effect of shares issued ⁽⁵⁾

0.19

(0.01)

Equity component of convertible notes

(0.02)

—

Distributions ⁽⁶⁾

(0.57)

(0.22)

Total increase/(decrease) in net assets

1.30

(2.36)

Net asset value, end of period

$
14.33

$
12.61

Shares outstanding, end of period

26,491,274

18,137,600

Weighted average shares outstanding

25,024,925

17,959,728
⁽³⁾
Total return based on net asset value ⁽⁷⁾ ⁽⁸⁾

14.4
%

(14.3)
% ⁽⁹⁾
Total return based on market value ⁽¹⁰⁾

7.5
%

na

Ratio/Supplemental Data:





Per share market value at end of period

$
14.48

n/a

Net assets, end of period*

$
379,720

$
228,646

Ratio of total expenses to average net assets ⁽¹¹⁾

11.7
%

13.2
%
Ratio of net investment income to average net assets ⁽¹¹⁾

10.4
%

12.1
%
Ratio of interest and credit facility expenses to average net assets ⁽¹¹⁾

5.4
%

8.3
%
Portfolio turnover rate ^{(8) (12)}

27.9
%

18.5
%
Asset coverage ratio ⁽¹³⁾

255.0
%

199.1
%
* Rounded to the nearest thousand.
(1) Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.
(2) The net asset value as of January 16, 2020 (commencement of operations) is calculated based on the initial common stock purchase price of $15.00 per share less the accumulated loss of $0.03 per share from August 12, 2019 (the date of inception) through December 31, 2019.
~~(3)~~ ~~Calculated based upon weighted average shares outstanding for the period from January 16, 2020 (commencement of operations) through June 30, 2020.~~
~~(4)~~ Net realized and unrealized gains/(losses) on investments include rounding adjustments to reconcile the change in net asset value per share.
65

~~(5)~~

(3)

Includes the impact of the different share amounts as a result of calculating certain per share data based on the weighted-average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. Also includes the impact of the issuance of shares related to the equity incentive plans. Refer to “Note 8 – Equity Incentive Plans” for further details.

~~(6)~~

(4)

The per share data reflects the actual amount of distributions declared per share for the applicable period.

~~(7)~~

(5)

Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared distributions per share during the period, divided by the beginning net asset value per share.

~~(8)~~

(6)

Not annualized.

~~(9)~~

~~Total return excluding costs related to acquisition of Trinity Capital Holdings and the Legacy Funds would have been (8.6)%.~~

~~(10)~~(7)

Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends. ~~The~~For the six months ended June 30, 2021, the beginning market value per share is

76

based on the market price of $14.00 per share on January 29, 2021, the date of the Company’s listing on the Nasdaq Global Select Market, and not annualized.

~~(11)~~

(8)

Annualized.

~~(12)~~

(9)

Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.

~~(13)~~

(10)

Based on outstanding debt of ~~$245.0~~$595.0 million and ~~$230.0~~$245.0 million as of June 30, 2022 and 2021, ~~and 2020,~~ respectively.

66

Senior Securities

Information about the Company’s senior securities (including debt securities and other indebtedness) is shown in the following table as of June 30, ~~2021 and~~2022, December 31, ~~2020.~~2021, 2020, and 2019. No senior securities were outstanding as of December 31, 2019.

Class and Period

Total
Amount
Outstanding
Exclusive of
Treasury
Securities ⁽¹⁾

Asset
Coverage
per Unit ⁽²⁾

Involuntary
Liquidating
Preference
per Unit ⁽³⁾

Average
Market Value
per Unit ⁽⁴⁾
Credit Suisse Credit Facility

June 30, 2022⁽⁵⁾

$
-

-

-

-
December 31, 2021

10,000

1,958

-

-
December 31, 2020

135,000

1,770

-

-
December 31, 2019

-

-

-

-

KeyBank Credit Facility

June 30, 2022

$
220,000

1,770

-

-
December 31, 2021

81,000

1,958

-

-
December 31, 2020

-

-

-

-
December 31, 2019

-

-

-

-

2025 Notes

June 30, 2022

$
125,000

1,770

-

-
December 31, 2021

125,000

1,958

-

-
December 31, 2020

125,000

1,770

-

-
December 31, 2019

-

-

-

-

Convertible Notes

June 30, 2022

$
50,000

1,770

-

-
December 31, 2021

50,000

1,958

-

-
December 31, 2020

50,000

1,770

-

-
December 31, 2019

-

-

-

-

August 2026 Notes

June 30, 2022

$
125,000

1,770

-

-
December 31, 2021

125,000

1,958

-

-
December 31, 2020

-

-

-

-
December 31, 2019

-

-

-

-

December 2026 Notes

June 30, 2022

$
75,000

1,770

-

-
December 31, 2021

75,000

1,958

-

-
December 31, 2020

-

-

-

-
December 31, 2019

-

-

-

-

Total

June 30, 2022

$
595,000

1,770

-

-
December 31, 2021

466,000

1,958

-

-
December 31, 2020

310,000

1,770

-

-
December 31, 2019

-

-

-

-

Class and Period

Total
Amount
Outstanding
Exclusive of
Treasury
Securities ⁽¹⁾

Asset
Coverage
per Unit ⁽²⁾

Involuntary
Liquidating
Preference
per Unit ⁽³⁾

Average
Market Value
per Unit ⁽⁴⁾
Credit Facility

June 30, 2021

$
70,000

2,550

-

na
December 31, 2020

135,000

1,770

-

na
December 31, 2019

-

-

-

na

2025 Notes

June 30, 2021

$
125,000

2,550

-

na
December 31, 2020

125,000

1,770

-

na
December 31, 2019

-

-

-

na

Convertible Notes

June 30, 2021

$
50,000

2,550

-

na
December 31, 2020

50,000

1,770

-

na
December 31, 2019

-

-

-

na

Total

June 30, 2021

$
245,000

2,550

-

na
December 31, 2020

310,000

1,770

-

na
December 31, 2019

-

-

-

na
(1) Total amount of each class of senior securities outstanding at the end of the period presented.
77

(2)

Asset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.

(3)

The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The “–“—” in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.

(4)

Not applicable because the senior securities are not registered for public ~~trading.~~
trading on a securities exchange.

(5)

Credit Suisse Credit Facility matured on January 8, 2022, in accordance with its terms, and all outstanding indebtedness thereunder was repaid.

Note ~~11.~~12. Related Party Transactions
Through the Formation Transactions, the Company acquired 100% of the equity interests of Trinity Capital Holdings and the Legacy Funds were merged with and into the Company. Members of the Company’s management, including Steven L. Brown, Kyle Brown, Gerald Harder and Ron Kundich, owned 100% of the equity interests in Trinity Capital Holdings and controlling interests in the general partners/managers of the Legacy Funds.

67

As a result of the Formation Transactions, Messrs. S. Brown, K. Brown, Harder and Kundich collectively received (i) 533,332 shares of the Company’s common stock valued at approximately $8.0 million and approximately $2.0 million in cash in exchange for their equity interests in Trinity Capital Holdings, and (ii) 377,441 shares of the Company’s common stock valued at approximately $5.7 million for their limited partner and general partner interests in the Legacy Funds.

During the three and six months ended June 30, ~~2021~~2022 and the year ended December 31, ~~2020,~~2021, certain related parties received distributions from the Company relating to their shares held. Refer to “Note 7 – Stockholder’s Equity” for further details on the Company’s ~~Distribution Reinvestment Plan~~DRIP and the distributions declared. Additionally, ~~during~~in connection with the Company’s IPO, certain related parties purchased additional shares of the Company’s common stock. These acquisitions were made at the IPO price of $14.00 per share. During the three and six months ended June 30, 2022 and the year ended December 31, 2021, the Company’s directors and executive officers and certain employees received restricted stock awards under the 2019 Long Term Incentive Plan and the 2019 Restricted Stock Plan. Refer to “Note 8 – Equity Incentive Plans” for further details on the Company’s share-based compensation plans.

The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company’s directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

The Company and its executives and directors are covered by directors and officers insurance. In addition, each of our directors and officers have entered into an indemnification agreement with us pursuant to which our directors and officers are indemnified by us to the maximum extent permitted by Maryland law subject to the restrictions of the 1940 Act.

Note ~~12.~~13. Recent Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, “~~Reference rate reform~~“Reference Rate Reform (Topic 848) -: Facilitation of the ~~effects~~Effects of ~~reference rate reform~~Reference Rate Reform on ~~financial reporting~~”Financial Reporting” and in January 2021, the FASB issued ASU 2021-01, ~~“Reference rate reform~~“Reference Rate Reform (Topic 848).” The amendments in these updates provide optional expedients and exceptions for applying U.S. GAAP to certain contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform and became effective upon issuance for all entities. ASU 2020-04 and ASU 2021-01 are elective and are effective on March 12, 2020 through December 31, 2022. The Company does not ~~plan on adopting,~~intend to adopt this guidance, as it expects ~~that the~~such adoption ~~of the guidance will~~would not have a material impact on its consolidated financial statements.

In ~~August 2020,~~June 2022, the FASB issued ~~ASU 2020-06,~~ ~~Debt – Debt with Conversion~~Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” This change prohibits entities from taking into account contractual restrictions on the sale of equity securities when estimating fair value and ~~Other Options~~ ~~(“ASU 2020-06”) under which the accounting~~introduces required disclosures for convertible instruments will be simplified by removing major separation models required under current GAAP. Accordingly, more convertible instruments will be reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception will be removed and, as a result, more equity contracts will qualify for the scope exception. ASU 2020-06 will also simplify the diluted earnings-per-share calculation in certain areas. ASU 2020-06 will besuch transactions. The standard is effective for ~~years beginning after December 31, 2021, including interim periods within those fiscal years. Early adoption will be permitted for fiscal~~annual periods beginning

78

after December 15, ~~2020 (including interim periods within the same fiscal year).~~2023, and should be applied prospectively. Early adoption is permitted. The ~~Company early adopted~~adoption of ASU ~~2020-06 on January 1, 2021, with no~~2022-03 is not expected to have a material impact toon the ~~consolidated~~Company’s future financial ~~statements other than no longer separately accounting for the embedded conversion feature.~~statements.

Rule 2a-5 under the 1940 Act was recently adopted by the SEC and establishes ~~requirements~~a framework for determining fair value in good faith for purposes of the 1940 Act. The Company is evaluating the impact of ~~adopting~~ Rule 2a-5 and intends to comply with the new rule’s requirements on or before the compliance date in September 2022.

Note ~~13.~~14. Subsequent Events
The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. ~~Other than the item~~Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.
~~Departure~~On July 22, 2022, the Company issued $50.0 million in aggregate principal amount of ~~Certain Officers~~the 2025 Notes in an additional issuance of such 2025 Notes. On July 27, 2022, the underwriters exercised, in full, their option to purchase from the Company an additional $7.5 million in aggregate principal amount of the 2025 Notes solely to cover over-allotments in accordance with the Underwriting Agreement. The 2025 Notes issued pursuant to this offering are treated as a single series with the existing 2025 Notes under the 2025 Notes Indenture (the “Existing 2025 Notes”) and have the same terms as the Existing 2025 Notes (other than issue date and issue price). The 2025 Notes have the same CUSIP number and are fungible and rank equally. Following this additional issuance of the 2025 Notes, the outstanding aggregate principal amount of the 2025 Notes is $182.5 million.
In connection with the additional issuance of the 2025 Notes, the 2025 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINL” on July 29, 2022.

6879

On August 2, 2021, Scott Harvey, the Company’s Chief Legal Officer and Chief Compliance Officer, resigned from such positions and from his employment with the Company in connection with his retirement. The Board accepted Mr. Harvey’s resignation, and there was no disagreement between Mr. Harvey and the Company on any matter relating to the Company’s operations, policies or practices. Also on August 2, 2021, the Board appointed Sarah Stanton as the Chief Compliance Officer of the Company. Ms. Stanton also serves, and will continue to serve, as the General Counsel and Secretary of the Company.

69

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “the Company” refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.

Forward-Looking Statements

This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. “Risk Factors” of Part II of this quarterly report and Item 1A. “Risk Factors” of Part I of our Annual Report on Form 10-K, filed with the SEC on March ~~4, 2021,~~3, 2022, including the following factors, among others:

●

our limited operating history as a business development company (“BDC”);

●

our future operating results, including the impact of the SARS-CoV-2 (“COVID-19”) pandemic;

●

our dependence upon our management team and key investment professionals;

●

our ability to manage our business and future growth;

●

risks related to investments in growth stage companies, other venture capital-backed companies and generally U.S. companies;

●

the ability of our portfolio companies to achieve their objectives, including as a result of the COVID-19 pandemic;

●

the use of leverage;

●

risks related to the uncertainty of the value of our portfolio investments;

●

changes in political, economic or industry conditions, the interest rate and inflation rate environments or conditions affecting the financial and capital markets, including as a result of the COVID-19 pandemic;

●

uncertainty surrounding the financial and/or political stability of the United States, the United Kingdom, the European Union and China, including as a result of the COVID-19 ~~pandemic;~~pandemic, and the military conflict between Russia and Ukraine;

●

the dependence of our future success on the general economy and its impact on the industries in which we invest;

●

risks related to changes in interest rates and inflation rates, our expenses, and other general economic conditions and the effect on our net investment income;

●

the effect of changes in tax laws and regulations and interpretations thereof;

7080

●

the impact on our business of new or amended legislation or regulations, including the Coronavirus Aid, Relief and Economic Security Act, the stimulus package passed by Congress and signed into law in December 2020 and the American Rescue Plan Act of 2021 signed into law in March 2021;

●

risks related to market volatility, including general price and volume fluctuations in stock markets;

●

our ability to make distributions, including as a result of the COVID-19 pandemic; and

●

our ability to maintain our status as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”), and qualify annually for tax treatment as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the Securities and Exchange Commission. Any forward-looking statements in this report should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995).

Overview

We are a specialty lending company providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as BDC under the 1940 Act. We ~~also intend to elect~~have elected to be treated, and intend to continue to qualify annually, ~~thereafter,~~ as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments. We seek to achieve our investment objective by making investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.

We target investments in growth stage companies, which are typically private companies, including venture-backed companies and companies with institutional equity investors. We define “growth stage companies” as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100.0 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.

Our loans and equipment financings may have initial interest-only periods of up to 24 months and generally fully amortize over a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth stage companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have

7181

achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company’s projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.

Our History

Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.

On January 16, 2020, through a series of transactions (the “Formation Transactions”), we acquired Trinity Capital Investment, LLC, ~~( “TCI, LLC”),~~ Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P. ~~(“Fund III”)~~, Trinity Capital Fund IV, L.P. ~~(“Fund IV”)~~ and Trinity Sidecar Income Fund, L.P. ~~(“Sidecar Fund,” and collectively,~~(collectively, the “Legacy Funds”) and all of their respective assets (the “Legacy Assets”), including their respective investment portfolios (the “Legacy Portfolio”), as well as Trinity Capital Holdings, LLC (“Trinity Capital Holdings”), a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, ~~2020 (refer to "Item 8. Consolidated Financial Statements and Supplementary Data - Note 1. Organization and Basis of Presentation" for further discussion of these transactions).~~2020.

The Legacy Funds were merged with and into the Company, and we issued 9,183,185 shares of our common stock for an aggregate amount of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners, managers or managing members of the Legacy Funds (the “Legacy Investors”), to acquire the Legacy Funds and all of their respective assets, including the Legacy Portfolio. Our senior management team, led by Steven L. Brown, comprises the majority of the senior management team that managed the Legacy Funds and sourced the Legacy Portfolio.

As part of the Formation Transactions, we also acquired 100% of the equity interests of Trinity Capital Holdings for an aggregate purchase price of $10.0 million, which was comprised of 533,332 shares of our common stock, totaling approximately $8.0 million, and approximately $2.0 million in cash. In connection with the acquisition of such equity interests, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. As a result of the Formation Transactions, Trinity Capital Holdings became a wholly owned subsidiary of the Company.

On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Suisse Credit Facility.

Critical Accounting Policies

The Company’s financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”). The Company follows accounting and reporting guidance as determined by the Financial Accounting Standards Board (“FASB”), in FASB Accounting Standards Codification (“ASC”) 946, Financial Services — Investment Companies.

7282

The preparation of our financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Valuation of investments, income recognition, realized / unrealized gains or losses and U.S. federal income taxes are considered to be our critical accounting policies and estimates. –For additional information, please refer to “Note 2 - Summary of Significant Accounting Policies” in the notes to the consolidated financial statements included with this Quarterly Report on Form 10-Q.

~~Reclassification~~

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. Included in interest income for the three and six months ended June 30, 2020 is the acceleration of OID and EOT of approximately $1.0 million and $1.4 million, respectively, which was reclassified from net realized gain/(loss) on investments. Included in fee income for the three and six months ended June 30, 2020 is non-recurring fees of approximately $0.4 million and $1.8 million, respectively, of which $0.1 million and $1.0 million, respectively, were reclassified from net realized gain/(loss) on investment and $0.3 million and $0.8 million, respectively, were reclassified from interest income. These reclassifications had no effect on the previously reported net increase (decrease) in net assets.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments

73

in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

83

Given the nature of lending to venture capital-backed growth stage companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. ~~Debt~~ EOT fees related to debt investments to be paid at the termination of the financing arrangements are accreted into interest income over the contractual life of the debt based on the effective yield method. As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company had an EOT ~~payment~~payments receivable of approximately ~~$37.0~~$53.2 million and $37.9 million, respectively, which is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Portfolio Composition and Investment Activity

Portfolio Composition

Through the Formation Transactions, we acquired the Legacy Assets, including the Legacy Portfolio, from the Legacy Funds, as well as Trinity Capital Holdings. The Legacy Portfolio became our investment portfolio. As of June 30, 2022, our investment portfolio had an aggregate fair value of approximately $1,051.1 million and was comprised of approximately $769.7 million in secured loans, $224.9 million in equipment financings, and $56.5 million in equity and warrants, across 108 portfolio companies. As of December 31, 2021, our investment portfolio had an aggregate fair value of approximately ~~$597.7 million and was comprised of~~

74

approximately $397.5 million in secured loans, $120.9 million in equipment financings, and $79.3 million in equity and equity-related investments, including warrants, across 80 portfolio companies. As of December 31, 2020, our investment portfolio had an aggregate fair value of approximately $493.7$873.5 million and was comprised of approximately ~~$320.7~~$551.9 million in secured loans, ~~$122.5~~$184.1 million in equipment financings, and ~~$50.5~~$137.5 million in equity and ~~equity-related investments, including~~ warrants, across 8094 portfolio companies.

84

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in following table as of June 30, ~~2021~~2022 and December 31, ~~2020:~~2021:


	June 30, 2021		December 31, 2020		June 30, 2022		December 31, 2021

		Fair		Fair		Fair		Fair
Type	Cost	Value	Cost	Value	Cost	Value	Cost	Value
Secured Loans	69.8%	66.4%	65.1%	65.0%	72.9%	73.2%	69.8%	63.2%
Equipment Financings	20.9%	20.2%	24.7%	24.8%	21.7%	21.4%	23.0%	21.1%
Equity	6.9%	8.8%	6.6%	6.6%	3.5%	2.2%	5.3%	11.5%
Warrants	2.4%	4.6%	3.6%	3.6%	1.9%	3.2%	1.9%	4.2%
Total	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of June 30, ~~2021~~2022 and December 31, ~~2020.~~2021. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.


	June 30, 2021			December 31, 2020			June 30, 2022		December 31, 2021
			Fair			Fair		Fair		Fair
Geographic Region	Cost		Value	Cost		Value	Cost	Value	Cost	Value
United States		x			x
West	48.7%		52.7%	49.6%		48.8%	44.1%	45.1%	46.5%	50.7%
Northeast	26.7%	x	24.0%	26.4%	x	25.9%	21.9%	22.1%	26.4%	24.5%
Mountain							9.9%	9.7%	8.2%	8.1%
South							9.7%	9.9%	7.6%	7.0%
Midwest	8.3%		7.3%	9.5%		8.9%	5.9%	5.0%	3.7%	2.7%
Mountain	6.7%		6.6%	6.8%		6.9%
Southeast	0.2%		0.1%	2.2%		3.6%	0.6%	0.6%	0.1%	0.1%
South	5.2%		5.2%	0.1%		0.4%
International:
Canada	4.2%		4.1%	5.4%		5.5%	6.2%	5.8%	7.5%	6.9%
Western Europe							1.7%	1.8%	0.0%	0.0%
Total	100.0%		100.0%	100.0%		100.0%	100.0%	100.0%	100.0%	100.0%

7585

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of June 30, ~~2021~~2022 and December 31, ~~2020:~~2021:


	June 30, 2021		December 31, 2020		June 30, 2022		December 31, 2021
		Fair		Fair		Fair		Fair
Industry	Cost	Value	Cost	Value	Cost	Value	Cost	Value
Manufacturing	23.7%	28.0%	20.8%	20.2%	25.1%	25.4%	21.1%	25.4%
Professional, Scientific, and Technical Services	14.5%	15.0%	15.6%	16.0%	22.9%	24.3%	17.6%	18.5%
Information					7.6%	8.0%	12.7%	12.3%
Finance and Insurance					6.4%	6.7%	7.8%	7.5%
Management of Companies and Enterprises					6.5%	6.6%	2.8%	2.6%
Rental and Leasing Services					4.6%	4.8%	4.1%	3.8%
Real Estate					4.3%	3.8%	5.1%	4.7%
Health Care and Social Assistance					4.8%	3.4%	6.3%	5.1%
Administrative and Support and Waste Management and Remediation Services					3.3%	3.3%	3.7%	3.4%
Retail Trade	15.7%	13.1%	15.7%	15.4%	3.3%	3.2%	5.0%	4.5%
Finance and Insurance	7.1%	7.1%	7.0%	7.2%
Information	5.9%	5.7%	6.4%	6.2%
Rental and Leasing Services	5.4%	5.3%	5.8%	5.9%
Space Research and Technology	5.2%	5.0%	0.0%	0.0%	2.9%	3.0%	3.8%	3.5%
Educational Services					1.7%	1.6%	2.3%	2.2%
Utilities	4.2%	4.1%	5.4%	5.5%	1.5%	1.5%	2.6%	2.3%
Agriculture, Forestry, Fishing and Hunting	3.1%	3.5%	4.2%	4.2%	1.1%	1.2%	1.5%	1.5%
Real Estate	3.5%	3.4%	3.5%	3.5%
Health Care and Social Assistance	3.6%	2.8%	2.9%	2.3%
Educational Services	2.4%	2.4%	1.9%	2.0%
Construction					1.3%	0.9%	1.7%	1.0%
Wholesale Trade	2.0%	1.9%	4.8%	4.8%	0.6%	0.7%	1.2%	1.1%
Construction	1.9%	1.3%	2.0%	1.4%
Other Services (except Public Administration)					0.5%	0.5%	0.0%	0.0%
Accommodation and Food Services					0.4%	0.4%	0.0%	0.0%
Transportation and Warehousing					0.9%	0.4%	0.0%	0.0%
Arts, Entertainment, and Recreation					0.3%	0.3%	0.0%	0.0%
Pharmaceutical	1.3%	1.2%	3.5%	4.9%	0.0%	0.0%	0.7%	0.6%
Administrative and Support and Waste Management and Remediation Services	0.5%	0.2%	0.5%	0.5%
Total	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%

As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately ~~3.1~~3.4 years. Additional information regarding our portfolio is set forth in the schedule of investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

Concentrations of Credit Risk

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company’s ten largest portfolio companies represented approximately ~~42.4%~~31.3% and ~~42.5%~~36.1%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company had 914 and 14nine portfolio companies that represented 5% or more of the Company’s net assets, respectively.

Investment Activity

During the six months ended June 30, ~~2021,~~2022, we made an aggregate of approximately ~~$139.3~~$229.6 million of investments in 1321 new portfolio companies and approximately ~~$70.2~~$186.7 million of investments in 1526 existing portfolio companies, excluding fees. During the six months ended June 30, ~~2021,~~2022, we received an aggregate of ~~$146.9~~$203.4 million in proceeds from repayments and sales of our investments, including proceeds of approximately ~~$92.0~~$86.5 million from early repayments on our debt investments.

During the year ended December 31, ~~2020, in addition to $417.0~~2021, we invested approximately $395.3 million in ~~investments we acquired in connection with the Formation Transactions, we made an aggregate of approximately $144.3 million of investments in 18~~33 new portfolio companies and approximately ~~$95.7~~$163.0 million ~~of investments~~ in 1824 existing portfolio ~~companies.~~companies, excluding deferred fees. During the

86

year ended December 31, ~~2020,~~2021, we received an aggregate of ~~$160.9~~approximately $290.2 million in proceeds from repayments ~~and sales~~ of our debt investments, including proceeds of approximately ~~$108.8~~$190.1 million from early debt repayments.

76

The following table provides a summary of the changes in the investment portfolio for the six months ended June 30, ~~2021~~2022 and the year ended December 31, ~~2020~~2021 (in thousands):

Six Months Ended

Year Ended

June 30, 2022

December 31, 2021
Beginning Portfolio, at fair value

$
873,470

$
493,651
Purchases, net of deferred fees

413,615

554,832
Non-cash conversion

—

916
Principal payments received on investments

(54,364)

(74,278)
Proceeds from early debt repayments

(86,534)

(190,107)
Sale of investments

(62,518)

(25,787)
Accretion of OID and EOT payments

15,516

21,238
Net realized gain/(loss)

43,027

12,708
Third party participation ⁽¹⁾

—

(283)
Change in unrealized appreciation/(depreciation)

(91,138)

80,580
Ending Portfolio, at fair value

$
1,051,074

$
873,470

Six Months

Ended

Year Ended

June 30, 2021

December 31, 2020
Beginning Portfolio

$
493,651

$
—
Formation Transactions acquisitions

—

417,023
Purchases, net of deferred fees

208,232

238,564
Non-cash conversion

—

1,263
Proceeds from Paydowns and Sales

(54,921)

(52,111)
Proceeds from early debt repayments

(91,958)

(108,790)
Accretion of OID and EOT payments

10,279

11,788
Net realized gain/(loss)

4,590

(9,403)
Third party participation ⁽¹⁾

(283)

283
Change in unrealized appreciation/(depreciation)

28,106

(4,966)
Ending Portfolio

$
597,696

$
493,651
(1) Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).
The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth stage companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.
Portfolio Asset Quality
Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our Investment Committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its Audit Committee.
87

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

77

The following table shows the distribution of our loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 (dollars in thousands):


		June 30, 2021			December 31, 2020				June 30, 2022			December 31, 2021
Investment Risk Rating		Investments at		Percentage of	Investments at		Percentage of		Investments at		Percentage of	Investments at		Percentage of
Scale Range	Designation	Fair Value		Total Portfolio	Fair Value		Total Portfolio	Designation	Fair Value		Total Portfolio	Fair Value		Total Portfolio
4.0 - 5.0	Very Strong Performance	$	83,915	16.2%	$	92,519	20.9%	Very Strong Performance	$	62,719	6.3%	$	84,785	11.5%
3.0 - 3.9	Strong Performance		206,852	39.9%		212,969	48.0%	Strong Performance		382,593	38.5%		236,466	32.1%
2.0 - 2.9	Performing		197,503	38.1%		116,895	26.4%	Performing		529,285	53.2%		396,846	53.9%
1.6 - 1.9	Watch		29,820	5.7%		19,230	4.3%	Watch		18,706	1.9%		13,427	1.9%
1.0 - 1.5	Default/Workout		343	0.1%		1,606	0.4%	Default/Workout		1,290	0.1%		4,444	0.6%
Total		$	518,433	100.0%	$	443,219	100.0%		$	994,593	100.0%	$	735,968	100.0%

At June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, our ~~loan and equipment financing~~debt investments had a weighted average risk rating score of ~~3.1.~~3.0 for each period.

Debt Investments on Non-Accrual Status

When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2022, loans to three portfolio companies and an equipment financing to one portfolio company were on non-accrual status with a total cost of approximately $20.5 million, and a total fair value of approximately $5.9 million, or 0.6%, of the fair value of the Company’s debt investment portfolio. As of December 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $1.2 million, and a total fair market value of approximately $0.9 million, or 0.2%, of the fair value of the Company’s investment portfolio. As of December 31, 2020, loans to three portfolio companies were on non-accrual status with a total cost of approximately $3.4$12.9 million, and a total fair value of approximately ~~$2.2~~$5.1 million, or ~~0.5%~~0.7%, of the total fair value of the Company’s debt investment portfolio.

7888

Results of Operations

The following discussion and analysis of our results of operations encompasses our consolidated results for the three and six months ended June 30, ~~2021~~2022 and 2020. We were formed on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for immaterial matters relating to our formation and organization as a BDC.2021.

Investment Income

The following table sets forth the components of investment income (in thousands):


	Three Months Ended				Six Months Ended				Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020		June 30, 2022		June 30, 2021		June 30, 2022		June 30, 2021
Stated interest income	$	12,429	$	9,491	$	24,179	$	18,200	$	25,097	$	12,429	$	45,355	$	24,179
Amortization of original issue discount		3,709		3,015		7,156		4,691		5,998		3,709		10,987		7,156
Acceleration of amortization of original issue discount		1,976		934		3,123		1,363		1,416		1,976		4,575		3,123
Prepayment penalty and related fees		1,239		100		1,946		1,057		125		1,239		2,680		1,946
Other fee income		123		307		391		784		822		123		1,706		391
Total investment income	$	19,476	$	13,847	$	36,795	$	26,095	$	33,458	$	19,476	$	65,303	$	36,795

We generate revenues primarily in the form of investment income from the investments we hold, generally in the form of interest income from our debt securities. Investment income represents interest income recognized as earned in accordance with the contractual terms of the loan agreement. Interest income from original issue discount (“OID”) represents the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, including loans and equipment financings and is accreted into interest income over the term of the loan as a yield enhancement. Interest income from payment-in-kind (“PIK”) represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

Loan and commitment fees in excess of related expenses are amortized into interest income over the contractual life of the loan. The Company also recognizes certain fees as one-time fee income, including, but not limited to, prepayment penalties, fees related to select covenant default, late-payment fees, structuring fees and exit fees related to a change in ownership of the portfolio company.

For the three months ended June 30, 2022, total investment income was approximately $33.5 million, which represents an approximate effective yield of 13.8% on the average investments during such period. For the three months ended June 30, 2021, total investment income was approximately $19.5 million, which represents an approximate effective yield of 15.9% on the ~~average investments during such period. For the three months ended June 30, 2020, total investment income was approximately $13.8 million, which represents an approximate yield of 14.6% on the~~ investments during the period. The increase in investment income for the ~~six~~three months ended June 30, ~~2021~~2022 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which fluctuates based on investment activity and early repayment activity.

For the six months ended June 30, 2022, total investment income was approximately $65.3 million, which represents an approximate effective yield of 14.9% on the average investments during such period. For the six months ended June 30, 2021, total investment income was approximately $36.8 million, which represents an approximate effective yield of 15.8% on the ~~average investments during such period. For the six months ended June 30, 2020, total investment income was approximately $26.1 million, which represents an approximate effective yield of 14.8% on the~~ investments during the period. The increase in investment income for the ~~three~~six months ended June 30, ~~2021~~2022 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which ~~can fluctuate~~fluctuates based on investment activity and early repayment activity.

Operating Expenses and Excise Taxes

Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees and general and administrative expenses. Our operating expenses totaled approximately ~~$9.4~~$17.1 million and ~~$7.1~~

79

$9.4 million for the three months ended June 30, ~~2021~~2022 and ~~2020,~~2021, respectively, and ~~$19.5~~$32.6 million and ~~$13.6~~$19.4 million for the six months then ended June 30, 2022 and 2021. For the three months ended June 30, 2022 and 2021, we expensed excise

89

taxes of $0.7 million and did not expense any excise tax for the three months ended June 30, 2021. For the six months ended June 30, 2022 and 2021, we expensed excise taxes of $1.3 million and ~~2020,~~$0.1 million, respectively. The increase in excise tax was primarily due to increase in estimated undistributed taxable income in 2022.

Interest Expense and Other Debt Financing Costs

Interest expense and other debt financing costs on our borrowings totaled approximately ~~$4.4~~$7.8 million and ~~$4.3~~$4.4 million for the three months ended June 30, ~~2021~~2022 and ~~2020,~~2021, respectively, and totaled approximately ~~$9.0~~$14.6 million and ~~$8.5~~$9.0 million for the six months ~~then ended.~~ended June 30, 2022 and 2021, respectively. These costs are primarily comprised of interest and fees related to the ~~Credit Facility,~~credit facilities, the 2025 Notes, the August 2026 Notes, the December 2026 Notes and the Convertible Notes. Our weighted average effective interest rate, comprised of interest and amortization of fees and discount was approximately ~~7.6%~~5.6% and ~~6.6%~~7.6% for the three months ended June 30, ~~2021~~2022 and ~~2020,~~2021, respectively, and ~~7.4%~~5.8% and ~~6.6%~~7.4% for the six months then ended. The increase in interest expense for both the three and six months ended June 30, ~~2021~~2022 was primarily due to ~~the issuance of the Convertible Notes in December 2020 and the six month increase partially offset by paydowns in the~~increased borrowings under our KeyBank Credit Facility.

Employee Compensation and Benefits

Employee compensation and benefits totaled approximately ~~$3.4~~$6.9 million and ~~$1.7~~$3.4 million for the three months ended June 30, 2022 and 2021, respectively, and ~~2020, respectively.~~approximately $13.3 million and $7.4 million for the six months then ended. The increase in employee compensation related expenses during the three months ended June 30, 2021 relates primarily to the accrual of bonuses expected to be paid at the discretion of management or upon approval of the Board, as applicable, as well as an increased headcount. Employee compensation and benefits totaled approximately $7.4 million and $3.1 million for the six months ended June 30, 2021 and 2020, respectively. The increase in employee compensation related expenses during the six months ended June 30, 2021 also relates primarily to the accrual of bonuses expected to be paid at the discretion of management or upon approval of the Board, as applicable, as well as an increased headcount. As of June 30, ~~2021~~2022 and ~~2020,~~2021, the Company had 3952 and 2939 employees, respectively.

The Board and the Company’s stockholders have adopted and approved the (i) 2019 Trinity Capital Inc., Long-Term Incentive ~~Plan;~~Plan (the “2019 Long Term Incentive Plan”); and (ii) Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”), with each plan becoming effective on June 17, 2021. During the six months ended June 30, 2022, the Company granted 598,988 shares of restricted stock, net of 96,727 vested shares and 3,218 forfeited shares under the plan of the 3.6 million authorized under the 2019 Long Term Incentive Plan. During the six months ended June 30, 2022, the Company granted 19,320 shares of restricted stock of the 60,000 authorized under the 2019 Restricted Stock Plan. See “Note 78 – ~~Stockholder’s Equity”~~Equity Incentive Plans” in the Notes to Consolidated Financial Statements. During the three and six months ended June 30, 2021, no shares were granted under either plan.
Professional Fees Expenses
Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees were approximately ~~$0.6~~$0.9 million and ~~$0.7~~$0.6 million for the three months ended June 30,��2022 and 2021, ~~and 2020,~~ respectively. Professional fees expenses were approximately $1.7 million and $1.2 million for the six months ended June 30, 2022 and 2021, ~~which is approximately equal to the amount~~respectively. The increase in professional fees expenses for the three and six months ended June 30, ~~2020.~~2022, resulted primarily from outside consulting expenses.
General and Administrative Expenses
General and administrative expenses include insurance premiums, rent, taxes and various other ~~various~~ expenses related to our ongoing operations. Our general and administrative expenses totaled approximately ~~$1.0~~$1.6 million and ~~$0.4~~$1.0 million for the three months ended June 30, ~~2021~~2022 and ~~2020,~~2021, respectively. General and administrative expenses totaled approximately ~~$1.8~~$3.0 million and ~~$0.8~~$1.8 million for the six months ended June 30, ~~2021~~2022 and ~~2020,~~2021, respectively. The increase in general and administrative expenses for the three and six months ended June 30, ~~2021~~2022 is primarily due to ~~a higher D&O insurance premiums.~~increases in directors and officers liability insurance.
Net Investment Income
As a result of approximately $33.5 million in total investment income as compared to approximately $17.8 million in total expenses including excise tax expense, net investment income for the three months ended June 30, 2022 was approximately $15.7 million. As a result of approximately $19.5 million in total investment income as compared to

90

~~Table~~As a result of ~~Contents~~

approximately $9.4 million in total expenses net investment income for the three months ended June, 2021 was approximately $10.1 million. As a result of approximately $13.9 million in total investment income as compared to approximately $7.1 million in total expenses,including excise tax expense, net investment income for the three months ended June 30, ~~2020~~2021 was approximately ~~$6.8~~$10.1 million.

80

approximately $65.3 million in total investment income as compared to approximately $34.0 million in total expenses including excise tax expense, net investment income for the six months ended June 30, 2022 was approximately $31.3 million. As a result of approximately $36.8 million in total investment income as compared to approximately $19.5 million in total expenses including excise tax expense, net investment income for the six months ended June 30, 2021 was approximately $17.3 million. As a result of approximately $26.1 million in total investment income as compared to approximately $13.6 million in total expenses, net investment income for the six months ended June 30, 2020 was approximately $12.5 million.

Net Realized Gains and Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period.

During the six months ended June 30, 2022, our gross realized gains primarily consisted of the sale of our equity positions in two portfolio companies, and our gross realized losses primarily consisted of the sale of our debt positions in two portfolio companies.

The net realized gains (losses) from the sales, repayments, or exits of investments were comprised of the following (in thousands):


	Three Months Ended				Six Months Ended				Three Months Ended		Three Months Ended			Six Months Ended		Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020		June 30, 2022		June 30, 2021		June 30, 2022		June 30, 2021
Net realized gain (loss) on investments:
Gross realized gains	$	2,502	$	41	$	5,469	$	835	$	511	$	2,502	$	53,807	$	5,469
Gross realized losses		(507)		(2,043)		(879)		(3,719)		(10,128)		(507)		(10,780)		(879)
Total net realized gains/(losses) on investments	$	1,995	$	(2,002)	$	4,590	$	(2,884)	$	(9,617)	$	1,995	$	43,027	$	4,590

Net Change in Unrealized Appreciation / (Depreciation) from Investments

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

91

Net unrealized appreciation and depreciation on investments for the three and six months ended June 30, ~~2021~~2022 and ~~2020~~2021 is comprised of the following (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended


June 30, 2022

June 30, 2021

June 30, 2022

June 30, 2021
Gross unrealized appreciation

$
9,945

$
28,342

$
17,826

$
57,110
Gross unrealized depreciation

(33,636)

(12,543)

(45,856)

(21,969)
Third party participation ⁽¹⁾

—

—

—

283
Net unrealized appreciation/depreciation reclassified related to net realized gains or losses

9,871

(3,169)

(63,108)

(7,318)
Total net unrealized gains (losses) on investments

$
(13,820)

$
12,630

$
(91,138)

$
28,106

Three Months Ended

Six Months Ended


June 30, 2021

June 30, 2020

June 30, 2021

June 30, 2020
Gross unrealized appreciation

$
28,342

$
11,820

$
57,110

$
3,996
Gross unrealized depreciation

(12,543)

(9,657)

(21,969)

(26,112)
Third party participation ⁽¹⁾

—

(40)

283

(53)
Net unrealized appreciation/depreciation reclassified related to net realized gains or losses ⁽²⁾

(3,169)

—

(7,318)

—
Total net unrealized gains (losses) on investments

$
12,630

$
2,123

$
28,106

$
(22,169)
(1) Certain third parties had rights to 17,485 shares of Ology Bioservices common stockat a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).
~~(2)~~ Investments were recorded at their fair values in the Formation Transactions on January 16, 2020, therefore no reclassification of unrealized appreciation (depreciation) was recorded during the three or six months ended June 30, 2020.
81

~~The significant changes in net unrealized appreciation (depreciation) from investments during~~During the three months ended June 30, ~~2021 consisted of the following (in thousands):~~

Net Unrealized

Appreciation
Portfolio Company

(Depreciation)
Atieva, Inc.

$
11,418
Bowery Farming, Inc.

2,773
Matterport, Inc.

2,692
The Fynder Group, Inc.

954
UnTuckIt, Inc.

924
Convercent, Inc.

(713)
Madison Reed, Inc.

(953)
Vertical Communications, Inc.

(1,302)
Ology Bioservices, Inc.

(1,511)
Birchbox, Inc.

(2,654)
Other, net

1,002
Total

$
12,630

~~The significant changes in~~2022, we recorded net unrealized ~~appreciation (depreciation)~~depreciation of $13.8 million, which was from ~~investments during the three months ended June 30, 2020 consisted of the following (in thousands):~~

Net Unrealized

Appreciation
Portfolio Company

(Depreciation)
Altierre Corporation

$
2,110
Vertical Communications, Inc.

956
Nanotherapeutics, Inc.

830
Birchbox, Inc.

857
Petal Card, Inc.

544
Project Frog, Inc.

(602)
Atieva, Inc.

(2,107)
Vidsys, Inc.

(2,280)
Other, net

1,815
Total

$
2,123

~~The significant changes in~~ net unrealized ~~appreciation (depreciation)~~depreciation of $6.1 million from our warrant investments, ~~during~~$5.3 million from our equity investments and $2.4 million from our debt investments. During the six months ended June 30, ~~2021 consisted of the following (in thousands):~~

Net Unrealized

Appreciation
Portfolio Company

(Depreciation)
Atieva, Inc.

$
33,611
Matterport, Inc

6,096
Bowery Farming, Inc.

2,976
UnTuckIt, Inc.

1,144
The Fynder Group, Inc.

897
Instart Logic, Inc.

(978)
Vertical Communications, Inc.

(1,035)
Incontext Solutions, Inc.

(1,044)
Ology Bioservices, Inc.

(7,259)
Birchbox, Inc.

(10,624)
Other, net

4,322
Total

$
28,106

82

~~The significant changes in~~2022, we recorded net unrealized ~~appreciation (depreciation)~~depreciation $91.1 million, which was primarily from ~~investments during~~gross unrealized depreciation reclassified related to net realized gains of approximately $70.5 million related to the ~~six months ended June 30, 2020 consisted~~sale of ~~the following (in thousands):~~two equity investments.

Net Unrealized

Appreciation
Portfolio Company

(Depreciation)
Nanotherapeutics, Inc.

$
1,101
Hytrust, Inc.

(538)
STS Media, Inc.

(637)
BaubleBar, Inc.

(1,011)
Edeniq, Inc.

(1,013)
UnTuckIt, Inc.

(1,562)
Project Frog, Inc.

(2,109)
WorkWell Prevention & Care

(2,116)
Vertical Communications, Inc.

(2,912)
Atieva, Inc.

(2,955)
Vidsys, Inc.

(3,782)
Other, net

(4,635)
Total

$
(22,169)

During the three and six months ended June 30, 2021, we recorded net unrealized appreciation of $12.6 million and $28.1 million, respectively, which was primarily from net unrealized appreciation of approximately $8.2 million and $20.2 million, respectively, from our equity investments and $6.3 million and $10.5 million, respectively, from our warrant investments, offset by the reversal of unrealized appreciation upon pay-off of our portfolio companies during the period.

During the three and six months ended June 30, 2020, we recorded net unrealized appreciation of $2.1 million and net unrealized depreciation of $22.2 million, respectively. The unrealized appreciation for the three months ended June 30, 2021, was primarily from unrealized appreciation of $1.9 million from our debt investments, and $1.6 million from equity investments offset by unrealized depreciation of $1.4 million from our warrant investments. The $22.2 million of unrealized depreciation was a result of $11.4 million of unrealized depreciation from our debt investments, $5.3 million of unrealized depreciation from our warrant investments, and $5.5 million of unrealized depreciation from our equity investments.

Net Increase (Decrease) in Net Assets Resulting from Operations

Net decrease in net assets resulting from operations during the three months ended June 30, 2022, was approximately $7.7 million. Net increase in net assets resulting from operations during the three months ended June 30, 2021, was approximately $24.7 million. Net ~~increase~~decrease in net assets resulting from operations ~~before formation costs~~ during the ~~three~~six months ended June 30, ~~2020,~~2022, was approximately ~~$6.9~~$16.8 million. Net increase in net assets resulting from operations during the six months ended June 30, 2021, was approximately $50.0 ~~million. Net decrease in net assets resulting from operations before formation costs during the six months ended June 30, 2020, was approximately $12.6~~ million.

Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share

For the three months ended June 30, 2021, and 2020, basic and fully diluted net increase in net assets per common share were $0.93 and $0.38, respectively. The increase in 2021 is result of overall increased net operating results. For the six months ended June 30, 2021, basic and fully diluted net increase in net assets per common share were $2.00 . For the six months ended June 30, 2020,2022 basic and diluted net decrease in net assets per common share were ~~$1.57. Costs related to~~$0.25. For the acquisition of Trinity Capital Holdings was approximately $13.5 million, and the cost related to the acquisition of the Legacy Funds was approximately $2.1 million. The total cost of $15.6 million, when added to thethree months ended June 30, 2021, basic net ~~decrease~~increase in net assets ~~resulting from operations before formation costs, resulted in a net~~per common share was $0.93. The decrease in 2022 is result of gross unrealized depreciation reclassified related to net ~~assets resulting from operations during~~realized gains. For the six months ended June 30, ~~2020, of approximately $(28.2) million.~~2022, basic and fully diluted net decrease in net assets per common share were $0.58. For the six months ended June 30, 2021, basic and diluted net decrease in net assets per common share were $2.00.

8392

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our initial public offering, the Private Offerings, the Convertible Notes offering, the August 2026 Notes offering and the ~~Convertible~~December 2026 Notes offering, borrowings under the KeyBank Credit Facility and cash flows from our operations, including investment sales and repayments, as well as income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the KeyBank Credit Facility or any future credit facility, and proceeds from the turnover of our portfolio to finance our investment objectives and activities.

We may, from time to time, enter into additional credit facilities, increase the size of our existing Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

For the six months ended June 30, 2022, we experienced a net decrease in cash and cash equivalents in the amount of $33.5 million, which is the net result of $195.7 million of cash used in operating activities partially offset by a $0.02 million of cash provided by investing activities and $162.2 million of cash provided by financing activities. During the six months ended June 30, 2021, we experienced a net decrease in cash and cash equivalents in the amount of $26.6 million, which is the net result of $54.9 million of cash used in operating activities and $0.8 million of cash used in investing activities partially offset by $29.1 million of cash provided by financing activities. During the six months ended June 30, 2020, we experienced a net increase in cash and cash equivalents in the amount of $38.4 million, which is the net result of $142.3 million of cash provided by financing activities partially offset by $91.8 million of cash used in investing activities and $12.1 million of cash from operating activities.

As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, we had cash, cash equivalents and restricted cash of ~~$34.5~~$13.2 million and ~~$61.1~~$46.7 million, respectively, of which ~~$34.1~~$12.5 and ~~$60.3~~$43.4 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, ~~2021 and~~2022, we did not have any restricted cash. As of December 31, ~~2020,~~2021, restricted cash consisted of approximately ~~$15.3~~$15.1 million ~~and $15.7 million, respectively,~~ related to the Credit Suisse Credit Facility ~~covenants (See “Note 5 – Borrowings”), and an additional amount of approximately $0.7 million at December 31, 2020 was held in escrow related to~~covenants. In conjunction with the ~~payout of a severance related liability assumed as part~~maturity of the ~~Formation Transactions with respect to a former member of certain general partners of certain Legacy Funds.~~ Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

As of June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, we had approximately ~~$88.6~~$80.0 million and ~~$42.0~~$38.1 million, respectively, of available borrowings under the KeyBank Credit Facility, subject to its terms and regulatory requirements. Cash and cash equivalents, ~~and restricted cash,~~ taken together with available borrowings under the KeyBank Credit Facility, as of June 30, ~~2021,~~2022, are expected to be sufficient for our investing activities and to conduct our operations in the near term.

On January 16, 2020, in connection with the Formation Transactions, we became a party to, and assumed, the Credit Facility through our wholly owned subsidiary, Trinity Funding 1, LLC. The Credit Facility matures on January 8, 2022, unless extended, and we have the ability to borrow up to an aggregate of $300.0 million. In addition, borrowings under the Credit Facility are subject to floating interest rates based on LIBOR, generally bearing interest at a rate of the three-month LIBOR plus 3.25%. We may utilize the leverage available under the Credit Facility to finance future investments. We used a portion of the proceeds from the Private Offerings to repay a portion of the aggregate amount outstanding under the Credit Facility in amount of approximately $60 million. As of June 30, 2021 and December 31, 2020, approximately $70.0 million and $135.0 million, respectively, was outstanding under the Credit Facility. During the three months ended June 30, 2021 we borrowed $25.0 million under the Credit Facility and made no repayments. During the six months ended June 30, 2021, the Company borrowed an additional $25.0 million and made repayments of $90.0 million to Credit Suisse. During the three and six months ended June 30, 2020, we made repayments of approximately $25.0 million and $85.0 million, respectively, to Credit Suisse with no additional borrowings.

In January 2020, we completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act, pursuant to which we issued and sold 8,333,333 shares of our common stock for aggregate gross proceeds of approximately $125.0 million. A portion of the proceeds of the Private

84

~~Common Stock Offering were used to complete the Formation Transactions and repay a portion of the outstanding borrowings under the Credit Facility.~~

In January 2020, concurrent with the completion of the Private Common Stock Offering, we completed the 144A Note Offering in reliance upon the available exemptions from the registration requirements of the Securities Act, pursuant to which we issued and sold $125.0 million in aggregate principal amount of the unsecured 2025 Notes that mature on January 16, 2025, unless repurchased or redeemed in accordance with their terms prior to such date and bear interest at a fixed rate of 7.00% per year payable quarterly on March 15, June 15, September 15 and December 15 of each year. A portion of the proceeds of the 144A Note Offering were used to complete the Formation Transactions and repay a portion of the outstanding borrowings under the Credit Facility. Aggregate estimated offering expenses in connection with the transaction, including the fees and commissions, were approximately $4.8 million. As of June 30, 2021 and December 31, 2020, we had $125 million in aggregate principal amount of 2025 Notes outstanding.

In December 2020, we issued $50.0 million in aggregate principal amount of the Convertible Notes. The sale generated net proceeds of $47.0 million, including $1.7 million of debt issuance costs and $1.3 million of original issue discount. The Convertible Notes bear interest at a rate of 6.00% per year, payable semiannually in arrears on May 1 and November 1, of each year. The Convertible Notes mature on December 11, 2025, unless earlier converted by noteholders or purchased by the Company at the noteholders option upon the occurrence of a fundamental change, as defined in the indenture governing the Convertible Notes. As of June 30, 2021 and December 31, 2020, we had $50.0 million in aggregate principal amount of Convertible Notes outstanding.

On January 29, 2021, our common stock began trading on the Nasdaq Global Select Market under the symbol “TRIN.” On February 2, 2021, we completed our initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

Refer to “Item 2.1. Consolidated Financial Statements ~~and Supplementary Data~~ – Note 5 – Borrowings” included in the notes to our consolidated financial statements appearing elsewhere in this report for a discussion of our borrowings.

Reduced Asset Coverage Requirements

In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, ~~effective September 28, 2019, the asset coverage ratio under the 1940 Act applicable to us decreased from 200% to 150%, permitting us~~we are permitted to potentially borrow $2 for investment purposes of every $1 of investor equity. As of June 30, ~~2021,~~2022, our asset coverage ratio was approximately ~~255.0% and our asset coverage ratio per unit was approximately $2,550. As of December 31, 2020, our asset coverage ratio was approximately 177.0%~~177.1% and our asset coverage ratio per unit was approximately $1,770. ~~We target a leverage range~~As of ~~between 1.15x~~December 31, 2021, our asset coverage ratio was approximately 195.8% and ~~1.35x.~~our asset coverage ratio per unit was approximately $1,958.

93

Commitments and Off-Balance Sheet Arrangements

Other than contractual commitments with respect to our portfolio companies and other legal contingencies incurred in the normal course of our business, we do not have any off-balance sheet financings or liabilities as of June 30, ~~2021~~2022 or December 31, ~~2020.~~2021.

The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of June 30, ~~2021~~2022 and December 31, ~~2020~~2021 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made

85

commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. As of June 30, 2022 and December 31, 2021, the Company ~~had~~did not have any outstanding unfunded commitments of approximately $4.0 million to two portfolio companies, Dandelion, Inc. and Greenlight Biosciences, Inc. As of December 31, 2020, the Company had outstanding unfunded commitments of approximately $0.1 million to one portfolio company, Dandelion, Inc.commitments. The Company will fund ~~its~~ future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the KeyBank Credit Facility).

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Contractual Obligations

A summary of our contractual payment obligations as of June 30, ~~2021,~~2022, is as follows:

Payments Due by Period



Less than 1

year

1 - 3 years

4 - 5 years

After 5 years

Total
KeyBank Credit Facility

$
—

—

220,000

—

220,000
2025 Notes

—

—

125,000

—

125,000
Convertible Notes

—

—

50,000

—

50,000
August 2026 Notes

—

—

125,000

—

125,000
December 2026 Notes

—

—

75,000

—

75,000
Operating Leases ⁽¹⁾

208

765

782

821

2,576
Total Contractual Obligations

$
208

$
765

$
595,782

$
821

$
597,576


Payments Due by Period



Less than 1

year

1 - 3 years

4 - 5 years

After 5 years

Total
Credit Facility

$
—

$
70,000

$
—

$
—

$
70,000
7.00% Notes

—

—

125,000

—

125,000
Convertible Notes

—

—

50,000

—

50,000
Operating Leases ⁽¹⁾

112

845

751

1,619

3,327
Total Contractual Obligations

$
112

$
70,845

$
175,751

$
1,619

$
248,327
(1) Relates to the lease for our headquarters in downtown Phoenix, Arizona which commenced on June 4, 2021. Also includes the lease for our Chandler office, which expires on July 31, 2022 and is subject to a five-year extension option that will not be exercised. Also includes the lease for our new headquarters in downtown Phoenix, Arizona which commenced on June 4, 2021. We are in the process of securing a subtenant to sublease the Chandler office for the remainder of the lease term.
Distributions
We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.
~~During~~94

The following table summarizes distributions declared and/or paid by the ~~six months ended June 30,~~Company since inception:

Declaration Date

Type

Record Date

Payment Date

Per Share Amount
May 7, 2020

Quarterly

May 29, 2020

June 5, 2020

$
0.22
August 10, 2020

Quarterly

August 21, 2020

September 4, 2020

0.27
November 9, 2020

Quarterly

November 20, 2020

December 4, 2020

0.27
December 22, 2020

Quarterly

December 30, 2020

January 15, 2021

0.27
March 23, 2021

Quarterly

March 31, 2021

April 16, 2021

0.28
June 15, 2021

Quarterly

June 30, 2021

July 15, 2021

0.29
September 13, 2021

Quarterly

September 30, 2021

October 15, 2021

0.33
December 16, 2021

Quarterly

December 31, 2021

January 14, 2022

0.36
March 15, 2022

Quarterly

March 31, 2022

April 15, 2022

0.40
March 15, 2022

Supplemental

March 31, 2022

April 15, 2022

0.15
June 15, 2022

Quarterly

June 30, 2022

July 15, 2022

0.42
June 15, 2022

Supplemental

June 30, 2022

July 15, 2022

0.15

Total

$
3.41

Price Range of Common Stock
Our common stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on January 29, 2021 under the symbol “TRIN” in connection with our initial public offering, which closed on February 2, 2021 (“IPO”). Prior to our IPO, the shares of our common stock were offered and sold in transactions exempt from registration under the Securities Act. As such, there was no public market for shares of our common stock during our fiscal quarters and years preceding December 31, 2020. Since our IPO, our common stock has traded at prices both above and below our net asset value per share. It is not possible to predict whether our common stock will trade at a price per share at, above or below net asset value per share.
The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on Nasdaq, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we ~~declared a distribution~~began trading on ~~March 23, 2021~~Nasdaq. On August 3, 2022, the last reported closing sales price of ~~$0.28~~our common stock on Nasdaq was $14.94 per share, which ~~was paid on April 16, 2021~~represented a premium of approximately 2.2% to ~~stockholders of record as of March 31, 2021 and declared a distribution on June 15, 2021 of $0.29~~our net asset value per share ~~which was paid on July 15, 2021 to stockholders~~ of ~~record~~$14.62 as of June 30, ~~2021. During the six months ended June 30, 2020,~~2022. As of August 3, 2022, we ~~declared a distribution on May 14, 2020 of $0.22 per share that was paid on June 5, 2020 to shareholders~~had approximately 90 stockholders of record, aswhich does not include stockholders for whom shares are held in nominee or “street” name.

Price Range

Class and Period

Net Asset Value⁽¹⁾

High

Low

High Sales Price Premium (Discount) to Net Asset Value⁽²⁾

Low Sales Price Premium (Discount) to Net Asset Value⁽²⁾

Cash Dividend Per Share⁽³⁾

Year Ending December 31, 2022

Third Quarter (through August 3, 2022)

*

$
15.02

$
14.01

*

*

*

Second Quarter

$
14.62

$
19.44

$
14.27

33.0
%

(2.4)
%

$
0.57
⁽⁵⁾
First Quarter

$
15.15

$
20.11

$
17.00

32.7
%

12.2
%

$
0.55
⁽⁵⁾
Year Ending December 31, 2021

Fourth Quarter

$
16.40

$
17.65

$
15.79

7.6
%

(3.7)
%

$
0.36

Third Quarter

$
14.70

$
16.73

$
14.14

13.8
%

(3.8)
%

$
0.33

Second Quarter

$
14.33

$
15.00

$
14.10

4.7
%

(1.6)
%

$
0.29

First Quarter⁽⁴⁾

$
13.69

$
15.65

$
13.75

14.3
%

0.4
%

$
0.28

95

Table of ~~May 29, 2020.~~Contents

(1)

Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of the relevant quarter.

(2)

Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the applicable quarter).

(3)

Represents the dividend or distribution declared in the relevant quarter.

(4)

Shares of our common stock began trading on Nasdaq on January 29, 2021, under the trading symbol “TRIN”.

(5)

Consists of a quarterly dividend and a supplemental dividend.

* Not determined at time of filing.

Related Party Transactions

~~As discussed herein, the Legacy Funds were merged with and into~~Certain members of management as well as employees of the Company and we issued 9,183,185 shares of our common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Investors, which include the general partners/managers of the Legacy Funds. In addition,

86

as part of the Formation Transactions, we acquired 100% of the equity interests of Trinity Capital Holdings for shares of our common stock and cash. Members of our management, including Steven L. Brown, Kyle Brown, Gerald Harder and Ron Kundich, owned 100% of the equity interests in Trinity Capital Holdings and controlling interests in the general partners/managers of the Legacy Funds.

~~As a result of the Formation Transactions, Messrs. S. Brown, K. Brown, Harder and Kundich collectively received (i) 533,332~~hold shares of the Company’s common stock valued at approximately $8.0 million and approximately $2.0 million in cash in exchange for their equity interests in Trinity Capital Holdings, and (ii) 377,441 shares of the Company’s common stock valued at approximately $5.7 million for their limited partner and general partner interests in the Legacy Funds.stock.

We have entered into indemnification agreements with our directors and executive officers. The indemnification agreements are intended to provide our directors and executive officers with the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that we shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Refer to “Item 1. Consolidated Financial Statements – Note 12 – Related Party Transactions” included in the notes to our consolidated financial statements appearing elsewhere in this report for additional information.

Recent Developments

~~Departure~~On July 22, 2022, the Company issued $50.0 million in aggregate principal amount of ~~Certain Officers~~

the 2025 Notes in an additional issuance of such 2025 Notes. On ~~August 2, 2021, Scott Harvey,~~July 27, 2022, the ~~Company’s Chief Legal Officer and Chief Compliance Officer, resigned~~underwriters exercised their option, in full, to purchase from ~~such positions and from his employment~~the Company an additional $7.5 million in aggregate principal amount of the 2025 Notes solely to cover over-allotments in accordance with the ~~Company in~~Underwriting Agreement. The 2025 Notes issued pursuant to this offering are treated as a single series with the existing 2025 Notes under the 2025 Notes Indenture (the “Existing 2025 Notes”) and have the same terms as the Existing 2025 Notes (other than issue date and issue price). The 2025 Notes have the same CUSIP number and are fungible and rank equally. Following this additional issuance of the 2025 Notes, the outstanding aggregate principal amount of the 2025 Notes is $182.5 million.

In connection with ~~his retirement. The Board accepted Mr. Harvey’s resignation, and there was no disagreement between Mr. Harvey and~~ the ~~Company on any matter relating to the Company’s operations, policies or practices. Also on August 2, 2021, the Board appointed Sarah Stanton as the Chief Compliance Officer~~additional issuance of the ~~Company. Ms. Stanton also serves, and will continue to serve, as~~2025 Notes, the ~~General Counsel and Secretary~~2025 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINL” on July 29, 2022.

96

Table of ~~the Company.~~Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the COVID-19 pandemic has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.
Valuation Risk
Our investments may not have a readily available market price, and we value these investments at fair value as determined in good faith by the Board of Directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period, including as a result of the impact of the COVID-19 pandemic on the economy and financial and capital markets. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.

87

Interest Rate Risk

Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the KeyBank Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates, including as a result of inflation, will not have a material adverse effect on our net investment income.

As of June 30, ~~2021,~~2022, approximately ~~49.3%~~64.4% of our debt investments based on outstanding principal balance represented floating-rate investments based on Prime or LIBOR, and approximately ~~50.7%~~35.6% of our debt investments based on outstanding principal balance represented ~~fixed-rate~~fixed rate investments. In addition, borrowings under the KeyBank Credit Facility are subject to floating interest rates based on ~~LIBOR,~~SOFR, generally bearing interest at a rate of the ~~three-month LIBOR~~Term SOFR Reference Rate plus ~~3.25%~~2.85%. subject to the number of eligible debt investments in the collateral pool

Based on our Consolidated Statements of Operations as of June 30, ~~2021,~~2022, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime rate on our debt investments (considering interest rate floors for floating rate instruments) and the hypothetical base rate changes in the ~~three-month LIBOR~~SOFR on our KeyBank Credit Facility, ~~and~~assuming that there are no changes in our investment and borrowing structure (in thousands):

Interest

Interest

Net

Income

Expense

Income/(Loss)
Up 300 basis points

$
18,990

$
6,600

$
12,390
Up 200 basis points

$
12,643

$
4,400

$
8,243
Up 100 basis points

$
6,295

$
2,200

$
4,095
Down 100 basis points

$
(523)

$
(1,100)

$
577
Down 200 basis points

$
(7,260)

$
(1,100)

$
(6,160)
Down 300 basis points

$
(7,260)

$
(1,100)

$
(6,160)

Interest

Interest

Net

Income

Expense

Income/(Loss)
Up 300 basis points

$
6,800

$
2,100

$
4,700
Up 200 basis points

$
4,276

$
1,400

$
2,876
Up 100 basis points

$
1,989

$
700

$
1,289
Down 100 basis points

$
—

$
(83)

$
83
Down 200 basis points

$
—

$
(83)

$
83
Down 300 basis points

$
—

$
(83)

$
83
97

Currency Risk

In addition, any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of June 30, ~~2021,~~2022, we had ~~two~~five foreign domiciled portfolio companies. Our exposure to currency risk related to the debt investments is minimal as payments from such portfolio companies are received in U.S. dollars. ~~Our equity investments in such portfolio companies are also settled using U.S. dollars.~~ No other investments at June 30, ~~2021~~2022 were subject to currency risk.

Hedging

We do not currently engage in any hedging activities. However, we may, in the future, hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.

Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
In accordance with Rules 13a-15(b) and 15d-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in

88

Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the ~~period~~three months ended June 30, ~~2021~~2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

8998

PART IIII: OTHER INFORMATION

Item 1. Legal Proceedings
We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of these legal or regulatory proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

Item 1A. Risk Factors
Investing in our securities involves a number of significant risks. In addition to the other information set forth in this quarterly report on Form 10-Q, including the risk factors set forth below, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” of Annual Report on Form ~~10 K~~10-K filed with the SEC on March ~~4, 2021,~~3, 2022, all of which could materially affect our business, financial condition and/or results of operations. Although the risks described below and in our other SEC filings referenced above represent the principal risks associated with an investment in us, they are not the only risks we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, might materially and adversely affect our business, financial condition and/or results of operations.
Other than as described below, during the six months ended June 30, ~~2021,~~2022, there have been no material changes to the risk factors discussed in our SEC filings referenced above.
~~We are exposed~~Existing stockholders may incur dilution if, in the future, we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.
The 1940 Act prohibits us from selling shares of our common stock at a price below the current net asset value per share of such stock, with certain exceptions. One such exception is prior stockholder approval of issuances below net asset value provided that our Board of Directors makes certain determinations. At our 2022 Annual Meeting of Stockholders held on June 8, 2022, our stockholders voted to ~~risks associated with changes~~allow us to issue common stock at a price below net asset value per share for the period ending on the earlier of the one-year anniversary of the date of our 2022 Annual Meeting of Stockholders and the date of our 2023 Annual Meeting of Stockholders, which is expected to be held in ~~interest rates.~~
~~Because we may borrow money to make investments,~~May or June 2023. The proposal approved by our stockholders at our 2022 Annual Meeting of Stockholders did not specify a maximum discount below net ~~investment income will depend, in part, upon the difference between the rate~~asset value at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. A reduction in the interest rates on new investments relativeare able to interest rates on current investments could have an adverse impact on our net investment income. However, an increase in interest rates could decrease the value of any investments we hold which earn fixed interest rates and also could increase our interest expense, thereby decreasing our net income. Also, an increase in interest rates available to investors could make an investment inissue our common stock, ~~less attractive if~~although the number of shares sold in one or more offerings may not exceed 25% of our outstanding common stock as of the date of stockholder approval of this proposal.
If we ~~are not able~~were to ~~increase our distribution rate, which could reduce the value~~issue or sell shares of our common ~~stock. Further, rising interest rates could~~stock at a price below our net asset value per share, such sales would result in an immediate dilution to our net asset value per share and pose a risk of dilution to our stockholders. In particular, stockholders who do not purchase additional shares at or below such discounted price in proportion to their current ownership will experience an immediate decrease in net asset value per share (as well as in the aggregate net asset value of their shares if they do not participate at all). These stockholders will also experience a disproportionately greater decrease in their participation in our earnings and assets and their voting power than the increase we experience in our assets, potential earning power and voting interests from such issuance or sale. In addition, such issuances or sales may adversely affect the price at which our ~~performance if such increases cause our borrowing costs to rise at a rate in excess~~common stock trades.
Because the number of shares of common stock that could be so issued and the ~~rate that our investments yield.~~
~~In periods~~timing of rising interest rates, to the extent we borrow money subject to a floating interest rate, our cost of funds would increase, which could reduce our net investment income. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum interest rates (such as a LIBOR floor), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase our interest expense, even though our interest income from investmentsany issuance is not ~~increasing in a corresponding manner as a result of such minimum interest rates.~~currently known, the actual dilutive effect cannot be predicted.
If general interest rates rise, there is a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

9099

On July 27, 2017, the United Kingdom’s Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. On November 30, 2020, ICE Benchmark Administration (“IBA”), the administrator of LIBOR, with the support of the United States Federal Reserve and the FCA, announced plans to consult on ceasing publication of USD LIBOR on December 31, 2021 for only the one week and two month USD LIBOR tenors, and on June 30, 2023 for all other USD LIBOR tenors, which the FCA subsequently confirmed on March 5, 2021. The United States Federal Reserve concurrently issued a statement advising banks to stop new USD LIBOR issuances by the end of 2021. Such announcements indicate that the continuation of LIBOR on the current basis cannot and will not be guaranteed after 2021. It appears highly likely that LIBOR will be discontinued or modified by 2021.

The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions (the “ARRC”), is considering replacing U.S. dollar LIBOR with a new index calculated by short term repurchase agreements, backed by Treasury securities called the Secured Overnight Financing Rate (“SOFR”). The first publication of SOFR was released in April 2018. On July 29, 2021, the ARRC formally recommended SOFR as its preferred alternative replacement rate for LIBOR. Whether or not SOFR attains market traction as a LIBOR replacement remains a question and the future of LIBOR at this time is uncertain. Although SOFR appears to be the preferred replacement rate for U.S. dollar LIBOR, at this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or any other reforms to LIBOR that may be enacted. The elimination of LIBOR or any other changes or reforms to the determination or supervision of LIBOR could have an adverse impact on the market for or value of any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us or on our overall financial condition or results of operations. In addition, if LIBOR ceases to exist, we may need to renegotiate credit agreements extending beyond 2021 with our portfolio companies that utilize LIBOR as a factor in determining the interest rate, in order to replace LIBOR with the new standard that is established, which may have an adverse effect on our overall financial condition or results of operations. Following the replacement of LIBOR, some or all of these credit agreements may bear interest a lower interest rate, which could have an adverse impact on our results of operations. Furthermore, under the Credit Facility with Credit Suisse, borrowings generally will bear interest at a rate of the three-month LIBOR plus 3.25%. If LIBOR ceases to exist, we will need to renegotiate certain terms of the Credit Facility. If we are unable to do so, amounts drawn under the Credit Facility may bear interest at a higher rate, which would increase the cost of our borrowings and, in turn, affect our results of operations.

~~We cannot predict how new tax legislation will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.~~

Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our investors of such qualification or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On ~~April 16, 2021,~~July 15, 2022, pursuant to its amended and restated distribution reinvestment plan, the Company issued ~~75,999~~49,840 shares of its common stock, at a price of ~~$14.92~~$14.28 per share, to stockholders of record as of ~~March 31, 2021~~June 30, 2022 that did not opt out of the Company’s amended and restated distribution reinvestment plan in order to satisfy the reinvestment portion of the Company’s distribution. This issuance was not subject to the registration requirements of the Securities Act.

91

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information
None.

92100

Item 6. Exhibits

The following exhibits are filed as part of this Quarterly Report on Form 10-Q or hereby incorporated by reference to exhibits previously filed with the SEC:


Exhibit Number		Description of Exhibits
3.1		Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
3.2		Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
~~4.1~~10.1		~~Amended and Restated Registration Rights~~Underwriting Agreement, dated ~~December 15, 2020 (Common Stock) (incorporated~~April 5, 2022, by ~~reference to Exhibit 10.1 to~~among Trinity Capital Inc., on the ~~Company's Current Report~~one hand, and Keefe, Bruyette & Woods, Inc., Wells Fargo Securities, LLC and UBS Investment Bank, on ~~Form 8-K filed December 16, 2020).~~
~~4.2~~		~~Registration Rights Agreement, dated January 16, 2020 (Notes) (incorporated by reference to Exhibit 4.2 to~~ the ~~Company’s Registration Statement~~other hand, as representatives of the several underwriters named on ~~Form 10 filed on January 16, 2020).~~
~~4.3~~		~~Registration Rights Agreement, dated December 11, 2020 (Convertible Notes)~~Schedule A thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on ~~December 14, 2020)~~April 7, 2022).
~~4.4~~10.2		~~Indenture,~~Second Amendment to Credit Agreement, dated as of ~~January 16, 2020,~~April 13, 2022, relating to the KeyBank Credit Facility, by and ~~between~~among Trinity Capital Inc. ~~and U.S. Bank~~, as servicer, TrinCap Funding, LLC, as borrower, KeyBank National Association, as ~~trustee (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).~~
~~4.5~~		~~First Supplemental Indenture, dated as of January 16, 2020, relating to the 7.00% Notes due 2025, by~~administrative agent and ~~between Trinity Capital Inc. and U.S. Bank~~syndication agent, Wells Fargo, National Association, as ~~trustee (incorporated by reference to Exhibit 4.4 to~~collateral custodian and paying agent, and the ~~Company’s Registration Statement on Form 10 filed on January 16, 2020).~~
~~4.6~~		~~Form of 7.00% Note due 2025 (included as part of and incorporated by reference to Exhibit 4.5 hereto)~~.
~~4.7~~		Second Supplemental Indenture, dated January 16, 2020, relating to the 6.00% Convertible Notes due 2025, between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on December 14, 2020).
~~4.8~~		~~Form of 6.00% Convertible Notes due 2025 (included as part of and incorporated by reference to Exhibit 4.7 hereto).~~
~~10.1~~		~~2019 Trinity Capital Inc. Long-Term Incentive Plan~~lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on ~~June 23, 2021)~~April 19, 2022).
~~10.2~~		~~Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on June 23, 2021).~~
31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Filed herewith

93101